Fecha;Edad;Talla;Peso;ISC;GEN;TFG;"CREA (MG/DL) "",""";TFG CALC;Medicamento 1;Medicamento 2;Medicamento 3;Medicamento 4;Medicamento 5;Medicamento 6;Medicamento 7;Medicamento 8;Medicamento 9;Medicamento 10;Medicamento 11;Medicamento 12;Medicamento 13;Medicamento 14;#;LLAMADOS PROTOCOLO;NOMBRE PROTOCOLO;Palabras en justi clinica;DX;CICLO
26/09/2024;69;1,58;66;1,74;M;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,125,3,80,,,80,0,139,2,90%,null,,1,8,15,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal;#N/D;Tumor maligno de la vejiga urinaria, parte no especificada;1
26/09/2024;62;1,74;80;1,99;M;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,258,7,130,,,130,0,258,7,100%,ADMINISTRAR 260 MG IV DIA 1,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,Oxali,PLATINO;Tumor maligno del recto;1
26/09/2024;69;1,66;64;1,73;M;Sin Cr;;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,224,9,130,,,130,0,224,9,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;INF,XELOX;Tumor maligno del colon, parte no especificada;3
26/09/2024;66;1,55;55,6;1,57;F;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,173,5,130,FALSE,,130,0,204,1,85%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;#N/D;Tumor maligno del recto;3
26/09/2024;59;1,56;45;1,4;F;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,180,0,180,,,130,0,182,0,99%,Oxaliplatino (130 mg/m2). Dosis calculada 180 mg IV. Administrar el d√≠a 1 de cada ciclo.,,1,Frec Check;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,180,180,,,130,182,0,99%,Oxaliplatino (130 mg/m2). Dosis calculada 180 mg IV. Administrar el d√≠a 1 de cada ciclo.;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,180,180,,,130,0,182,0,99%,Oxaliplatino (130 mg/m2). Dosis calculada 180 mg IV. Administrar el d√≠a 1 de cada ciclo.;;;;;;;;;;;;3;OXALIplatino,OXALIplatino,OXALIplatino;CAPEOX;Capec,CAPEOX,INF,Oxali,PLATINO, SC,AJUSTE,AJUST,CREA,CREAT;Tumor maligno del recto;1
26/09/2024;77;1,61;49,5;1,49;M;Sin Cr;;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,150,0,150,TRUE,Dosis fija,130,0,150,0,100%,150 mg DOSIS FIJA,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;#N/D;Tumor maligno del estomago, parte no especificada;5
27/09/2024;37;1,62;71;1,82;F;Sin Cr;;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,255,6,4,,,3,6,255,6,100%,null,,1,21,Inconsistente, seg˙n proto: 1;Trastuzumab Emtansina 160mg Polv Iny,,255,6,3,6,,,4,255,6,100%,null;;;;;;;;;;;;;2;Trastuzumab_Emtansina,Trastuzumab_Emtansina;Emilia; SC,AJUSTE,AJUST;Tumor maligno de la mama, parte no especificada;5
27/09/2024;69;1,77;68;1,83;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,135,8,75,,,75,0,137,3,99%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;#N/D;Tumor maligno de la prostata;3
27/09/2024;60;1,53;53;1,53;F;Sin Cr;;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,924,0,600,,,600,0,918,0,101%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,92,4,60,,,60,91,8,101%,null;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC; AC , GC ,INF,40%,100%;Tumor maligno de la mama, parte no especificada;3
28/09/2024;70;1,58;57;1,6;F;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,208,0,130,,,130,0,208,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;CAPEOX,VIDE,XELOX,CREA,CREAT;Tumor maligno del colon, parte no especificada;2
28/09/2024;64;1,6;76;1,88;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,150,4,80,,,80,0,150,4,100%,null,,1,8,15,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal;INF,5%,75%,80%;Tumor maligno de la mama, parte no especificada;1
28/09/2024;41;1,55;60;1,64;F;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,123,0,75,,,75,0,123,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE, GC ,INF, RT ,TAXANO,20%;Tumor maligno de la mama, parte no especificada;2
28/09/2024;33;1,6;63;1,7;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,,Pertuzumab 420mg. Administrar d√≠a 1.,,1,Frec Check;Trastuzumab 440mg Polv Iny,,380,380,,,6,378,0,101%,Trastuzumab (6 mg/kg). Dosis calculada 380 mg/IV, Administrar d√≠a 1.;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;PERTU, SC,TrastU,CREA,CREAT;Tumor maligno de la mama, parte no especificada;3
28/09/2024;47;1,7;76;1,92;M;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,192,0,100,TRUE,,130,0,192,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,INF,Oxali,PLATINO, SC,XELOX,AJUSTE,AJUST,100%,CREA,CREAT;Tumor maligno del recto;3
30/09/2024;34;1,54;77,2;1,88;F;Sin Cr;;Sin Cr;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,150,4,80,,,80,0,150,4,100%,null,,1,8,15,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,150,4,80,,,80,150,4,100%,null;;;;;;;;;;;;;2;PACLItaxel,PACLItaxel;Paclitaxel semanal;#N/D;Tumor maligno de la mama, parte no especificada;1
30/09/2024;36;1,62;59;1,65;F;Sin Cr;;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,990,0,600,,,600,0,990,0,100%,null,,1,15,Inconsistente, seg˙n proto: 1;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,99,60,,,60,99,0,100%,null;;;;;;;;;;;;;2;Ciclofosfamida,DOXOrubicina;AC; AC ,INF, SC,60%;Tumor maligno de la mama, parte no especificada;1
30/09/2024;64;1,61;67,8;1,77;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,132,8,75,,,75,0,132,8,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE, RT , SC;Tumor maligno de la prostata;4
30/09/2024;59;1,52;59;1,62;F;Sin Cr;;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,179,0,130,,,130,0,210,6,85%,,,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,INF,Oxali,PLATINO, RT ,XELOX,AJUSTE,AJUST;Tumor maligno del recto;4
30/09/2024;66;1,53;88;2,01;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,Frec Check;Trastuzumab 440mg Polv Iny,,528,6,,,6,528,0,100%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;PERTU,TRAIN ,TrastU;Tumor maligno de la mama, parte no especificada;8
30/09/2024;67;1,5;51;1,49;F;Sin Cr;;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,894,0,600,,,600,0,894,0,100%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,89,4,60,,,60,89,4,100%,null;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC; AC ,CICLOF,DOXO,DOXO,INF, SC,20%,100%;Tumor maligno de la mama, parte no especificada;4
30/09/2024;62;1,51;69;1,76;F;Sin Cr;;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,978,0,600,,,600,0,1056,0,93%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,97,8,60,,,60,105,6,93%,null;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC; AC ,40%,100%;Tumor maligno de la mama, parte no especificada;2
30/09/2024;74;1,59;53;1,54;F;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,200,2,130,,,130,0,200,2,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,EMA CO,INF,Oxali,PLATINO,XELOX,100%,CREA,CREAT;Tumor maligno del recto;4
30/09/2024;58;1,51;64;1,69;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,Frec Check;Trastuzumab 440mg Polv Iny,,354,6,,,6,384,0,92%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;Capec,cleopatra,Cleopatra,INF,PERTU,TrastU,VIDE,80%,90%;Tumor maligno de la mama, parte no especificada;3
30/09/2024;61;1,54;67;1,74;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;Trastuzumab 440mg Polv Iny,,402,6,,,6,402,0,100%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV; CAP ;Tumor maligno de la mama, parte no especificada;8
30/09/2024;49;1,53;55;1,56;F;Sin Cr;;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,198,0,4,,,3,6,198,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;INF,TrastU,CREA,CREAT;Tumor maligno de la mama, parte no especificada;1
30/09/2024;44;1,58;54;1,56;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,106,3,125,,,80,0,124,8,85%,ajuste del  15 %,,1,8,15,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal;PACLI,semanal,TAXANO,AJUST,5%,15%;Tumor maligno de la mama, parte no especificada;1
30/09/2024;40;1,58;69;1,78;F;Sin Cr;;Sin Cr;Trastuzumab Emtansina 160mg Polv Iny,,248,4,4,,,3,6,248,4,100%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;cleopatra,Cleopatra,DOCE,INF,60%;Tumor maligno de la mama, parte no especificada;2
30/09/2024;63;1,65;90;2,08;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,157,5,75,,,75,0,156,0,101%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE,INF;Tumor maligno de la prostata;4
1/10/2024;21;1,75;59;1,69;M;Sin Cr;;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,219,7,130,,,130,0,219,7,100%,,,,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,CAPEOX,Oxali,PLATINO;Tumor maligno del recto;1
1/10/2024;27;1,58;51,7;1,52;F;Sin Cr;;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,800,0,800,FALSE,,600,0,912,0,88%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,80,80,,,60,91,2,88%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;;;;;;;;;;;;3;Ciclofosfamida,DOXOrubicina,PEMBROlizumab;AC; AC ,AC IO,CICLOF,DOXO,DOXO,PEMBRO, SC,AJUST,10%;Tumor maligno de la mama, parte no especificada;1
1/10/2024;74;1,7;87;2,07;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,120,0,120,FALSE,60,00,75,0,124,2,97%,Dosis calculada 120 mg IV. Administrar en infusi√≥n de 60 minutos el d√≠a 1.,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT; AC ,DOCE,INF,TAXANO,AJUST;Tumor maligno de la prostata;9
1/10/2024;74;1,7;68;1,81;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,133,5,75,,,75,0,135,8,98%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE,INF,5%;Tumor maligno de la prostata;2
1/10/2024;68;1,69;62;1,71;M;Sin Cr;;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,222,3,130,,,130,0,222,3,100%,,,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,INF,Oxali,PLATINO;Tumor maligno del recto;1
1/10/2024;40;1,52;81;1,92;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,130,6,80,,,80,0,153,6,85%,null,,1,8,15,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal;CICLOF,DOXO,DOXO,PACLI, SC,TAXANO,AJUST,5%,15%;Tumor maligno de la mama, parte no especificada;1
1/10/2024;68;1,55;55;1,56;F;Sin Cr;;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,198,0,4,,,3,6,198,0,100%,Administrar 198 mg iv dia 1,,1,Frec Check;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;#N/D;Tumor maligno de la mama, parte no especificada;5
1/10/2024;56;1,5;58,6;1,6;F;Sin Cr;;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,96,0,60,,,60,0,96,0,100%,null,,1,Frec Check;Ciclofosfamida 500mg  Polv Iny,,960,600,,,600,960,0,100%,null;;;;;;;;;;;;;2;DOXOrubicina,CICLOfosfamida;AC;#N/D;Tumor maligno de la mama, parte no especificada;1
1/10/2024;51;1,56;56;1,58;F;Sin Cr;;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,201,6,4,,,3,6,201,6,100%,Administrar 198 mg iv dia 1,,1,Frec Check;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;#N/D;Tumor maligno de la mama, parte no especificada;4
1/10/2024;51;1,54;76;1,86;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,Frec Check;Trastuzumab 440mg Polv Iny,,456,6,,,6,456,0,100%,APLICAR 440 MG DIA 1;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;PERTU,TrastU;Tumor maligno de la mama, parte no especificada;7
1/10/2024;46;1,54;60;1,64;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,131,2,80,,,80,0,131,2,100%,null,,1,8,15,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal; AC ,PACLI,TAXANO,100%;Tumor maligno de la mama, parte no especificada;1
1/10/2024;56;1,68;73;1,87;M;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,243,1,130,,,130,0,243,1,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;TC ,5%;Tumor maligno del colon, parte no especificada;1
2/10/2024;40;1,81;83;2,05;M;Sin Cr;;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,266,5,130,,,130,0,266,5,100%,,,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,INF,Oxali,PLATINO, SC,XELOX,100%;Tumor maligno del recto;3
2/10/2024;38;1,63;61,8;1,69;F;Sin Cr;;Sin Cr;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,135,2,80,,,80,0,135,2,100%,null,,1,8,15,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,135,2,80,,,80,135,2,100%,null;;;;;;;;;;;;;2;PACLItaxel,PACLItaxel;Paclitaxel semanal;PACLI, SC,CREA,CREAT;Tumor maligno de la mama, parte no especificada;1
2/10/2024;54;1,48;55;1,54;F;Sin Cr;;Sin Cr;Trastuzumab 440mg Polv Iny,,330,0,6,,,6,0,330,0,100%,null,,1,Frec Check;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,TRUE,,840,420,0,100%,null;Trastuzumab 440mg Polv Iny,,330,6,,,6,0,330,0,100%,null;Trastuzumab 440mg Polv Iny,,330,6,,,6,330,0,100%,null;Trastuzumab 440mg Polv Iny,,330,6,,,6,330,0,100%,null;;;;;;;;;;5;TRAStuzumab,PERTUzumab,TRAStuzumab,TRAStuzumab,TRAStuzumab;cleopatra trastuzu IV;PERTU,TrastU,80%;Tumor maligno de la mama, parte no especificada;76
2/10/2024;57;1,55;59;1,63;F;Sin Cr;;Sin Cr;Trastuzumab 440mg Polv Iny,,472,0,8,TRUE,,6,0,472,0,100%,null,,1,Frec Check;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,840,840,,,840,840,0,100%,DOSIS CARGA;;;;;;;;;;;;;2;TRAStuzumab,PERTUzumab;cleopatra trastuzu IV; CAP ,INF,PERTU,TAXANO,TrastU,100%;Tumor maligno de la mama, parte no especificada;1
2/10/2024;83;1,45;49;1,44;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,Frec Check;Trastuzumab 440mg Polv Iny,,300,6,,,6,294,0,102%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;#N/D;Tumor maligno de la mama, parte no especificada;5
2/10/2024;77;1,55;60;1,64;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;Trastuzumab 440mg Polv Iny,,337,8,6,,,6,360,0,94%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;PERTU, SC,TrastU;Tumor maligno de la mama, parte no especificada;18
2/10/2024;67;1,62;54;1,57;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,FALSE,420,0,420,TRUE,,840,0,420,0,100%,PERTUZUMAB 420 MG IV D√çA 1 Y 21,,1,21,Inconsistente, seg˙n proto: 1;Trastuzumab 440mg Polv Iny,,324,6,,,6,324,0,100%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;DOCE,INF,PERTU,TrastU,VIDE,30%;Tumor maligno de la mama, parte no especificada;1
2/10/2024;80;1,46;61;1,63;F;Sin Cr;;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,83,1,60,,,60,0,97,8,85%,null,,1,Frec Check;Ciclofosfamida 500mg  Polv Iny,,831,3,600,,,600,978,0,85%,null;;;;;;;;;;;;;2;DOXOrubicina,CICLOfosfamida;AC;#N/D;Tumor maligno de la mama, parte no especificada;1
2/10/2024;65;1,58;96;2,13;F;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,260,0,260,,,130,0,276,9,94%,130 mg/m2 IV dia 1, calculado con SC 2,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;#N/D;Tumor maligno del recto;4
2/10/2024;56;1,5;78;1,87;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,149,6,80,,,80,0,149,6,100%,null,,1,8,15,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal; AC ,INF,semanal,TAXANO,80%,100%;Tumor maligno de la mama, parte no especificada;4
2/10/2024;49;1,53;55;1,56;F;Sin Cr;;Sin Cr;Trastuzumab 440mg Polv Iny,,330,0,6,,,6,0,330,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,TRUE,,840,420,0,100%,null;;;;;;;;;;;;;2;TRAStuzumab,PERTUzumab;cleopatra trastuzu IV;#N/D;Tumor maligno de la mama, parte no especificada;1
2/10/2024;48;1,59;65;1,73;F;Sin Cr;;Sin Cr;Trastuzumab Emtansina 160mg Polv Iny,,234,0,3,,,3,6,234,0,100%,null,,1,Frec Check;Trastuzumab Emtansina 100mg Polv iny,,234,3,,,4,234,0,100%,null;;;;;;,,,,,,,,;;;;;;;2;Trastuzumab_Emtansina,Trastuzumab_Emtansina;Emilia; AC , CAP , GC ,PACLI, RT ,TrastU,40%,100%;Tumor maligno de la mama, parte no especificada;1
2/10/2024;43;1,6;64;1,72;F;Sin Cr;;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,192,0,3,TRUE,,3,6,192,0,100%,null,,1,21,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;VIDE,AJUSTE,AJUST,100%;Tumor maligno de la mama, parte no especificada;1
2/10/2024;40;1,53;65;1,71;F;Sin Cr;;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,1.000,0,1.000,,,600,0,1026,0,97%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,100,100,,,60,102,6,97%,null;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC; AC ,CICLOF,DOXO,DOXO, SC;Tumor maligno de la mama, parte no especificada;1
2/10/2024;63;1,7;69;1,82;M;Sin Cr;;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,241,8,130,,,130,0,236,6,102%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,XELOX;Tumor maligno del recto;3
3/10/2024;67;1,7;57;1,64;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,123,0,75,,,75,0,123,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE,INF, SC;Tumor maligno de la prostata;1
3/10/2024;62;1,64;84;2;F;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,260,0,130,,,130,0,260,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,CONCURRENTE,INF,XELOX;Tumor maligno del recto;1
3/10/2024;59;1,41;40;1,27;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,Frec Check;Trastuzumab 440mg Polv Iny,,240,6,,,6,240,0,100%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;PERTU,TrastU,5%,60%;Tumor maligno de la mama, parte no especificada;27
3/10/2024;77;1,52;77,9;1,88;F;Sin Cr;;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,902,4,600,,,600,0,1128,0,80%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,90,24,60,,,60,112,8,80%,null;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC;#N/D;Tumor maligno de la mama, parte no especificada;1
3/10/2024;69;1,5;62;1,65;F;Sin Cr;;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,1.000,0,1.000,,,600,0,990,0,101%,,.,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,100,100,,,60,99,0,101%,,;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC; AC ,INF,PACLI,semanal,VIDE,5%,25%,90%,100%;Tumor maligno de la mama, parte no especificada;4
3/10/2024;83;1,65;67;1,78;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,80,1,50,TRUE,,75,0,89,0,90%,null,,1,15,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE, SC,CREA,CREAT,Suspend;Tumor maligno de la prostata;1
3/10/2024;60;1,6;64;1,72;F;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,223,6,130,,,130,0,223,6,100%,null,,1,Frec Check;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,223,6,130,,,130,223,6,100%,null;;;;;;;;;;;;;2;OXALIplatino,OXALIplatino;CAPEOX;CAPEOX,INF;Tumor maligno del colon, parte no especificada;1
3/10/2024;58;1,56;69,6;1,78;F;Sin Cr;;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,1.068,0,600,,,600,0,1068,0,100%,Aplicar 100 mg IV D1,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,106,8,60,,,60,106,8,100%,Aplicar 100 mg IV D1;;;;;;;;;;;;;2;Ciclofosfamida,DOXOrubicina;AC; AC ,CICLOF,DOXO,DOXO,INF, SC,TAXANO,CREA,CREAT;Tumor maligno de la mama, parte no especificada;1
3/10/2024;55;1,53;47;1,43;F;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,TRUE,150,0,150,,,130,0,185,9,81%,Oxaliplatino (130 mg/m2). Dosis calculada 150 mg IV. Administrar el d√≠a 1 de cada ciclo.,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,INF,Oxali,PLATINO, SC,VIDE,XELOX,CREA,CREAT;Tumor maligno del colon, parte no especificada;1
3/10/2024;43;1,58;68;1,77;F;Sin Cr;;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,106,2,60,,,60,0,106,2,100%,,,,1,Frec Check;Ciclofosfamida 500mg  Polv Iny,,1062,600,,,600,1062,0,100%,,;;;;;;;;;;;;;2;DOXOrubicina,CICLOfosfamida;AC; AC ,INF,PACLI,10%,100%;Tumor maligno de la mama, parte no especificada;1
4/10/2024;69;1,61;70;1,8;M;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,234,0,130,,,130,0,234,0,100%,null,,1,Frec Check;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,234,130,,,130,234,0,100%,null;;;;;;;;;;;;;2;OXALIplatino,OXALIplatino;CAPEOX;Capec,INF,Oxali,PLATINO, SC,XELOX;Tumor maligno del recto;2
4/10/2024;50;1,59;65;1,73;F;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,224,9,130,,,130,0,224,9,100%,null,,1,Frec Check;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,224,9,130,,,130,224,9,100%,null;;;;;;;;;;;;;2;OXALIplatino,OXALIplatino;CAPEOX;CAPEOX;Tumor maligno del recto;3
4/10/2024;48;1,61;89;2,06;F;Sin Cr;;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,320,4,4,,,3,6,320,4,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;#N/D;Tumor maligno de la mama, parte no especificada;1
4/10/2024;41;1,58;51;1,51;F;Sin Cr;;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,900,0,900,,,600,0,906,0,99%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,90,90,,,60,90,6,99%,null;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC;CICLOF,DOXO,DOXO, SC;Tumor maligno de la mama, parte no especificada;3
4/10/2024;66;1,78;86;2,08;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,153,0,75,,,75,0,156,0,98%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE;Tumor maligno de la prostata;6
4/10/2024;57;1,64;63;1,71;F;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,222,3,130,,,130,0,222,3,100%,null,,1,Frec Check;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,222,3,130,,,130,222,3,100%,null;;;;;;;;;;;;;2;OXALIplatino,OXALIplatino;CAPEOX;Capec,Oxali,PLATINO;Tumor maligno del ciego;5
5/10/2024;57;1,62;56,4;1,61;F;Sin Cr;;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,200,0,200,,,3,6,203,0,99%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;CARBO,DOCE,INF,MAYO ,PERTU,PLATINO,TrastU,60%;Tumor maligno de la mama, parte no especificada;1
6/10/2024;50;1,57;65;1,72;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;Trastuzumab 440mg Polv Iny,,390,6,,,6,390,0,100%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;CARBO,PACLI,PERTU,PLATINO, RT ,TrastU,20%;Tumor maligno de la mama, parte no especificada;10
7/10/2024;37;1,55;55;1,56;F;Sin Cr;;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,200,0,0,,,130,0,202,8,99%,null,,null,Revise recomd, seg˙n proto: 1;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,Oxali,PLATINO,AJUSTE,AJUST,5%,15%;Tumor maligno del colon, parte no especificada;null
7/10/2024;63;1,65;64;1,73;M;Sin Cr;;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,173,0,100,,,130,0,224,9,77%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,INF,Oxali,PLATINO,XELOX,AJUSTE,AJUST;Tumor maligno del recto;4
7/10/2024;70;1,66;59;1,66;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,124,5,75,,,75,0,124,5,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE, RT ;Tumor maligno de la prostata;3
7/10/2024;69;1,66;64;1,73;M;Sin Cr;;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,224,9,130,,,130,0,224,9,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;INF,XELOX;Tumor maligno del colon, parte no especificada;4
7/10/2024;53;1,51;75;1,84;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,Frec Check;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,840,0,840,0,50%,null;Trastuzumab 440mg Polv Iny,,450,6,,,6,0,450,0,100%,null;Trastuzumab 440mg Polv Iny,,450,6,,,6,0,450,0,100%,null;Trastuzumab 440mg Polv Iny,,450,6,,,6,0,450,0,100%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,840,0,840,0,50%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,840,0,840,0,50%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,840,0,840,0,50%;;;;;;;8;PERTUzumab,PERTUzumab,TRAStuzumab,TRAStuzumab,TRAStuzumab,PERTUzumab,PERTUzumab,PERTUzumab;cleopatra trastuzu IV;PERTU, RT ,TrastU,50%;Tumor maligno de la mama, parte no especificada;6
7/10/2024;55;1,53;62;1,66;F;Sin Cr;;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,223,2,4,,,3,6,223,2,100%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;TrastU,AJUSTE,AJUST,80%;Tumor maligno de la mama, parte no especificada;11
7/10/2024;47;1,63;65;1,74;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,140,0,140,,,80,0,139,2,101%,null,,1,8,15,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal;INF,PACLI;Tumor maligno de la mama, parte no especificada;2
7/10/2024;45;1,65;60;1,67;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,,,,1,22,Inconsistente, seg˙n proto: 1;Trastuzumab 440mg Polv Iny,,360,360,,,6,0,360,0,100%,Administrar 360 mg iv dia 1 Y 22;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;#N/D;Tumor maligno de la mama, parte no especificada;16
7/10/2024;41;1,55;54;1,55;F;Sin Cr;;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,190,8,4,,,3,6,194,4,98%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;#N/D;Tumor maligno de la mama, parte no especificada;12
7/10/2024;39;1,58;66;1,74;F;Sin Cr;;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,100,0,100,,,3,6,237,6,42%,null,,1,Frec Check;Trastuzumab Emtansina 160mg Polv Iny,,137,137,,,3,6,237,6,58%,null;;;;;;;;;;;;;2;Trastuzumab_Emtansina,Trastuzumab_Emtansina;Emilia;#N/D;Tumor maligno de la mama, parte no especificada;6
8/10/2024;36;1,62;62;1,69;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1,1,PERTUzumab,ONCM11,,;Trastuzumab 440mg Polv Iny,,378,6,,,6,0,372,0,102%,null,,1,22,Inconsistente, seg˙n proto: 1,1,TRAStuzumab,2854,,;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;PERTU,TrastU;Tumor maligno de la mama, parte no especificada;11
8/10/2024;40;1,8;75;1,94;M;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,252,2,130,,,130,0,252,2,100%,null,,1,Frec Check,1,OXALIplatino,4172,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,252,2,130,,,130,0,252,2,100%,null,,1,Frec Check,1,OXALIplatino,4172,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,252,2,130,,,130,0,252,2,100%,null,,1,Frec Check,1,OXALIplatino,4172,,;;;;;;;;;;;;3;OXALIplatino,OXALIplatino,OXALIplatino;CAPEOX;CAPOX;Tumor maligno del colon, parte no especificada;1
8/10/2024;79;1,66;64;1,73;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,97,3,75,,,75,0,129,8,75%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;#N/D;Tumor maligno de la prostata;6
8/10/2024;76;1,75;65,5;1,78;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,131,3,75,,,75,0,133,5,98%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;#N/D;Tumor maligno de la prostata;1
8/10/2024;75;1,65;81;1,97;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,144,0,75,,,75,0,147,8,97%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;#N/D;Tumor maligno de la prostata;3
8/10/2024;54;1,7;59;1,67;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,100,2,75,,,75,0,125,3,80%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE,INF,AJUSTE,AJUST,80%,100%,CREA,CREAT;Tumor maligno de la prostata;2
8/10/2024;56;1,47;60,7;1,62;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,.,,1,22,Inconsistente, seg˙n proto: 1,1,PERTUzumab,ONCM11,,;Trastuzumab 440mg Polv Iny,,360,6,,,6,0,364,2,99%,.,,1,22,Inconsistente, seg˙n proto: 1,1,TRAStuzumab,2854,,;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV; AC ,INF,PERTU,TC ,TrastU,50%;Tumor maligno de la mama, parte no especificada;6
8/10/2024;63;1,56;56;1,58;F;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,205,4,130,,,130,0,205,4,100%,null,,1,Frec Check,1,OXALIplatino,4172,,;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;#N/D;Tumor maligno del colon, parte no especificada;1
8/10/2024;61;1,45;55;1,53;F;Sin Cr;;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,826,2,600,,,600,0,918,0,90%,null,,1,Frec Check,1,Ciclofosfamida,1171,,;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,82,62,60,,,60,0,91,8,90%,null,,1,Frec Check,1,DOXOrubicina,4838,,;;;;;;;;;;;;;2;Ciclofosfamida,DOXOrubicina;AC; AC ,INF,40%,100%;Tumor maligno de la mama, parte no especificada;4
8/10/2024;44;1,44;49;1,44;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,,,,1,22,Inconsistente, seg˙n proto: 1,1,PERTUzumab,ONCM11,,;Trastuzumab 440mg Polv Iny,TRUE,6,6,FALSE,,6,0,294,0,2%,,,,1,22,Inconsistente, seg˙n proto: 1,1,TRAStuzumab,2854,,;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV; AC , CAP ,CARBO,INF,PACLI,PERTU,TrastU,90%;Tumor maligno de la mama, parte no especificada;9
8/10/2024;51;1,4;70;1,73;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,138,4,80,,,80,0,138,4,100%,null,,1,8,15,Frec Check,1,8,15,PACLItaxel,2385,,;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal;PACLI,semanal,TAXANO,AJUSTE,AJUST,70%,80%,100%;Tumor maligno de la mama, parte no especificada;2
8/10/2024;49;1,56;44;1,38;F;Sin Cr;;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,828,0,600,,,600,0,828,0,100%,null,,1,Frec Check,1,Ciclofosfamida,1171,,;Ciclofosfamida 500mg  Polv Iny,,828,600,,,600,0,828,0,100%,null,,1,Frec Check,1,CICLOfosfamida,852,,;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,TRUE,88,2,,,200,0,200,0,44%,null,,1,Frec Check,1,PEMBROlizumab,ONCM74,,;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,82,8,60,,,60,0,82,8,100%,null,,1,Frec Check,1,DOXOrubicina,4838,,;;;;;;;;;;;4;Ciclofosfamida,CICLOfosfamida,PEMBROlizumab,DOXOrubicina;AC; AC ,PEMBRO,80%,100%;Tumor maligno de la mama, parte no especificada;3
8/10/2024;43;1,75;70;1,85;M;Sin Cr;;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,244,4,130,,,130,0,240,5,102%,null,,1,Frec Check,1,OXALIplatino,258,,;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;CAPEOX,INF;Tumor maligno del estomago, parte no especificada;6
8/10/2024;59;1,66;78;1,93;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,144,8,75,,,75,0,144,8,100%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE,INF,TCH ;Tumor maligno de la prostata;1
9/10/2024;28;1,52;43;1,36;F;Sin Cr;;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,822,0,600,,,600,0,816,0,101%,null,,1,Frec Check,1,Ciclofosfamida,1171,,;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,82,2,60,,,60,0,81,6,101%,null,,1,Frec Check,1,DOXOrubicina,4838,,;;;;;;;;;;;;;2;Ciclofosfamida,DOXOrubicina;AC; AC ,INF,semanal,TAXANO,20%,100%;Tumor maligno de la mama, parte no especificada;4
9/10/2024;77;1,67;60,2;1,68;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,126,0,75,,,75,0,126,0,100%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;#N/D;Tumor maligno de la prostata;1
9/10/2024;73;1,6;57;1,61;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,120,8,75,,,75,0,120,8,100%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE, SC,CREA,CREAT;Tumor maligno de la prostata;4
9/10/2024;76;1,57;62;1,68;F;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,218,4,130,,,130,0,218,4,100%,null,,1,Frec Check,1,OXALIplatino,4172,,;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Beva,CAPEOX,INF;Tumor maligno del recto;1
9/10/2024;81;1,66;82;1,99;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,126,9,75,,,75,0,149,3,85%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE,TAXANO;Tumor maligno de la prostata;3
9/10/2024;58;1,71;70;1,84;M;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,239,2,130,,,130,0,239,2,100%,null,,1,Frec Check,1,OXALIplatino,4172,,;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;CAPEOX,MAYO ;Tumor maligno del colon, parte no especificada;5
9/10/2024;85;1,62;58;1,63;M;Sin Cr;;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,169,5,130,,,130,0,211,9,80%,null,,1,Frec Check,1,OXALIplatino,258,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,169,52,130,,,130,0,211,9,80%,null,,1,Frec Check,1,OXALIplatino,4172,,;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,169,52,130,,,130,0,211,9,80%,null,,1,Frec Check,1,OXALIplatino,258,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,169,52,130,,,130,0,211,9,80%,null,,1,Frec Check,1,OXALIplatino,4172,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,169,52,130,,,130,0,211,9,80%,null,,1,Frec Check,1,OXALIplatino,4172,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,169,52,130,,,130,0,211,9,80%,null,,1,Frec Check,1,OXALIplatino,4172,,,;;;;;;;;;6;OXALIplatino,OXALIplatino,OXALIplatino,OXALIplatino,OXALIplatino,OXALIplatino;CAPEOX;#N/D;Tumor maligno de la prostata;1
9/10/2024;38;1,56;83;1,96;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1,1,PERTUzumab,ONCM11,,;Trastuzumab 440mg Polv Iny,,498,6,,,6,0,498,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1,1,TRAStuzumab,2854,,;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;#N/D;Tumor maligno de la mama, parte no especificada;8
9/10/2024;77;1,48;44;1,36;F;Sin Cr;;Sin Cr;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,108,8,80,,,80,0,108,8,100%,null,,1,8,15,Frec Check,1,8,15,PACLItaxel,1456,,;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal;DOXO,DOXO,INF,PACLI,semanal,TAXANO,20%,100%;Tumor maligno de la mama, parte no especificada;2
9/10/2024;62;1,69;71;1,85;F;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,131,3,75,,,75,0,138,8,95%,,,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;Capec,CARBO,DOCE,INF,monoagente,PLATINO,70%;Tumor maligno de la mama, parte no especificada;1
9/10/2024;58;1,55;56;1,58;F;Sin Cr;;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,93,6,60,,,60,0,94,8,99%,null,,1,Frec Check,1,DOXOrubicina,4838,,;Ciclofosfamida 1gr (1000mg) Polv Iny,,936,600,,,600,0,948,0,99%,null,,1,Frec Check,1,Ciclofosfamida,1171,,;Ciclofosfamida 1gr (1000mg) Polv Iny,,936,600,,,600,0,948,0,99%,null,,1,Frec Check,1,Ciclofosfamida,1171,,;Ciclofosfamida 1gr (1000mg) Polv Iny,,936,600,,,600,0,948,0,99%,null,,1,Frec Check,1,Ciclofosfamida,1171,,;;;;;;;;;;;4;DOXOrubicina,Ciclofosfamida,Ciclofosfamida,Ciclofosfamida;AC; AC ,40%;Tumor maligno de la mama, parte no especificada;3
9/10/2024;51;1,52;69;1,76;F;Sin Cr;;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,1.056,0,600,,,600,0,1056,0,100%,null,,1,Frec Check,1,CICLOfosfamida,852,,;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,105,6,60,,,60,0,105,6,100%,null,,1,Frec Check,1,DOXOrubicina,4838,,;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC; AC ,INF,70%,100%;Tumor maligno de la mama, parte no especificada;4
9/10/2024;68;1,64;64;1,73;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,129,8,75,,,75,0,129,8,100%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE, SC;Tumor maligno de la prostata;6
9/10/2024;44;1,73;54;1,6;M;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,187,2,130,,,130,0,208,0,90%,null,,1,Frec Check,1,OXALIplatino,4172,,;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;CAPEOX,INF,PLATINO,AJUST,10%;Tumor maligno del estomago, parte no especificada;5
26/09/2024;31;1,52;57;1,59;F;Sin Cr;;Sin Cr;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,129,6,80,,,80,0,127,2,102%,null,,1,8,15,22,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Revisar manualmente;PACLI,semanal,30%;Tumor maligno de la mama, parte no especificada;2
26/09/2024;27;1,61;79;1,93;F;Sin Cr;;Sin Cr;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,154,4,80,,,80,0,154,4,100%,null,,1,8,15,22,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;2
26/09/2024;38;1,55;52,5;1,52;F;81;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,318,2,3,TRUE,,6,0,318,1,100%,CARBOPLATINO ( AUC 3 )   MG IV D√çA 1 Y 8,,1,8,Inconsistente, seg˙n proto: 1;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,124,8,80,,,80,121,6,103%,null;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,124,8,80,,,80,0,121,6,103%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,TRUE,,840,420,0,100%,PERTUZUMAB 420 MG IV D√çA 1 DOSIS DE FIJA;Trastuzumab 440mg Polv Iny,,315,6,TRUE,,8,315,0,100%,TRASTUZUMAB  (6 MG/KG)   IV D√çA 1 DOSIS FIJA;;;;;;;;;;5;CARBOplatino,PACLItaxel,PACLItaxel,PERTUzumab,TRAStuzumab;Revisar manualmente;CARBO,INF,PACLI,PERTU,PLATINO,TRAIN ,TrastU,20%,80%,AUC;Tumor maligno de la mama, parte no especificada;2
26/09/2024;84;1,58;63;1,69;M;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,400,0,400,FALSE,,400,0,400,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno de la prostata;1
26/09/2024;67;1,81;82;2,04;M;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,367,2,180,,,180,0,367,2,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4896,2400,,,2.400,4896,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,816,400,,,400,0,816,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,816,400,,,400,816,0,100%,null;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,367,2,180,,,180,367,2,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4896,2400,,,2.400,4896,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,816,400,,,400,816,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,816,400,,,400,816,0,100%;Bevacizumab 100mg polv iny,,410,5,,,5,410,0,100%,null;;;;;;9;Irinotecan,Fluorouracilo,Fluorouracilo,Folinato,Irinotecan,Fluorouracilo,Fluorouracilo,Folinato,Bevacizumab;Revisar manualmente;CAPEOX,FOLFIRI,INF,MAYO ,VIDE;Tumor maligno del colon, parte no especificada;2
26/09/2024;69;1,65;70;1,82;M;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,510,0,8,,,7,5,525,0,97%,null,,1,Frec Check;;;;;;;;;;;;;;1;Bevacizumab;Revisar manualmente;#N/D;Tumor maligno del colon, parte no especificada;3
26/09/2024;68;1,59;62;1,68;M;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,310,0,5,,,5,0,310,0,100%,,,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4032,2400,,,2.400,4032,0,100%,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,672,400,,,400,0,672,0,100%,,;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,672,400,,,400,672,0,100%,,;;;;;;;;;;;4;Bevacizumab,Fluorouracilo,Fluorouracilo,Folinato;Revisar manualmente;Beva,Capec,FOLFOX,GRAMONT;Tumor maligno del colon, parte no especificada;5
26/09/2024;76;1,53;60;1,63;F;Sin Cr;;Sin Cr;Gemcitabina 1000mg/100mL (10mg/mL) Sol Iny,,930,0,930,FALSE,,1.000,0,1630,0,57%,GEMCITABINA (1000 MG/M2). DOSIS CALCULADA 930 MG. ADMINISTRAR PRIMERO LOS D√çAS 1, 8, 15.,,1,8,15,Frec Check;Nab-Paclitaxel 100mg Polv Iny,,115,115,,,125,203,8,56%,NAB-PACLITAXEL (125 MG/M2). DOSIS CALCULADA 115 MG. ADMINISTRAR PRIMERO LOS D√çAS 1, 8, 15.;;;;;;;;;;;;;2;GEMcitabina,Paclitaxel LIGADO a ALBUMINA;Revisar manualmente;#N/D;Tumor maligno de otras partes especificadas del pancreas;4
26/09/2024;56;1,5;54;1,53;F;Sin Cr;;Sin Cr;Ipilimumab 50mg/10mL(5mg/mL) Sol Iny,,162,0,3,,,3,0,162,0,100%,null,,1,Frec Check;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,54,1,,,1,54,0,100%,null;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,54,1,,,1,0,54,0,100%,null;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,480,480,TRUE,Dosis fija,1,480,0,100%,programar para el  28  de octubre  2024 - previa revision de laboratorios;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,480,480,,,1,54,0,889%,null;;;;;;;;;;5;IPILImumab,NIVOLUmab,NIVOLUmab,NIVOLUmab,NIVOLUmab;Revisar manualmente;#N/D;Melanoma maligno del miembro inferior, incluida la cadera;1
26/09/2024;71;1,57;65,5;1,73;M;Sin Cr;;Sin Cr;Cabazitaxel 60mg/1.5mL (4%) Sol Iny,,34,6,20,,,20,0,34,6,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;CABAzitaxel;Revisar manualmente;#N/D;Tumor maligno de la prostata;7
26/09/2024;71;1,6;52;1,53;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,260,0,5,,,5,0,260,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,2570,4,2400,,,2.400,3672,0,70%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,428,4,400,,,400,0,612,0,70%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,612,400,,,400,612,0,100%,null;;;;;;;;;;;4;Bevacizumab,Fluorouracilo,Fluorouracilo,Folinato;Revisar manualmente;Beva,FOLFOX,INF,PLATINO,AJUSTE,AJUST,30%,90%;Tumor maligno del colon, parte no especificada;7
26/09/2024;52;1,61;65;1,73;F;99,3;;Sin Cr;Bevacizumab 100mg polv iny,,960,0,15,,,15,0,975,0,98%,BV 15 Mg/peso,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,300,300,,,175,302,8,99%,Paclitaxel 175 mg/m2,;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,621,55,5,TRUE,,6,0,621,5,100%,,;;;;;;;;;;;;3;Bevacizumab,PACLItaxel,CARBOplatino;Revisar manualmente;#N/D;Tumor maligno del cuello del utero, sin otra especificacion;3
26/09/2024;57;1,53;56;1,57;F;Sin Cr;;Sin Cr;Eribulina 0.88/2mL (0.44mg/mL) Sol Iny,,3,0,0,,1,85,1,4,2,9,103%,ERIBULINA (1.23MG/M2). DOSIS CALCULADA 1.85 MG IV ADMINISTRAR D√çA 1 Y 8.,,null,Revise recomd, seg˙n proto: 1,8;;;;;;;;;;;;;;1;Eribulina;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;3
26/09/2024;50;1,52;54;1,54;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,270,0,5,,,5,0,270,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3696,2400,,,2.400,3696,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,616,400,,,400,0,616,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,130,9,85,,,85,130,9,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,616,400,,,400,616,0,100%,null;;;;;;;;;;5;Bevacizumab,Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;Revisar manualmente;Beva,FOLFOX,INF,MAYO ,TCH ,VIDE,CREA;Tumor maligno del recto;6
26/09/2024;74;1,65;88;2,06;M;Sin Cr;;Sin Cr;Cabazitaxel 60mg/1.5mL (4%) Sol Iny,,40,8,20,,,20,0,41,2,99%,null,,1,Frec Check;;;;;;;;;;;;;;1;CABAzitaxel;Revisar manualmente;CABAzI,INF, SC,AUC;Tumor maligno de la prostata;1
26/09/2024;41;1,75;65;1,78;M;Sin Cr;;Sin Cr;Cetuximab 100mg/20mL (5mg/mL) Sol Iny,,462,5,250,,,250,0,445,0,104%,CETUXIMAB 250 MG/M2 SC* DIA 1, 8, 15,,1,8,15,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,148,80,,,80,142,4,104%,DIA 1, 8, 15;;;;;;;;;;;;;2;CETUximab,PACLItaxel;Revisar manualmente;CETU,INF,PACLI, SC,VIDE;Tumor maligno de la glandula parotida;5
27/09/2024;32;1,52;53,6;1,53;F;136,7;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,230,0,230,,1,50,2,0,224,2,103%,REC15022021-1,,1,8,15,Frec Check;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,122,4,80,TRUE,,60,122,4,100%,null;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,122,4,80,,,60,0,91,8,133%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,200,0,100%,null;;;;;;;;;;;4;CARBOplatino,PACLItaxel,PACLItaxel,PEMBROlizumab;Revisar manualmente; AC ,CARBO,INF,PACLI,PEMBRO,PLATINO, SC,TAXANO,AUC;Tumor maligno de la mama, parte no especificada;1
27/09/2024;80;1,65;65;1,75;M;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,517,5,8,,,7,5,487,5,106%,null,,1,Frec Check;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,136,5,130,,,130,227,5,60%,null;;;;;;;;;;;;;2;Bevacizumab,OXALIplatino;Revisar manualmente;#N/D;Tumor maligno del colon, parte no especificada;8
27/09/2024;66;1,71;79;1,96;M;53,8;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,383,7,5,,,5,0,393,9,97%,null,,1,Frec Check;Etoposido 100mg/5mL (20mg/mL) Sol Iny,,192,100,,,100,196,0,98%,null;;;;;;;;;;;;;2;CARBOplatino,Etoposido;Revisar manualmente;CARBO,Etopo,PLATINO,XELOX;Tumor maligno del recto;2
27/09/2024;75;1,67;36;1,26;M;Sin Cr;;Sin Cr;Atezolizumab 1200mg/20mL (60mg/mL) Solucion Inyectable,,1.200,0,0,,,1.200,0,1200,0,100%,Aplicar 1200 mg IV D1,,null,Revise recomd, seg˙n proto: 1;Bevacizumab 100mg polv iny,TRUE,705,15,,,15,540,0,131%,null;;;;;;;;;;;;;2;Atezolizumab,Bevacizumab;Revisar manualmente;#N/D;Carcinoma de vias biliares intrahepaticas;10
27/09/2024;59;1,53;61;1,65;F;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,297,0,180,,,180,0,297,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3960,2400,,,2.400,3960,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,660,400,,,400,0,660,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,660,400,,,400,660,0,100%,null;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,240,240,TRUE,Dosis fija,3,240,0,100%,null;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,240,240,,,3,183,0,131%,null;;;;;;;;;6;Irinotecan,Fluorouracilo,Fluorouracilo,Folinato,NIVOLUmab,NIVOLUmab;Revisar manualmente;FOLFIRI,NIVO;Tumor maligno del estomago, parte no especificada;6
27/09/2024;58;1,74;52,1;1,57;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3.768,0,2.400,,,2.400,0,3768,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,628,400,,,400,628,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,106,76,85,FALSE,,85,0,133,5,80%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,628,400,,,400,628,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;Revisar manualmente;#N/D;Tumor maligno del estomago, parte no especificada;7
27/09/2024;67;1,65;65;1,75;M;Sin Cr;0,96;68,6;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,450,0,450,FALSE,,5,0,468,2,96%,null,,1,Frec Check;Pemetrexed 100mg Polv Iny,,875,500,,,500,875,0,100%,null;Pemetrexed 500mg Polv Iny,,875,500,,,500,0,875,0,100%,null;;;;;;;;;;;;3;CARBOplatino,Pemetrexed,Pemetrexed;Revisar manualmente;CARBO,IFOSF,INF,Peme,PLATINO,AUC;Tumor maligno de los bronquios o del pulmon, parte no especificada;2
27/09/2024;56;1,5;39;1,28;F;Sin Cr;0,91;42,5;Bevacizumab 100mg polv iny,FALSE,585,0,15,,,15,0,585,0,100%,null,,1,Frec Check;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,TRUE,394,394,,,5,478,9,82%,null;Pemetrexed 100mg Polv Iny,,640,500,,,500,0,640,0,100%,null;;;;;;;;;;;;3;Bevacizumab,CARBOplatino,Pemetrexed;Revisar manualmente;Beva,CARBO,Peme,PLATINO, SC,AUC;Mesotelioma de la pleura;6
27/09/2024;44;1,65;72;1,85;F;Sin Cr;0,73;111,8;Bevacizumab 100mg polv iny,,540,0,8,,7,50,15,0,540,0,100%,null,,1,Frec Check;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,TRUE,500,500,,5,6,626,6,80%,.;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,310,310,,,175,0,323,8,96%,Dosis calculada 310 mg IV. Administrar d√≠a 1.;;;;;;;;;;;;3;Bevacizumab,CARBOplatino,PACLItaxel;Revisar manualmente;Beva,CARBO,INF,PACLI,PLATINO, SC,AJUSTE,AJUST,AUC,CREA,CREAT;Tumor maligno del ovario;4
27/09/2024;56;1,53;59;1,62;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,Frec Check;Pemetrexed 100mg Polv Iny,,800,500,,,500,810,0,99%,null;;;;;;;;;;;;;2;PEMBROlizumab,Pemetrexed;Revisar manualmente;CARBO,PEMBRO,Peme,PLATINO;Tumor maligno de los bronquios o del pulmon, parte no especificada;9
27/09/2024;73;1,44;50;1,45;F;Sin Cr;;Sin Cr;Doxorrubicina liposomal 20mg/10mL (2mg/mL) Susp Iny,,58,0,40,TRUE,,50,0,58,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOXOrubicina_LIPOSOMAL;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;10
27/09/2024;75;1,48;39;1,27;F;Sin Cr;;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,500,0,500,,,400,0,508,0,98%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,500,500,,,400,508,0,98%,5 Fluorouracilo  (400 mg/m2) Dosis 500 mg IV EN 2 HORAS D√≠as 1 y 15;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,2133,6,2400,,,2.400,0,3048,0,70%,5 Fluorouracilo (2400 mg/m2) dosis 2133 mg  IV infusi√≥n contin√∫a de 46 horas  D√≠as 1 y 15  ***dosis ajustada 30%;;;;;;;;;;;;3;Folinato,Fluorouracilo,Fluorouracilo;Revisar manualmente;#N/D;Tumor maligno del estomago, parte no especificada;15
27/09/2024;67;1,51;50;1,47;F;67,3;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,554,0,6,TRUE,,5,0,554,0,100%,REC15022021-2,,1,Frec Check;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,257,25,175,,,175,257,3,100%,null;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,257,25,175,,,175,0,257,3,100%,null;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,PACLItaxel;Revisar manualmente;#N/D;Tumor maligno del ovario;2
27/09/2024;61;1,57;58;1,62;F;Sin Cr;;Sin Cr;Gemcitabina 1000mg/100mL (10mg/mL) Sol Iny,,1.570,0,1.570,,,1.000,0,1620,0,97%,Gemcitabina (1000 mg/m2). Dosis calculada 1570 mg. Administrar primero los d√≠as 1, 8, 15.,,1,8,15,Frec Check;Nab-Paclitaxel 100mg Polv Iny,,190,190,,,125,202,5,94%,Nab-Paclitaxel (125 mg/m2). Dosis calculada  190 mg. Administrar primero los d√≠as 1, 8, 15.;;;;;;;;;;;;;2;GEMcitabina,Paclitaxel LIGADO a ALBUMINA;Revisar manualmente;GEMci,Nab-pacli,Nab-pacli,PACLI, SC,CREA,CREAT;Tumor maligno de la mama, parte no especificada;5
27/09/2024;57;1,52;51;1,49;F;96,1;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,535,4,5,FALSE,,5,0,605,5,88%,REC15022021-2,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,221,64,175,,,175,260,8,85%,null;;;;;;;;;;;;;2;CARBOplatino,PACLItaxel;Revisar manualmente;#N/D;Tumor maligno del ovario;6
27/09/2024;56;1,58;55;1,57;F;76,8;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,200,0,200,,,2,0,203,6,98%,REC15022021-1,,1,8,15,22,29,36,Frec Check;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,125,6,80,TRUE,,50,125,6,100%,null;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,125,6,80,,,50,0,78,5,160%,null;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,PACLItaxel;Revisar manualmente;CARBO,CisplA,INF,PACLI,PLATINO, SC,semanal,AUC;Tumor maligno del cuello del utero, sin otra especificacion;1
27/09/2024;56;1,56;75;1,86;F;Sin Cr;;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,100,0,100,FALSE,,60,0,111,6,90%,Doxorubicina (60 mg/m2). Dosis calculada 100 mg IV. Administrar d√≠a 1 y 15.,,1,15,Frec Check;Ciclofosfamida 1gr (1000mg) Polv Iny,,1050,1050,,,600,1116,0,94%,Ciclofosfamida (600 mg/m2). Dosis calculada 1050 mg IV. Administrar d√≠a 1 y 15.;;;;;;;;;;;;;2;DOXOrubicina,Ciclofosfamida;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;1
27/09/2024;51;1,6;78;1,91;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,pembrolizumab 200 mg IV d√≠a 1,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;Capec,PEMBRO,CREA,CREAT;Tumor maligno de la mama, parte no especificada;3
27/09/2024;46;1,54;73;1,82;F;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,327,6,180,,,180,0,327,6,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,728,400,,,400,728,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4368,2400,,,2.400,0,4368,0,100%,null;;;;;;;;;;;;3;Irinotecan,Fluorouracilo,Fluorouracilo;Revisar manualmente;FOLFIRI,PANItU;Tumor maligno del colon, parte no especificada;2
27/09/2024;54;1,62;72;1,84;M;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,200,0,200,,,3,0,216,0,93%,Nivolumab (3 mg/kg). Dosis calculada 200 mg  IV. Administrar d√≠a 1.,,1,Frec Check;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,20,20,,,3,216,0,9%,Nivolumab (3 mg/kg). Dosis calculada 20 mg  IV. Administrar d√≠a 1.;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;NIVO,VIDE,CREA,CREAT;Tumor maligno del recto;7
27/09/2024;39;null;null;null;M;Sin Cr;;Sin Cr;Bleomicina sulfato 15 UI (10mg) Polv Iny,,30,0,30,,,30,0,30,0,100%,null,,8,15,Inconsistente, seg˙n proto: 1,8,15;;;;;;;;;;;;;;1;Bleomicina sulfato;Revisar manualmente;#N/D;Tumor maligno del retroperitoneo;2
27/09/2024;67;1,57;44;1,39;M;Sin Cr;;Sin Cr;Ifosfamida 1gr (1000mg) Polv Iny,,2.780,0,2.000,TRUE,,1.500,0,2780,0,100%,null,,1,2,3,Inconsistente, seg˙n proto: 1,2,3,4,5;Mesna 400mg/4mL (100mg/mL) Sol Iny,,1800,1800,FALSE,,300,417,0,432%,APLICAR 600 MG A LAS O HORAS 600 ALAS 4 HORAS Y 600 A LAS 8 HORAS DIAS Y A 3;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,34,75,25,,,20,0,27,8,125%,null;;;;;;;;;;;;3;IFOSfamida,Mesna,DOXOrubicina;Revisar manualmente;#N/D;Tumor maligno del tejido conjuntivo y tejido blando del abdomen;1
28/09/2024;29;1,6;71;1,82;M;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,36,4,20,,,20,0,36,4,100%,null,,1,2,3,4,5,Frec Check;Etoposido 100mg/5mL (20mg/mL) Sol Iny,,182,100,,,100,182,0,100%,null;Bleomicina sulfato 15 UI (10mg) Polv Iny,,30,30,,,30,0,30,0,100%,null;;;;;;;;;;;;3;CISplatino,Etoposido,Bleomicina sulfato;Revisar manualmente;#N/D;Tumor maligno de glandula endocrina no especificada;1
28/09/2024;76;1,73;51;1,55;M;Sin Cr;;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,620,0,400,,,400,0,620,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,620,400,,,400,620,0,100%,null;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,251,1,180,,,180,0,279,0,90%,AJUSTADO 10%;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,105,4,85,,,85,131,8,80%,AJUSTE AL 20%;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,105,4,85,,,85,131,8,80%,AJUSTE AL 20%;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3720,2400,,,2.400,3720,0,100%,null;;;;;;;;;6;Folinato,Fluorouracilo,Irinotecan,OXALIplatino,OXALIplatino,Fluorouracilo;Revisar manualmente;#N/D;Tumor maligno del pancreas, parte no especificada;1
28/09/2024;73;1,5;62;1,65;F;Sin Cr;0,71;69,1;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,500,0,500,,,5,0,470,4,106%,null,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,288,75,175,,,175,288,8,100%,null;;;;;;;;;;;;;2;CARBOplatino,PACLItaxel;Revisar manualmente;CARBO,INF,PACLI,PLATINO,TAXOL;Tumor maligno del endometrio;1
28/09/2024;57;1,68;61;1,7;F;Sin Cr;;Sin Cr;Calcio folinato 50mg Polv Iny,FALSE,500,0,500,,,400,0,680,0,74%,√Åcido Fol√≠nico (400mg/m2). Dosis calculada 500 mg IV. Administrar d√≠a 1 y 15 en infusi√≥n de 120 mins.,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,500,500,,,400,680,0,74%,5 - FU (400 mg/m2). Dosis calculada 500 mg IV. Administrar  en bolo los d√≠as 1 y 15;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,100,100,,,85,0,144,5,69%,Oxaliplatino (85 mg/m2). Dosis calculada 100mg IV. Administrar d√≠a 1 y 15.;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3000,3000,,,2.400,4080,0,74%,Despu√©s (2400 mg/m2). Dosis calculada 3000 mg IV. Administrar en infusi√≥n continua de 48 horas.;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,200,200,,,3,183,0,109%,Nivolumab 200 mg IV. Administrar d√≠a 1 y 15.;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,40,40,,,3,183,0,22%,Nivolumab 40 mg IV. Administrar d√≠a 1 y 15.;;;;;;;;;6;Folinato,Fluorouracilo,OXALIplatino,Fluorouracilo,NIVOLUmab,NIVOLUmab;Revisar manualmente;FOLFOX,INF,NIVO,Oxali,PLATINO, SC,BOLO ,AJUST,5%,75%,CREA,CREAT;Tumor maligno del estomago, parte no especificada;6
28/09/2024;63;1,68;75;1,9;M;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,562,5,8,,,7,5,562,5,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;Bevacizumab;Revisar manualmente;Capec,CAPEOX,INF,MAYO ,PLATINO, RT ,XELOX;Tumor maligno del colon, parte no especificada;2
28/09/2024;44;1,45;54;1,52;F;Sin Cr;;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,912,0,600,,,600,0,912,0,100%,null,,1,15,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,91,2,60,,,60,91,2,100%,null;;;;;;;;;;;;;2;Ciclofosfamida,DOXOrubicina;Revisar manualmente; AC ,CICLOF,CisplA,INF,PLATINO,TC ,VIDE,10%,5%,95%;Tumor maligno de la mama, parte no especificada;3
28/09/2024;73;1,58;66;1,74;F;Sin Cr;;Sin Cr;Gemcitabina 1000mg/100mL (10mg/mL) Sol Iny,,1.392,0,1.000,,,1.000,0,1740,0,80%,null,,1,15,Inconsistente, seg˙n proto: 1,8,15;Nab-Paclitaxel 100mg Polv Iny,,174,125,,,125,217,5,80%,null;;;;;;;;;;;;;2;GEMcitabina,Paclitaxel LIGADO a ALBUMINA;Revisar manualmente;GEMci,PACLI,AJUSTE,AJUST,CREA,CREAT;Tumor maligno del pancreas, parte no especificada;1
28/09/2024;43;1,61;50;1,5;F;Sin Cr;;Sin Cr;Dacarbazina 200mg Polv Iny,,1.500,0,1.000,TRUE,,500,0,1500,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;Dacarbazina;Revisar manualmente;INF,IPILI,NIVO;Melanoma maligno de piel, sitio no especificado;1
28/09/2024;84;1,55;55;1,56;M;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,300,0,300,,,3,0,165,0,182%,Nivolumab 300 mg IV d√≠a 1.,,1,Frec Check;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,60,60,,,3,165,0,36%,Nivolumab 60 mg IV d√≠a 1.;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;#N/D;Tumor maligno del estomago, parte no especificada;7
28/09/2024;74;1,55;49;1,47;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,690,0,15,TRUE,,10,0,735,0,94%,null,,1,Frec Check;;;;;;;;;;;;;;1;Bevacizumab;Revisar manualmente;Beva,CARBO,MAYO ,Peme,PLATINO,80%;Mesotelioma de la pleura;1
28/09/2024;72;1,55;47;1,43;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,235,0,5,,,5,0,235,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,2574,2400,,,2.400,3432,0,75%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,429,400,,,400,0,572,0,75%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,91,16,85,,,85,121,6,75%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,91,16,85,,,85,121,6,75%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,429,400,,,400,572,0,75%,null;;;;;;;;;6;Bevacizumab,Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;Revisar manualmente;Beva,FOLFOX,AJUSTE,AJUST,5%,25%;Tumor maligno del colon, parte no especificada;3
28/09/2024;71;1,44;61;1,62;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,900,0,900,,15,0,10,0,915,0,98%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;Bevacizumab;Revisar manualmente;Beva,monoagente,VIDE;Tumor maligno del ovario;9
28/09/2024;51;1,55;74;1,84;F;Sin Cr;0,32;243;Pemetrexed 500mg Polv Iny,,736,0,500,,,500,0,920,0,80%,null,,1,Frec Check;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,FALSE,450,450,,3,5,438,9,103%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;;;;;;;;;;;;3;Pemetrexed,CARBOplatino,PEMBROlizumab;Revisar manualmente;CARBO,PEMBRO,Peme,PLATINO,5%,95%;Tumor maligno de los bronquios o del pulmon, parte no especificada;1
28/09/2024;43;1,64;55;1,59;F;Sin Cr;;Sin Cr;Trastuzumab 440mg Polv Iny,,330,0,6,,,6,0,330,0,100%,ADMINISTRAR 330 MG IV  DIA 1 Y 22,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;TRAStuzumab;Revisar manualmente;TrastU;Tumor maligno de la mama, parte no especificada;70
28/09/2024;50;1,59;59;1,64;F;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,65,0,65,,40,00,35,0,65,6,99%,Cisplatino (40 mg/m2). Dosis calculada 65 mg/IV. Administrar d√≠a 1.,,1,Inconsistente, seg˙n proto: 1,8,15,22,29;;;;;;;;;;;;;;1;CISplatino;Revisar manualmente;CisplA,CONCURRENTE,INF,PLATINO, SC,BOLO ,CREA,CREAT;Tumor maligno de seno paranasal no especificado;1
28/09/2024;48;1,54;61;1,65;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,132,0,80,,,80,0,132,0,100%,null,,1,8,15,22,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;1
30/09/2024;30;1,78;114;2,42;M;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,200,0,100%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;;;;;;;;;;;;3;PEMBROlizumab,PEMBROlizumab,PEMBROlizumab;Revisar manualmente;INF,keynote,keynote 564,PEMBRO,VIDE;Tumor maligno del ri√±on, excepto de la pelvis renal;7
30/09/2024;62;1,8;48;1,52;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3.648,0,2.400,,,2.400,0,3648,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,608,400,,,400,608,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,129,2,85,,,85,0,129,2,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,129,2,85,,,85,129,2,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,608,400,,,400,608,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;Revisar manualmente;FOLFOX,INF;Tumor maligno del esofago, parte no especificada;1
30/09/2024;28;1,71;90;2,11;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,168,8,80,,,80,0,168,8,100%,null,,1,8,15,Frec Check;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,168,8,80,,,80,168,8,100%,null;Ramucirumab  500mg/50mL (10mg/mL) Sol Iny,,720,0,,,8,0,720,0,100%,-RAMUCIRUMAB ( 8 MG/KG)  APLICAR 720 MG IV DIAS 1 Y 15.;;;;;;;;;;;;3;PACLItaxel,PACLItaxel,Ramucirumab;Revisar manualmente;PACLI,RAMUC, SC;Tumor maligno del estomago, parte no especificada;3
30/09/2024;79;1,68;46;1,45;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,72,5,50,,,50,0,72,5,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3770,2600,,,2.600,3770,0,100%,null;Calcio folinato 50mg Polv Iny,,290,200,,,200,0,290,0,100%,null;Docetaxel 80mg/2mL (40mg/mL) Sol Iny,,72,5,50,,,50,72,5,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,123,25,85,,,85,123,3,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,123,25,85,,,85,123,3,100%,null;;;;;;;;;6;DOCEtaxel,Fluorouracilo,Folinato,DOCEtaxel,OXALIplatino,OXALIplatino;Revisar manualmente;FLOT,80%,CREA;Tumor maligno del estomago, parte no especificada;1
30/09/2024;70;1,75;53;1,59;M;Sin Cr;;Sin Cr;Durvalumab 50mg/mL (500mg/10mL) Solucion Inyectable,,1.500,0,0,,Dosis fija,1.500,0,1500,0,100%,null,,null,Revise recomd, seg˙n proto: 1;;;;;;;;;;;;;;1;Durvalumab;Revisar manualmente;CisplA,Durva,PLATINO,VIDE,80%,100%;Tumor maligno del lobulo superior, bronquio o pulmon;1
30/09/2024;72;1,63;71,9;1,84;M;Sin Cr;;Sin Cr;Cabazitaxel 60mg/1.5mL (4%) Sol Iny,FALSE,46,0,25,TRUE,,20,0,46,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;CABAzitaxel;Revisar manualmente;CABAzI,MAYO , SC,CREA,CREAT;Tumor maligno de la prostata;1
30/09/2024;69;1,78;84;2,05;M;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,400,0,400,TRUE,Dosis fija,3,0,400,0,100%,dosis total 480 mg IV dia 1,,1,Inconsistente, seg˙n proto: 1,15;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,80,80,,,3,252,0,32%,dosis total 480 mg IV dia 1;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;INF,IPILI,NIVO,VIDE;Melanoma maligno del tronco;1
30/09/2024;65;1,68;60;1,68;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.032,0,2.400,,,2.400,0,4032,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,672,400,,,400,672,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,142,8,85,,,85,0,142,8,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,142,8,85,,,85,142,8,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,672,400,,,400,672,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;Revisar manualmente;FOLFOX,INF;Tumor maligno del estomago, parte no especificada;1
30/09/2024;70;1,43;53;1,5;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno de los bronquios o del pulmon, parte no especificada;13
30/09/2024;59;1,57;54;1,55;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,260,0,5,,,5,0,270,0,96%,null,,1,15,Frec Check;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,620,400,,,400,620,0,100%,.;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,608,400,,,400,0,620,0,98%,null;;;;;;;;;;;;3;Bevacizumab,Folinato,Fluorouracilo;Revisar manualmente;#N/D;Tumor maligno secundario del peritoneo y del retroperitoneo;6
30/09/2024;83;1,57;47;1,44;F;Sin Cr;0,65;48,7;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,560,0,560,,,5,0,533,3,105%,null,,1,Frec Check;Pemetrexed 500mg Polv Iny,,720,500,,,500,720,0,100%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;;;;;;;;;;;;3;CARBOplatino,Pemetrexed,PEMBROlizumab;Revisar manualmente;CARBO,EMA CO,PEMBRO;Tumor maligno de los bronquios o del pulmon, parte no especificada;1
30/09/2024;68;1,49;49;1,45;F;Sin Cr;;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,188,5,130,TRUE,,100,0,188,5,100%,null,,1,Frec Check;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,360,360,,,3,147,0,245%,null;;;;;;;;;;;;;2;OXALIplatino,NIVOLUmab;Revisar manualmente;CAPEOX,INF,VIDE;Tumor maligno del estomago, parte no especificada;2
30/09/2024;61;1,61;69;1,79;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.296,0,2.400,,,2.400,0,4296,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,716,400,,,400,716,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,716,400,,,400,0,716,0,100%,null;Panitumumab 100mg/5mL (20mg/mL) Sol Iny,,331,2,6,,,6,414,0,80%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,Folinato,PANItumumab;Revisar manualmente;PANItU,AJUSTE,AJUST,20%;Tumor maligno del colon, parte no especificada;1
30/09/2024;58;1,65;58;1,64;F;Sin Cr;;Sin Cr;Trastuzumab 440mg Polv Iny,,348,0,6,,,6,0,348,0,100%,null,,1,21,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;TRAStuzumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;7
30/09/2024;56;1,61;54;1,57;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,MANTENIMIENTO PEMBROLIZUMAB  - PEMBROLIZUMAB 200 MG IV DIA 1,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;CARBO,PEMBRO,VIDE;Tumor maligno del cuello del utero, sin otra especificacion;11
30/09/2024;44;1,55;56;1,58;F;Sin Cr;0,78;81,4;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,118,5,75,,,80,0,126,4,94%,null,,1,8,15,Frec Check;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,605,605,,,5,588,2,103%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;;;;;;;;;;;;3;PACLItaxel,CARBOplatino,PEMBROlizumab;Revisar manualmente;100%;Tumor maligno de la mama, parte no especificada;1
30/09/2024;53;1,49;55;1,55;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,200,0,100%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;;;;;;;;;;;;3;PEMBROlizumab,PEMBROlizumab,PEMBROlizumab;Revisar manualmente;FOLFOX,INF,Oxali,PEMBRO,PLATINO,VIDE,CREA,CREAT;Tumor maligno del colon, parte no especificada;1
30/09/2024;73;1,6;56;1,59;F;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,2.289,6,2.400,,,2.400,0,3816,0,60%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,381,6,400,,,400,636,0,60%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,381,6,400,,,400,0,636,0,60%,null;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,240,240,,,240,13440,0,2%,null;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,240,240,,,240,13440,0,2%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,Folinato,NIVOLUmab,NIVOLUmab;Revisar manualmente;CAPEOX,NIVO,Oxali,PLATINO,VIDE;Tumor maligno del estomago, parte no especificada;1
30/09/2024;76;1,4;55;1,52;F;Sin Cr;;Sin Cr;Trastuzumab 440mg Polv Iny,,330,0,6,,,6,0,330,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;TRAStuzumab;Revisar manualmente;#N/D;Tumor maligno del endometrio;1
30/09/2024;72;1,6;79;1,92;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,1.185,0,15,,,15,0,1185,0,100%,null,,1,Frec Check;Atezolizumab 1200mg/20mL (60mg/mL) Solucion Inyectable,,1200,0,,,1.200,1200,0,100%,null;;;;;;;;;;;;;2;Bevacizumab,Atezolizumab;Revisar manualmente;Atezo,RICE,VIDE;Tumor maligno del higado, no especificado;9
30/09/2024;71;1,6;60;1,66;F;Sin Cr;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,405,0,405,,,5,0,SIN TFG,Select proto,null,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,232,4,175,,,175,290,5,80%,null;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,246,93,175,,,175,0,290,5,85%,null;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,PACLItaxel;Revisar manualmente;CARBO,INF,MITOm,PACLI,PLATINO, RT ,TAXANO,TAXOL,AJUSTE,AJUST,20%;Tumor maligno del recto;4
30/09/2024;66;1,47;63;1,66;F;Sin Cr;;Sin Cr;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,132,8,80,,,80,0,132,8,100%,null,,1,8,15,22,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Revisar manualmente;50%;Tumor maligno de la mama, parte no especificada;2
30/09/2024;69;1,55;41;1,33;F;49,8;;Sin Cr;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,79,8,80,,,80,0,106,4,75%,cada 4 semanas,,1,8,15,Frec Check;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,224,43,4,TRUE,,5,299,2,75%,,;;;;;;;;;;;;;2;PACLItaxel,CARBOplatino;Revisar manualmente;CARBO,INF,PACLI,TC ,VIDE,AJUST,5%,25%;Tumor maligno del recto;8
30/09/2024;57;1,56;39;1,3;F;Sin Cr;;Sin Cr;Pemetrexed 100mg Polv Iny,,589,5,500,,,500,0,650,0,91%,null,,1,Frec Check;Pemetrexed 500mg Polv Iny,,589,5,500,,,500,650,0,91%,null;;;;;;;;;;;;;2;Pemetrexed,Pemetrexed;Revisar manualmente;Peme,PLATINO,AJUSTE,AJUST,10%;Tumor maligno de los bronquios o del pulmon, parte no especificada;6
30/09/2024;58;1,49;65;1,69;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,136,8,80,,,80,0,135,2,101%,null,,1,8,15,Frec Check;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,136,8,80,,,80,135,2,101%,null;Trastuzumab 440mg Polv Iny,,396,6,,,6,0,390,0,102%,null;;;;;;;;;;;;3;PACLItaxel,PACLItaxel,TRAStuzumab;Revisar manualmente; GC ,PACLI,TrastU;Tumor maligno de la mama, parte no especificada;3
30/09/2024;54;1,67;79,6;1,96;F;Sin Cr;;Sin Cr;Trastuzumab 440mg Polv Iny,,486,0,6,FALSE,,6,0,477,6,102%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;TRAStuzumab;Revisar manualmente; AC , GC ,INF,TC ,TrastU;Tumor maligno de la mama, parte no especificada;8
30/09/2024;53;1,63;79;1,94;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;PEMBRO;Tumor maligno de la mama, parte no especificada;1
30/09/2024;50;1,52;51;1,49;F;Sin Cr;;Sin Cr;Trastuzumab 440mg Polv Iny,,300,0,300,,,6,0,306,0,98%,DOSIS CALCULADA 300 MG IV. ADMINISTRAR DIA 1 Y 21.,,1,21,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;TRAStuzumab;Revisar manualmente; SC,TrastU,CREA,CREAT;Tumor maligno de la mama, parte no especificada;83
30/09/2024;38;1,64;67;1,77;F;Sin Cr;;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,106,2,60,,,60,0,106,2,100%,null,,1,Frec Check;Ciclofosfamida 1gr (1000mg) Polv Iny,,1000,1000,,,600,1062,0,94%,600mg/m2;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;;;;;;;;;;;;3;DOXOrubicina,Ciclofosfamida,PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;1
30/09/2024;51;1,51;58;1,6;F;Sin Cr;;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,960,0,600,,,600,0,960,0,100%,null,,1,15,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,96,60,,,60,96,0,100%,null;;;;;;;;;;;;;2;Ciclofosfamida,DOXOrubicina;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;1
30/09/2024;43;1,67;69;1,81;F;Sin Cr;;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,1.110,0,600,,,600,0,1086,0,102%,null,,1,15,Frec Check;Ciclofosfamida 500mg  Polv Iny,,1110,600,,,600,1086,0,102%,null;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,111,60,,,60,0,108,6,102%,null;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,111,60,,,60,108,6,102%,null;Ciclofosfamida 500mg  Polv Iny,,1110,600,,,600,1086,0,102%,null;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,111,60,,,60,108,6,102%,null;;;;;;;;;6;CICLOfosfamida,CICLOfosfamida,DOXOrubicina,DOXOrubicina,CICLOfosfamida,DOXOrubicina;Revisar manualmente; AC ,INF,PACLI,semanal,TAXANO,30%,90%,100%;Tumor maligno de la mama, parte no especificada;7
30/09/2024;42;1,55;54;1,55;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,217,0,175,,,175,0,271,3,80%,null,,1,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Revisar manualmente;CARBO,INF,PACLI,PLATINO, RT , SC,TAXANO,AJUST,20%;Tumor maligno del endocervix;1
30/09/2024;59;1,51;47;1,42;F;Sin Cr;;Sin Cr;Doxorrubicina liposomal 20mg/10mL (2mg/mL) Susp Iny,,60,4,50,,,40,0,56,8,106%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOXOrubicina_LIPOSOMAL;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;1
30/09/2024;68;1,63;70;1,81;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,724,0,400,,,400,0,724,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4344,2400,,,2.400,4344,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,724,400,,,400,0,724,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,123,08,85,,,85,153,9,80%,null;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,325,8,180,,,180,325,8,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,Folinato,OXALIplatino,Irinotecan;Revisar manualmente;FOLFIRI,FOLFIRINOX,INF,Irino,80%,CREA;Tumor maligno de la cabeza del pancreas;5
30/09/2024;60;1,76;93;2,16;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,5.184,0,2.400,,,2.400,0,5184,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,864,400,,,400,864,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,864,400,,,400,0,864,0,100%,null;Bevacizumab 100mg polv iny,,465,5,,,5,465,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,Folinato,Bevacizumab;Revisar manualmente;Beva,FOLFOX,INF,MAYO ,VIDE;Tumor maligno del colon, parte no especificada;2
30/09/2024;51;1,68;62;1,71;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.104,0,2.400,,,2.400,0,4104,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,684,400,,,400,684,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,145,35,85,,,85,0,145,4,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,684,400,,,400,684,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;Revisar manualmente;#N/D;Tumor maligno del recto;8
30/09/2024;73;1,5;43;1,35;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3.240,0,2.400,,,2.400,0,3240,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,540,400,,,400,540,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,114,75,85,,,85,0,114,8,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,114,75,85,,,85,114,8,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,540,400,,,400,540,0,100%,null;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,200,200,,,3,129,0,155%,dosis fija 240 mg iv;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,40,40,,,3,129,0,31%,dosis fija 240 mg iv;;;;;;;;7;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato,NIVOLUmab,NIVOLUmab;Revisar manualmente;FOLFOX,INF,NIVO,70%;Tumor maligno del estomago, parte no especificada;1
30/09/2024;70;1,78;85;2,07;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.800,0,4.800,,,2.400,0,4968,0,97%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,800,800,,,400,828,0,97%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,828,400,,,400,0,828,0,100%,null;Panitumumab 100mg/5mL (20mg/mL) Sol Iny,,408,6,,,6,510,0,80%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,Folinato,PANItumumab;Revisar manualmente;#N/D;Tumor maligno del colon, parte no especificada;12
1/10/2024;21;1,61;51;1,52;F;140,5;;Sin Cr;Bleomicina sulfato 15 UI (10mg) Polv Iny,,30,0,30,,,30,0,30,0,100%,null,,1,8,15,Frec Check;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,31,4,20,,,20,30,4,103%,null;Etoposido 100mg/5mL (20mg/mL) Sol Iny,,157,100,,,100,0,152,0,103%,null;;;;;;;;;;;;3;Bleomicina sulfato,CISplatino,Etoposido;Revisar manualmente; BEP ,Bleom,CisplA,Etopo,INF,PLATINO, SC;Tumor maligno del ovario;2
1/10/2024;34;1,69;57;1,64;M;Sin Cr;;Sin Cr;Bleomicina sulfato 15 UI (10mg) Polv Iny,,22,5,30,,,30,0,30,0,75%,null,,1,8,15,Frec Check;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,24,6,20,,,20,32,8,75%,null;Etoposido 100mg/5mL (20mg/mL) Sol Iny,,123,100,,,100,0,164,0,75%,null;;;;;;;;;;;;3;Bleomicina sulfato,CISplatino,Etoposido;Revisar manualmente; BEP ,Bleom,INF,TC ,AJUSTE,AJUST,5%,25%;Tumor maligno del testiculo, no especificado;4
1/10/2024;30;1,63;80;1,95;F;Sin Cr;0,54;192,4;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,TRUE,187,0,187,FALSE,1,50,2,0,223,4,84%,null,,1,8,15,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,155,2,80,TRUE,,60,156,0,99%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;3
1/10/2024;75;1,67;79;1,95;M;Sin Cr;;Sin Cr;Atezolizumab 1200mg/20mL (60mg/mL) Solucion Inyectable,,1.200,0,0,,,1.200,0,1200,0,100%,null,,null,Revise recomd, seg˙n proto: 1;Bevacizumab 100mg polv iny,,1185,15,,,15,1185,0,100%,null;;;;;;;;;;;;;2;Atezolizumab,Bevacizumab;Revisar manualmente;Atezo,Beva;Tumor maligno del higado, no especificado;1
1/10/2024;62;1,7;67;1,79;M;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,400,0,400,TRUE,,200,0,400,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno del ri√±on, excepto de la pelvis renal;1
1/10/2024;59;1,68;65;1,76;F;91,4;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,582,1,5,TRUE,,6,0,603,1,97%,null,,1,Frec Check;Docetaxel 20mg/mL Sol Iny,,139,5,75,,,75,132,0,106%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,420,0,420,0,100%,null;Trastuzumab 440mg Polv Iny,,432,6,,,6,390,0,111%,null;;;;;;;;;;;4;CARBOplatino,DOCEtaxel,PERTUzumab,TRAStuzumab;Revisar manualmente;CARBO,DOCE,INF,PERTU,PLATINO,TrastU,5%,15%,50%,60%,AUC,CREA,CREAT;Tumor maligno de la mama, parte no especificada;5
1/10/2024;61;1,53;50;1,48;F;Sin Cr;;Sin Cr;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,360,0,360,TRUE,Dosis fija,3,0,360,0,100%,null,,1,Frec Check;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,360,360,,,3,150,0,240%,null;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;Capec,FOLFOX,NIVO,CREA;Tumor maligno del estomago, parte no especificada;8
1/10/2024;69;1,61;70,4;1,81;F;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.344,0,2.400,,,2.400,0,4344,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,724,400,,,400,724,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,153,85,85,,,85,0,153,9,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,724,400,,,400,724,0,100%,null;Panitumumab 100mg/5mL (20mg/mL) Sol Iny,,422,4,6,,,6,422,4,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato,PANItumumab;Revisar manualmente;Beva,Capec,FOLFIRI,FOLFOX,INF,PANItU,AJUST,30%,90%;Tumor maligno del colon, parte no especificada;1
1/10/2024;70;1,63;49;1,49;F;Sin Cr;0,7;57,8;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,414,0,414,,,5,0,414,2,100%,null,,1,Frec Check;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,200,0,100%,PEMBROLIZUMAB 200 MG IV DIA 1;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,PEMBROLIZUMAB 200 MG IV DIA 1;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,200,0,100%,PEMBROLIZUMAB 200 MG IV DIA 1;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,200,0,100%,PEMBROLIZUMAB 200 MG IV DIA 1;Pemetrexed 100mg Polv Iny,,745,500,,,500,745,0,100%,null;Pemetrexed 100mg Polv Iny,,745,500,,,500,745,0,100%,null;Pemetrexed 100mg Polv Iny,,745,500,,,500,745,0,100%;;;;;;;8;CARBOplatino,PEMBROlizumab,PEMBROlizumab,PEMBROlizumab,PEMBROlizumab,Pemetrexed,Pemetrexed,Pemetrexed;Revisar manualmente;CARBO,monoagente,PEMBRO,Peme,PLATINO,AJUSTE,AJUST,60%,AUC;Tumor maligno de los bronquios o del pulmon, parte no especificada;3
1/10/2024;89;1,46;61;1,63;F;41,3;;Sin Cr;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,65,2,40,TRUE,,50,0,65,2,100%,null,,1,8,15,Frec Check;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,99,41,1,5,TRUE,,2,99,4,100%,null;;;;;;;;;;;;;2;PACLItaxel,CARBOplatino;Revisar manualmente;CARBO,INF,PACLI,PLATINO,semanal,TAXOL,AJUST,AUC;Tumor maligno del endometrio;1
1/10/2024;44;1,59;58;1,62;F;Sin Cr;;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,648,0,400,,,400,0,648,0,100%,.,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,648,400,,,400,648,0,100%,null;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,291,6,180,,,180,0,291,6,100%,null;Bevacizumab 100mg polv iny,,290,5,,,5,290,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3888,2400,,,2.400,3888,0,100%,null;;;;;;;;;;5;Folinato,Fluorouracilo,Irinotecan,Bevacizumab,Fluorouracilo;Revisar manualmente;Beva,FOLFIRI,FOLFOX;Tumor maligno del abdomen;8
1/10/2024;86;1,56;63;1,69;M;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,228,2,135,TRUE,,175,0,228,2,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Revisar manualmente;INF,PACLI,AJUST;Sarcoma de kaposi de la piel;3
1/10/2024;66;1,68;77;1,93;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;PEMBRO,50%;Tumor maligno de los bronquios o del pulmon, parte no especificada;14
1/10/2024;72;1,58;45,5;1,42;F;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,480,0,480,TRUE,Dosis fija,3,0,480,0,100%,null,,1,29,Inconsistente, seg˙n proto: 1,15;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,480,480,,,3,136,5,352%,null;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;NIVO,AJUST;Tumor maligno del ri√±on, excepto de la pelvis renal;1
1/10/2024;47;1,65;55;1,59;F;71,9;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,484,5,5,,,5,0,484,4,100%,,,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,278,25,175,,,175,278,3,100%,,;;;;;;;;;;;;;2;CARBOplatino,PACLItaxel;Revisar manualmente;CARBO,GEMci,TAXOL,TC ;Tumor maligno de la mama, parte no especificada;1
1/10/2024;76;1,39;42;1,3;F;Sin Cr;;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,468,0,400,,,400,0,520,0,90%,Administrar 470 mg iv dia 1,15,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,468,400,,,400,520,0,90%,Administrar 470 mg iv dia 1,15;Panitumumab 100mg/5mL (20mg/mL) Sol Iny,,201,6,6,,,6,0,252,0,80%,Administrar 200 mg iv dia 1,15;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,2808,2400,,,2.400,3120,0,90%,Administrar 2800 mg iv dia 1,15;;;;;;;;;;;4;Folinato,Fluorouracilo,PANItumumab,Fluorouracilo;Revisar manualmente;INF,PANItU, RT ,VIDE,AJUSTE,AJUST,10%,20%,CREA,CREAT;Tumor maligno del recto;19
1/10/2024;66;1,55;61;1,66;F;Sin Cr;0,61;87,4;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,TRUE,450,0,450,,,5,0,561,8,80%,null,,1,Frec Check;Pemetrexed 500mg Polv Iny,,830,500,,,500,830,0,100%,null;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,160,160,,,360,0,21960,0,1%,null;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,200,200,,,360,21960,0,1%,null;;;;;;;;;;;4;CARBOplatino,Pemetrexed,NIVOLUmab,NIVOLUmab;Revisar manualmente;CARBO,INF,NIVO,PACLI,PLATINO,70%,AUC;Tumor maligno de los bronquios o del pulmon, parte no especificada;1
1/10/2024;63;1,56;75;1,86;F;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,225,0,3,,,3,0,225,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;NIVOLUmab;Revisar manualmente;NIVO,AJUST;Tumor maligno del colon, parte no especificada;1
1/10/2024;66;1,44;62;1,63;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,912,0,15,TRUE,,10,0,930,0,98%,null,,1,Frec Check;;;;;;;;;;;;;;1;Bevacizumab;Revisar manualmente;#N/D;Tumor maligno del ovario;6
1/10/2024;56;1,55;50;1,48;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,750,0,15,TRUE,,10,0,750,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;Bevacizumab;Revisar manualmente;Beva,CARBO,DOXO,DOXO,INF,MAYO ,PLATINO,TAXOL,AJUSTE,AJUST;Tumor maligno del ovario;1
1/10/2024;51;1,54;49;1,46;F;80,4;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,527,2,5,FALSE,,5,0,527,2,100%,null,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,255,5,175,,,175,255,5,100%,null;Bevacizumab 100mg polv iny,,367,5,7,5,FALSE,,7,5,367,5,100%,null;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,Bevacizumab;Revisar manualmente;Beva,CARBO,INF,PACLI,PLATINO,TAXOL;Tumor maligno del ovario;1
1/10/2024;47;1,63;68;1,78;F;102,3;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,625,0,625,,,5,0,636,4,98%,AUC 5 FORMULA CALCULADA CON CALVERT CON TFG DE 100.   PROTOCOLO DESENSIBILIZACION,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,311,5,175,,,175,311,5,100%,protocolo desensibilizacion;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,625,0,,,5,0,636,4,98%,CARBOPLATINO 625 MG IV  DOSIS FIJA DIA 22;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,CARBOplatino;Revisar manualmente;CARBO,MAYO ,PACLI,PLATINO;Tumor maligno del ovario;9
1/10/2024;52;1,5;54;1,53;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,270,0,5,,,5,0,270,0,100%,null,,1,15,Frec Check;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,608,400,,,400,612,0,99%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,608,400,,,400,0,612,0,99%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3672,2400,,,2.400,3672,0,100%,null;Bevacizumab 100mg polv iny,,405,7,5,TRUE,,5,405,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3672,2400,,,2.400,3672,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,612,400,,,400,612,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,612,400,,,400,612,0,100%;;;;;;;8;Bevacizumab,Folinato,Fluorouracilo,Fluorouracilo,Bevacizumab,Fluorouracilo,Fluorouracilo,Folinato;Revisar manualmente;Beva,FLUORO,Folin,INF;Tumor maligno del colon, parte no especificada;1
1/10/2024;40;1,5;44;1,37;F;65,8;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,300,0,300,,3,0,2,0,272,3,110%,null,,1,8,Inconsistente, seg˙n proto: 1,8,15;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,109,6,80,,,80,109,6,100%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,420,0,420,0,100%,null;Trastuzumab 440mg Polv Iny,,288,6,,,6,264,0,109%,null;;;;;;;;;;;4;CARBOplatino,PACLItaxel,PERTUzumab,TRAStuzumab;Revisar manualmente; AC ,CARBO,INF,PACLI,PERTU,PLATINO,TRAIN ,TrastU,10%,AUC;Tumor maligno de la mama, parte no especificada;5
1/10/2024;77;1,65;71;1,83;M;Sin Cr;;Sin Cr;Doxorrubicina liposomal 20mg/10mL (2mg/mL) Susp Iny,,36,6,20,TRUE,,40,0,36,6,100%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;DOXOrubicina_LIPOSOMAL;Revisar manualmente;#N/D;Sarcoma de kaposi de la piel;6
1/10/2024;83;1,7;61;1,7;M;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,TRUE,12.200,0,200,FALSE,,200,0,200,0,6100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;INF,PEMBRO, RT ;Tumor maligno de la piel del cuero cabelludo y del cuello;1
1/10/2024;63;1,65;60;1,67;F;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,400,0,400,TRUE,Dosis fija,3,0,400,0,100%,null,,1,29,Inconsistente, seg˙n proto: 1,15;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,80,80,,,3,180,0,44%,null;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;IPILI,monoagente,NIVO,PERTU, RT ;Melanoma maligno de las otras partes y las no especificadas de la cara;1
1/10/2024;56;1,69;62;1,71;M;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,277,0,180,,,180,0,307,8,90%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3693,6,2400,,,2.400,4104,0,90%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,615,6,400,,,400,0,684,0,90%,null;Calcio folinato 50mg Polv Iny,,615,6,400,,,400,684,0,90%,null;;;;;;;;;;;4;Irinotecan,Fluorouracilo,Fluorouracilo,Folinato;Revisar manualmente;#N/D;Tumor maligno del estomago, parte no especificada;1
1/10/2024;66;1,71;59,5;1,68;M;Sin Cr;;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,672,0,400,,,400,0,672,0,100%,null,,1,15,Frec Check;Cetuximab 100mg/20mL (5mg/mL) Sol Iny,,840,500,TRUE,,400,840,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,672,400,,,400,0,672,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,114,24,85,,,85,142,8,80%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,114,24,85,,,85,142,8,80%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4032,2400,,,2.400,4032,0,100%,null;;;;;;;;;6;Folinato,CETUximab,Fluorouracilo,OXALIplatino,OXALIplatino,Fluorouracilo;Revisar manualmente;CETU,FOLFOX,Oxali,PLATINO,AJUSTE,AJUST,20%;Tumor maligno del colon, parte no especificada;5
1/10/2024;48;1,83;120;2,51;M;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,900,0,8,TRUE,,10,0,900,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;Bevacizumab;Revisar manualmente;#N/D;Tumor maligno del colon, parte no especificada;3
1/10/2024;39;1,75;71;1,87;F;Sin Cr;;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,635,8,400,,,400,0,748,0,85%,Administrar 635 mg iv dia 1,15,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,635,8,400,,,400,748,0,85%,Administrar 635 mg iv dia 1,15;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,158,95,85,,,85,0,159,0,100%,administrar 160 mg iv dia 1,15;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3814,8,2400,,,2.400,4488,0,85%,Administrar  3800 mg iv dia 1,15;;;;;;;;;;;4;Folinato,Fluorouracilo,OXALIplatino,Fluorouracilo;Revisar manualmente;FOLFOX,AJUST,5%,15%,CREA,CREAT;Tumor maligno del colon, parte no especificada;6
2/10/2024;29;1,5;54,4;1,54;F;Sin Cr;0,92;77,5;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,560,0,700,,,6,0,614,9,91%,AJUSTE  DEL  20 %,,1,Frec Check;Docetaxel 20mg/mL Sol Iny,,98,18,75,,,75,115,5,85%,AJUSTE DEL  15 %;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,420,0,420,0,100%,null;Trastuzumab 440mg Polv Iny,,326,4,6,,,6,326,4,100%,null;;;;;;;;;;;4;CARBOplatino,DOCEtaxel,PERTUzumab,TRAStuzumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;1
2/10/2024;32;1,51;48,5;1,45;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,450,0,10,TRUE,,15,0,485,0,93%,null,,1,21,Inconsistente, seg˙n proto: 1;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,200,0,100%,null;;;;;;;;;;;;;2;Bevacizumab,PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno de exocervix;17
2/10/2024;34;1,63;50,6;1,52;F;Sin Cr;;Sin Cr;Trastuzumab 440mg Polv Iny,,288,0,6,,,6,0,303,6,95%,null,,1,Frec Check;;;;;;;;;;;;;;1;TRAStuzumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;21
2/10/2024;31;1,67;65;1,75;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,140,0,80,,,80,0,140,0,100%,Placlitaxel 80 mg/m2  (1-8-5-22: 4 semanas).,,1,8,15,22,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;1
2/10/2024;29;1,49;53;1,51;F;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,113,3,75,,,75,0,113,3,100%,null,,1,Frec Check;Ciclofosfamida 500mg  Polv Iny,,906,600,,,600,906,0,100%,null;;;;;;;;;;;;;2;DOCEtaxel,CICLOfosfamida;Revisar manualmente;INF,TC ,10%,100%;Tumor maligno de la mama, parte no especificada;2
2/10/2024;34;1,67;67;1,78;F;Sin Cr;0,71;118,1;Docetaxel 20mg/mL Sol Iny,,131,3,75,,,75,0,133,5,98%,null,,1,Frec Check;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,420,420,0,100%,null;Trastuzumab 440mg Polv Iny,,390,6,,,6,0,402,0,97%,null;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,650,650,,5,6,715,4,91%,null;;;;;;;;;;;4;DOCEtaxel,PERTUzumab,TRAStuzumab,CARBOplatino;Revisar manualmente;INF;Tumor maligno de la mama, parte no especificada;3
2/10/2024;28;1,57;75;1,86;F;Sin Cr;0,59;168,1;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,225,0,225,,1,50,2,0,222,0,101%,CARBOPLATINO (AUC 1.5) DOSIS TOTAL 225 MG IV EN INFUSI√ìN DE 1 HORAS D√çA 1,8,15,,1,8,15,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,148,8,80,TRUE,,60,148,8,100%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,PEMBROlizumab;Revisar manualmente; AC ,CARBO,INF,PACLI,PEMBRO,PLATINO, SC,semanal,50%,100%,AUC;Tumor maligno de la mama, parte no especificada;1
2/10/2024;70;1,71;64,8;1,76;M;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,281,6,200,,,200,0,352,0,80%,null,,1,Frec Check;;;;;;;;;;;;;;1;Irinotecan;Revisar manualmente;Beva,FOLFOX,INF,MAYO ,PLATINO,VIDE,XELIRI,XELIRI,Suspend;Tumor maligno del colon, parte no especificada;4
2/10/2024;78;1,71;50;1,53;M;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,750,0,15,,,15,0,750,0,100%,null,,1,Frec Check;Atezolizumab 1200mg/20mL (60mg/mL) Solucion Inyectable,,1200,0,,,1.200,1200,0,100%,null;;;;;;;;;;;;;2;Bevacizumab,Atezolizumab;Revisar manualmente;Atezo,VIDE,AJUST;Tumor maligno de los bronquios o del pulmon, parte no especificada;1
2/10/2024;77;1,55;58;1,61;M;Sin Cr;;Sin Cr;Atezolizumab 1200mg/20mL (60mg/mL) Solucion Inyectable,,1.200,0,0,,,1.200,0,1200,0,100%,null,,null,Revise recomd, seg˙n proto: 1;Bevacizumab 100mg polv iny,,870,15,,,15,870,0,100%,null;;;;;;;;;;;;;2;Atezolizumab,Bevacizumab;Revisar manualmente;Atezo,Beva,RICE,VIDE,AJUST,20%,70%,Suspend;Tumor maligno del higado, no especificado;4
2/10/2024;74;1,71;73;1,88;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.512,0,2.400,,,2.400,0,4512,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,752,400,,,400,752,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,159,8,85,,,85,0,159,8,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,159,8,85,,,85,159,8,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,752,400,,,400,752,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;Revisar manualmente;#N/D;Tumor maligno del colon, parte no especificada;5
2/10/2024;71;1,59;51;1,51;M;Sin Cr;;Sin Cr;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,120,8,80,,,80,0,120,8,100%,null,,1,8,15,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,120,8,80,,,80,120,8,100%,null;Ramucirumab  100mg/10mL (10mg/mL) Sol Iny,,408,8,,,8,0,408,0,100%,null;;;;;;;;;;;;3;PACLItaxel,PACLItaxel,Ramucirumab;Revisar manualmente;#N/D;Tumor maligno del estomago, parte no especificada;1
2/10/2024;69;1,55;58;1,61;M;64,3;;Sin Cr;Bevacizumab 100mg polv iny,,870,0,15,,,15,0,870,0,100%,null,,1,Frec Check;Pemetrexed 500mg Polv Iny,,805,500,,,500,805,0,100%,null;;;;;;;;;;;;;2;Bevacizumab,Pemetrexed;Revisar manualmente;Beva,INF,Peme,PLATINO;Mesotelioma de la pleura;10
2/10/2024;75;1,57;65;1,72;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,325,0,5,,,5,0,325,0,100%,null,,1,15,Frec Check;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,550,4,400,,,400,688,0,80%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,550,4,400,,,400,0,688,0,80%,null;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,247,68,180,,,180,309,6,80%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3302,4,2400,,,2.400,4128,0,80%,null;;;;;;;;;;5;Bevacizumab,Folinato,Fluorouracilo,Irinotecan,Fluorouracilo;Revisar manualmente;Beva,Folin,INF,Irino, SC,AJUSTE,BOLO ,AJUST,20%,CREA,CREAT;Tumor maligno del colon, parte no especificada;5
2/10/2024;84;1,52;65;1,7;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;PEMBRO,100%,CREA;Tumor maligno del colon, parte no especificada;1
2/10/2024;82;1,52;67;1,73;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,495,0,7,,,7,5,502,5,99%,null,,1,Frec Check;;;;;;;;;;;;;;1;Bevacizumab;Revisar manualmente;AVEX,Beva,Capec,INF,Suspend;Tumor maligno del colon, parte no especificada;3
2/10/2024;63;1,6;61;1,67;F;Sin Cr;0,66;84;Bevacizumab 100mg polv iny,TRUE,770,0,770,,15,0,10,0,915,0,84%,null,,1,Inconsistente, seg˙n proto: 1,15;Doxorrubicina liposomal 20mg/10mL (2mg/mL) Susp Iny,TRUE,40,40,,,30,50,1,80%,null;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,TRUE,450,450,,,5,0,545,1,83%,null;;;;;;;;;;;;3;Bevacizumab,DOXOrubicina_LIPOSOMAL,CARBOplatino;Revisar manualmente;#N/D;Tumor maligno del ovario;6
2/10/2024;52;1,55;68,5;1,76;F;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,205,5,3,,,3,0,205,5,100%,,,,1,15,Frec Check;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,205,5,3,,,3,205,5,100%,,;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;INF,NIVO,TC ;Melanoma maligno de piel, sitio no especificado;3
2/10/2024;50;1,5;48;1,44;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;INF,PEMBRO;Tumor maligno del cuello del utero, sin otra especificacion;6
2/10/2024;46;1,49;37;1,24;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,555,0,15,,,15,0,555,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,200,0,100%,null;;;;;;;;;;;;;2;Bevacizumab,PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno del endocervix;1
2/10/2024;49;1,87;87;2,13;M;Sin Cr;;Sin Cr;Bleomicina sulfato 15 UI (10mg) Polv Iny,,30,0,30,,,30,0,30,0,100%,null,,1,8,15,Frec Check;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,42,6,20,,,20,42,6,100%,null;Etoposido 100mg/5mL (20mg/mL) Sol Iny,,217,100,,,100,0,213,0,102%,null;;;;;;;;;;;;3;Bleomicina sulfato,CISplatino,Etoposido;Revisar manualmente;#N/D;Tumor maligno del testiculo, no especificado;2
2/10/2024;50;1,6;65;1,73;F;Sin Cr;0,63;109,6;Docetaxel 20mg/mL Sol Iny,,129,8,75,,,75,0,129,8,100%,null,,1,Frec Check;Trastuzumab 440mg Polv Iny,,520,8,FALSE,,8,520,0,100%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,840,840,,,840,0,840,0,100%,null;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,600,600,,,5,643,7,93%,null;;;;;;;;;;;4;DOCEtaxel,TRAStuzumab,PERTUzumab,CARBOplatino;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;1
2/10/2024;39;1,57;67;1,75;F;Sin Cr;;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,1.050,0,600,,,600,0,1050,0,100%,null,,1,15,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,105,60,,,60,105,0,100%,null;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;Revisar manualmente; AC ,INF,semanal,TAXANO,40%;Tumor maligno de la mama, parte no especificada;1
2/10/2024;43;1,59;51,3;1,52;F;Sin Cr;;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,729,6,600,,,600,0,912,0,80%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,72,96,60,,,60,91,2,80%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;;;;;;;;;;;;3;CICLOfosfamida,DOXOrubicina,PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;3
2/10/2024;59;1,52;43;1,36;F;Sin Cr;;Sin Cr;Gemcitabina 1000mg/100mL (10mg/mL) Sol Iny,,918,0,675,,675,0,1.000,0,918,0,100%,null,,1,8,Frec Check;Docetaxel 20mg/mL Sol Iny,,102,75,,,75,102,0,100%,null;;;;;;;;;;;;;2;GEMcitabina,DOCEtaxel;Revisar manualmente;DOCE,Eribu,GEMci, SC,Trabe,VIDE,100%;Tumor maligno del retroperitoneo;1
2/10/2024;61;1,48;65,7;1,7;F;51,1;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,304,2,4,,,4,0,304,2,100%,null,,1,Frec Check;Gemcitabina 1000mg/100mL (10mg/mL) Sol Iny,,1530,1000,,,1.000,1700,0,90%,ajuste del  10 %;;;;;;;;;;;;;2;CARBOplatino,GEMcitabina;Revisar manualmente;CARBO,GEMci,INF,PLATINO, SC,AJUST,10%,AUC;Tumor maligno del ovario;1
2/10/2024;55;1,51;61;1,64;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,305,0,5,,,5,0,305,0,100%,null,,1,15,Frec Check;Calcio folinato 50mg Polv Iny,,557,6,400,,,400,656,0,85%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,557,6,400,,,400,0,656,0,85%,null;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,206,64,180,,,180,295,2,70%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3345,6,2400,,,2.400,3936,0,85%,null;;;;;;;;;;5;Bevacizumab,Folinato,Fluorouracilo,Irinotecan,Fluorouracilo;Revisar manualmente;Beva,FLUORO,FOLFIRI,Folin,INF,Irino, SC,AJUSTE,AJUST,5%,15%,30%;Tumor maligno del colon, parte no especificada;11
2/10/2024;59;1,52;59;1,62;F;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,480,0,480,,Dosis fija,3,0,3,0,16000%,null,,1,Frec Check;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,480,480,,,3,177,0,271%,null;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;#N/D;Melanoma maligno de piel, sitio no especificado;42
2/10/2024;53;1,54;55;1,56;F;74,3;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,496,7,5,,,5,0,496,6,100%,REC15022021-2,,1,Frec Check;Doxorrubicina liposomal 20mg/10mL (2mg/mL) Susp Iny,,46,8,30,,,30,46,8,100%,null;;;;;;;;;;;;;2;CARBOplatino,DOXOrubicina_LIPOSOMAL;Revisar manualmente;Beva,CARBO,DOXO,DOXO,Doxo Lipo,PLATINO,TAXANO,TAXOL,VIDE,supende;Tumor maligno del ovario;1
2/10/2024;42;1,6;58;1,63;F;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,122,3,75,,,80,0,130,4,94%,null,,1,Inconsistente, seg˙n proto: 2;Etoposido 100mg/5mL (20mg/mL) Sol Iny,,163,100,,,100,163,0,100%,null;;;;;;;;;;;;;2;CISplatino,Etoposido;Revisar manualmente;CisplA,PLATINO,VIDE,5%,95%;Tumor maligno de glandula endocrina no especificada;1
2/10/2024;75;1,43;67,6;1,71;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno del colon, parte no especificada;21
2/10/2024;73;1,5;44;1,37;F;Sin Cr;;Sin Cr;Gemcitabina 1000mg/100mL (10mg/mL) Sol Iny,,1.370,0,1.000,,,1.000,0,1370,0,100%,null,,1,8,15,Frec Check;;;;;;;;;;;;;;1;GEMcitabina;Revisar manualmente;#N/D;Tumor maligno de la cabeza del pancreas;1
2/10/2024;73;1,52;54;1,54;F;Sin Cr;;Sin Cr;Trastuzumab 440mg Polv Iny,,336,0,6,,,6,0,324,0,104%,null,,1,Frec Check;;;;;;;;;;;;;;1;TRAStuzumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;4
2/10/2024;67;1,57;70;1,79;F;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,322,2,180,,,180,0,322,2,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4296,2400,,,2.400,4296,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,716,400,,,400,0,716,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,716,400,,,400,716,0,100%,null;;;;;;;;;;;4;Irinotecan,Fluorouracilo,Fluorouracilo,Folinato;Revisar manualmente;Beva,FOLFIRI,XELOX;Tumor maligno del recto;1
2/10/2024;79;1,83;91;2,16;M;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,455,0,5,,,5,0,455,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,5184,2400,,,2.400,5184,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,864,400,,,400,0,864,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,864,400,,,400,864,0,100%,null;;;;;;;;;;;4;Bevacizumab,Fluorouracilo,Fluorouracilo,Folinato;Revisar manualmente;GRAMONT,PLATINO,VIDE,AJUST;Tumor maligno del colon, parte no especificada;7
2/10/2024;81;1,72;74;1,9;M;51,8;;Sin Cr;Pemetrexed 500mg Polv Iny,,930,0,500,,,500,0,950,0,98%,null,,1,Frec Check;Pemetrexed 100mg Polv Iny,,930,500,,,500,950,0,98%,null;;;;;;;;;;;;;2;Pemetrexed,Pemetrexed;Revisar manualmente;CARBO,INF,Peme,PLATINO;Mesotelioma de la pleura;2
2/10/2024;74;1,57;56;1,59;M;Sin Cr;;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,640,0,400,,,400,0,636,0,101%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,640,400,,,400,636,0,101%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3816,2400,,,2.400,0,3816,0,100%,null;;;;;;;;;;;;3;Folinato,Fluorouracilo,Fluorouracilo;Revisar manualmente;FOLFOX,INF,VIDE,100%,Suspend;Tumor maligno del estomago, parte no especificada;1
2/10/2024;63;1,56;51;1,5;F;65,3;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,451,5,5,,,5,0,451,5,100%,,,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,262,5,175,,,175,262,5,100%,,;;;;;;;;;;;;;2;CARBOplatino,PACLItaxel;Revisar manualmente;CARBO,INF;Tumor maligno del endometrio;1
2/10/2024;61;1,6;63;1,7;F;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,127,5,75,,,75,0,127,5,100%,null,,1,Frec Check;Ciclofosfamida 1gr (1000mg) Polv Iny,,1020,600,,,600,1020,0,100%,null;Ciclofosfamida 500mg  Polv Iny,,1020,600,,,600,0,1020,0,100%,null;;;;;;;;;;;;3;DOCEtaxel,Ciclofosfamida,CICLOfosfamida;Revisar manualmente;INF,TC ;Tumor maligno de la mama, parte no especificada;1
2/10/2024;59;1,61;83;1,98;F;Sin Cr;1,08;73,5;Bevacizumab 100mg polv iny,,1.275,0,15,,,15,0,1245,0,102%,null,,1,Frec Check;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,325,325,,,4,325,7,100%,null;Gemcitabina 1000mg/100mL (10mg/mL) Sol Iny,,1683,1000,,,1.000,0,1980,0,85%,null;;;;;;;;;;;;3;Bevacizumab,CARBOplatino,GEMcitabina;Revisar manualmente;#N/D;Tumor maligno del ovario;4
2/10/2024;56;1,6;50,6;1,51;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,Frec Check;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,113,25,100,TRUE,,60,151,0,75%,AJUSTE DEL  25 %;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,FALSE,1500,1500,FALSE,,4.000,0,6040,0,25%,EN INFUSION CONTINUA  DE  96  HORAS;;;;;;;;;;;;3;PEMBROlizumab,CISplatino,Fluorouracilo;Revisar manualmente;#N/D;Tumor maligno de la cara dorsal de la lengua;1
2/10/2024;53;1,55;50;1,48;F;Sin Cr;;Sin Cr;Doxorrubicina liposomal 20mg/10mL (2mg/mL) Susp Iny,,53,3,40,,,40,0,59,2,90%,AJUSTE DEL 10 %,,1,Frec Check;;;;;;;;;;;;;;1;DOXOrubicina_LIPOSOMAL;Revisar manualmente;DOXO,DOXO,IFOSF, SC,AJUST,10%;Tumor maligno del endometrio;1
2/10/2024;53;1,61;64;1,72;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;1
2/10/2024;50;1,5;56;1,56;F;88,8;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,Frec Check;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,569,05,5,,,5,569,0,100%,null;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,124,8,80,,,80,0,124,8,100%,null;;;;;;;;;;;;3;PEMBROlizumab,CARBOplatino,PACLItaxel;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;2
2/10/2024;51;1,58;62;1,68;F;Sin Cr;0,74;88;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,264,0,330,,3,0,6,0,339,1,78%,null,,1,8,Inconsistente, seg˙n proto: 1;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,107,52,80,,,80,134,4,80%,null;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,107,52,80,,,80,0,134,4,80%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,TRUE,,840,420,0,100%,null;Trastuzumab 440mg Polv Iny,,372,6,TRUE,,8,372,0,100%,null;;;;;;;;;;5;CARBOplatino,PACLItaxel,PACLItaxel,PERTUzumab,TRAStuzumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;1
2/10/2024;48;1,52;60;1,63;F;Sin Cr;;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,978,0,600,,,600,0,978,0,100%,null,,1,15,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,97,8,60,,,60,97,8,100%,null;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;Revisar manualmente; AC ,CICLOF,DOXO,DOXO,INF,PACLI, SC,semanal,TAXANO,30%,100%;Tumor maligno de la mama, parte no especificada;1
2/10/2024;49;1,63;82;1,97;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,1.230,0,15,TRUE,,10,0,1230,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;Bevacizumab;Revisar manualmente;Beva,semanal,CREA,CREAT;Tumor maligno del ovario;1
2/10/2024;47;1,56;67;1,75;F;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.550,0,2.600,,,2.600,0,4550,0,100%,null,,1,15,Frec Check;Calcio folinato 50mg Polv Iny,,350,200,,,200,350,0,100%,null;Docetaxel 80mg/2mL (40mg/mL) Sol Iny,,87,5,50,,,50,0,87,5,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,148,75,85,,,85,148,8,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,148,75,85,,,85,148,8,100%,null;Docetaxel 20mg/mL Sol Iny,,87,5,50,,,50,87,5,100%,null;Docetaxel 20mg/mL Sol Iny,,87,5,50,,,50,87,5,100%,null;Docetaxel 20mg/mL Sol Iny,,87,5,50,,,50,87,5,100%;;;;;;;8;Fluorouracilo,Folinato,DOCEtaxel,OXALIplatino,OXALIplatino,DOCEtaxel,DOCEtaxel,DOCEtaxel;Revisar manualmente;FLOT;Tumor maligno del estomago, parte no especificada;1
2/10/2024;43;1,51;59;1,61;F;Sin Cr;0,64;105,6;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,257,0,257,,,2,0,261,1,98%,null,,1,8,15,Frec Check;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,128,80,TRUE,,60,128,8,99%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,PEMBROlizumab;Revisar manualmente;CARBO,INF,PACLI,PEMBRO,PLATINO,30%;Tumor maligno de la mama, parte no especificada;4
2/10/2024;53;1,61;62,6;1,7;F;Sin Cr;;Sin Cr;Doxorrubicina liposomal 20mg/10mL (2mg/mL) Susp Iny,,48,6,30,TRUE,,40,0,51,0,95%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOXOrubicina_LIPOSOMAL;Revisar manualmente;DOXO,DOXO,Doxo Lipo, SC,Trabe,5%,55%;Tumor maligno del retroperitoneo;1
2/10/2024;44;1,51;72;1,8;F;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,72,0,40,TRUE,,35,0,72,0,100%,null,,1,8,15,22,29,36,Inconsistente, seg˙n proto: 1,8,15,22,29;;;;;;;;;;;;;;1;CISplatino;Revisar manualmente;#N/D;Tumor maligno de exocervix;1
2/10/2024;44;1,45;56;1,55;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,124,0,80,,,80,0,124,0,100%,4 SEMANAS,,1,8,15,22,Inconsistente, seg˙n proto: 1,8,15;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,420,420,0,100%,DIAS 1 Y 22;Trastuzumab 440mg Polv Iny,,336,6,TRUE,,2,0,336,0,100%,null;;;;;;;;;;;;3;PACLItaxel,PERTUzumab,TRAStuzumab;Revisar manualmente;PACLI,PERTU,TAXANO,TrastU;Tumor maligno de la mama, parte no especificada;1
2/10/2024;59;1,65;65;1,75;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,400,0,400,,,400,0,400,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;PEMBRO;Tumor maligno del ri√±on, excepto de la pelvis renal;23
2/10/2024;61;1,69;79;1,96;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.704,0,2.400,,,2.400,0,4704,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,784,400,,,400,784,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,133,28,85,,,85,0,166,6,80%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,133,28,85,,,85,166,6,80%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,784,400,,,400,784,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;Revisar manualmente;Capec,FOLFOX,MAYO ,Oxali,PLATINO,AJUSTE,AJUST,20%;Tumor maligno del colon, parte no especificada;2
2/10/2024;59;1,75;60;1,7;M;Sin Cr;0,76;88,8;Pemetrexed 100mg Polv Iny,,850,0,500,,,500,0,850,0,100%,null,,1,Frec Check;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,550,550,,,5,569,1,97%,null;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,360,360,,,360,0,21600,0,2%,null;;;;;;;;;;;;3;Pemetrexed,CARBOplatino,NIVOLUmab;Revisar manualmente;CARBO,INF,NIVO,Peme;Tumor maligno de los bronquios o del pulmon, parte no especificada;1
2/10/2024;51;1,8;81;2,02;M;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;INF,PEMBRO;Tumor maligno del ri√±on, excepto de la pelvis renal;2
2/10/2024;45;1,75;70;1,85;M;Sin Cr;;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,740,0,400,,,400,0,740,0,100%,null,,1,15,Frec Check;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,740,400,,,400,740,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4440,2400,,,2.400,0,4440,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4440,2400,,,2.400,4440,0,100%,null;Bevacizumab 100mg polv iny,,350,5,,,5,350,0,100%,null;Bevacizumab 100mg polv iny,,350,5,,,5,350,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,740,400,,,400,740,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,740,400,,,400,740,0,100%;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,740,400,,,400,740,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4440,2400,,,2.400,4440,0,100%,null;Bevacizumab 100mg polv iny,,350,5,,,5,350,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,740,400,,,400,740,0,100%,null;;;12;Folinato,Folinato,Fluorouracilo,Fluorouracilo,Bevacizumab,Bevacizumab,Fluorouracilo,Fluorouracilo,Folinato,Fluorouracilo,Bevacizumab,Fluorouracilo;Revisar manualmente;#N/D;Tumor maligno del colon, parte no especificada;2
2/10/2024;43;1,65;85;2,02;M;98,7;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,620,0,620,,,5,0,618,6,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;CARBOplatino;Revisar manualmente;CARBO,INF,PLATINO,AUC;Tumor maligno del testiculo, no especificado;1
2/10/2024;43;1,71;50;1,53;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,612,0,400,,,400,0,612,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,612,400,,,400,612,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,612,400,,,400,0,612,0,100%,null;Panitumumab 100mg/5mL (20mg/mL) Sol Iny,,250,5,,,6,300,0,83%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,Folinato,PANItumumab;Revisar manualmente;PANItU,100%;Tumor maligno del colon, parte no especificada;1
2/10/2024;62;1,72;66;1,78;M;Sin Cr;;Sin Cr;Cabazitaxel 60mg/1.5mL (4%) Sol Iny,TRUE,44,5,25,FALSE,,20,0,35,6,125%,null,,1,Frec Check;;;;;;;;;;;;;;1;CABAzitaxel;Revisar manualmente;CABAzI,DOCE;Tumor maligno de la prostata;9
2/10/2024;59;1,69;74,7;1,9;F;Sin Cr;;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,744,0,400,,,400,0,760,0,98%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,744,400,,,400,760,0,98%,null;Panitumumab 100mg/5mL (20mg/mL) Sol Iny,,448,2,6,,,6,0,448,2,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4560,2400,,,2.400,4560,0,100%,null;;;;;;;;;;;4;Folinato,Fluorouracilo,PANItumumab,Fluorouracilo;Revisar manualmente;Folin,INF,BOLO ;Tumor maligno del colon, parte no especificada;1
2/10/2024;59;1,73;96;2,19;M;Sin Cr;1,93;56;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,TRUE,140,0,140,,,2,0,125,1,112%,null,,1,8,Frec Check;Gemcitabina 1000mg/100mL (10mg/mL) Sol Iny,TRUE,1800,1800,,,1.000,2190,0,82%,null;;;;;;;;;;;;;2;CARBOplatino,GEMcitabina;Revisar manualmente;Avelu,CARBO,GEMci,PLATINO, SC,AUC;Tumor maligno del ri√±on, excepto de la pelvis renal;1
2/10/2024;56;1,62;52;1,54;M;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,277,2,180,,,180,0,277,2,100%,null,,1,15,Frec Check;;;;;;;;;;;;;;1;Irinotecan;Revisar manualmente;FLOT,Irino,monoagente;Tumor maligno del estomago, parte no especificada;4
2/10/2024;72;1,6;45;1,41;M;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,FALSE,4.500,0,100,,,3,0,135,0,3333%,DOSIS TOTA 135 MG iv DIS 1 Y 15,,1,15,Inconsistente, seg˙n proto: 1;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,40,40,,,3,135,0,30%,DOSIS TOTA 135 MG iv DIS 1 Y 15;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;CONCURRENTE,MAYO ,NIVO,PLATINO,100%,CREA,CREAT;Tumor maligno de la pared posterior de la orofaringe;1
3/10/2024;57;1,82;79;2;M;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,200,0,100,,,100,0,200,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;CISplatino;Revisar manualmente;#N/D;Tumor maligno de la orofaringe, parte no especificada;1
3/10/2024;35;1,53;51;1,49;F;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,59,6,40,TRUE,,35,0,59,6,100%,concomitante con rt,,1,8,15,22,29,Frec Check;;;;;;;;;;;;;;1;CISplatino;Revisar manualmente;CisplA,INF,PLATINO;Tumor maligno del cuello del utero, sin otra especificacion;1
3/10/2024;25;1,55;45;1,4;F;Sin Cr;;Sin Cr;Doxorrubicina liposomal 20mg/10mL (2mg/mL) Susp Iny,,57,0,57,,,40,0,56,0,102%,Doxorrubicina (40mg/m2). Dosis calculada 57 mg IV. Administrar d√≠a 1.     *. Dosis acumulada m√°xima de Doxorubicina Liposomal (550 - 600 mg/m2).     *. Dosis actual actual: 400 mg/m2.,,1,Frec Check;;;;;;;;;;;;;;1;DOXOrubicina_LIPOSOMAL;Revisar manualmente;DOXO,DOXO, SC,AJUSTE,AJUST,CREA,CREAT;Tumor maligno de la mama, parte no especificada;10
3/10/2024;27;1,65;79;1,94;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,1.185,0,15,,,15,0,1185,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;Gemcitabina 1000mg/100mL (10mg/mL) Sol Iny,,1780,1000,,,1.000,1940,0,92%,null;;;;;;;;;;;;;2;Bevacizumab,GEMcitabina;Revisar manualmente;Beva,GEMci,Suspend;Tumor maligno del ovario;11
3/10/2024;32;1,59;75;1,87;F;Sin Cr;0,64;149,4;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,330,0,330,,,2,0,348,8,95%,Carboplatino (AUC 2). Dosis calculada 330 mg IV. Administrar d√≠as 1 y 8.,,1,8,Frec Check;Gemcitabina 1000mg/100mL (10mg/mL) Sol Iny,,1770,1770,,,1.000,1870,0,95%,Gemcitabina (1000 mg/m2). Dosis calculada 1770 mg IV. Administrar d√≠as 1 y 8.;;;;;;;;;;;;;2;CARBOplatino,GEMcitabina;Revisar manualmente;CARBO,GEMci,PLATINO, SC,AJUST,5%,85%,AUC,CREA,CREAT;Tumor maligno de la mama, parte no especificada;6
3/10/2024;68;1,67;69;1,81;M;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,480,0,480,TRUE,dosis fija,3,0,480,0,100%,null,,1,29,Inconsistente, seg˙n proto: 1;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,480,480,,,3,207,0,232%,null;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;#N/D;Tumor maligno del ri√±on, excepto de la pelvis renal;1
3/10/2024;62;1,74;77;1,95;M;Sin Cr;;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,768,0,400,,,400,0,780,0,98%,,,,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,768,400,,,400,780,0,98%,.;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,163,2,85,,,85,0,165,8,98%,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4680,2400,,,2.400,4680,0,100%,null;;;;;;;;;;;4;Folinato,Fluorouracilo,OXALIplatino,Fluorouracilo;Revisar manualmente;Beva,FLUORO,FOLFOX,VIDE;Tumor maligno del colon, parte no especificada;2
3/10/2024;77;1,73;85;2,05;M;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,Pembrolizumab 200 mg IV. Administrar d√≠a 1.,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;PEMBRO,CREA,CREAT;Tumor maligno del ri√±on, excepto de la pelvis renal;9
3/10/2024;66;1,56;49,8;1,48;M;Sin Cr;1,37;37,4;Pemetrexed 100mg Polv Iny,,740,0,500,,,500,0,740,0,100%,null,,1,Frec Check;Pemetrexed 500mg Polv Iny,,740,500,,,500,740,0,100%,null;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,360,360,,,5,0,394,7,91%,null;;;;;;;;;;;;3;Pemetrexed,Pemetrexed,CARBOplatino;Revisar manualmente;#N/D;Tumor maligno de los bronquios o del pulmon, parte no especificada;1
3/10/2024;75;1,63;58;1,63;M;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,120,0,120,,,75,0,122,3,98%,Cisplatino (75 mg/m2). Dosis calculada 120 mg IV. Administrar d√≠a 1.,,1,Frec Check;Pemetrexed 500mg Polv Iny,,800,800,,,500,815,0,98%,Pemetrexed (500 mg/m2). Dosis calculada  800 mg IV. Administrar el d√≠a 1.;;;;;;;;;;;;;2;CISplatino,Pemetrexed;Revisar manualmente;CONCURRENTE;Tumor maligno de los bronquios o del pulmon, parte no especificada;1
3/10/2024;73;1,63;49;1,49;M;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,245,0,5,,,5,0,245,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3576,2400,,,2.400,3576,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,596,400,,,400,0,596,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,126,65,85,,,85,126,7,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,596,400,,,400,596,0,100%,null;;;;;;;;;;5;Bevacizumab,Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;Revisar manualmente;#N/D;Tumor maligno del colon, parte no especificada;4
3/10/2024;72;1,7;75;1,91;M;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,400,0,400,,,400,0,400,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno del ri√±on, excepto de la pelvis renal;1
3/10/2024;70;1,73;73,3;1,89;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.536,0,2.400,,,2.400,0,4536,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,756,400,,,400,756,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,160,65,85,,,85,0,160,7,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,160,65,85,,,85,160,7,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,756,400,,,400,756,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;Revisar manualmente;#N/D;Tumor maligno del estomago, parte no especificada;2
3/10/2024;81;1,65;59;1,66;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,400,0,400,,,400,0,400,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;MAYO ,PEMBRO;Tumor maligno del colon, parte no especificada;3
3/10/2024;68;1,6;58,3;1,63;F;Sin Cr;;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,554,2,400,,,400,0,652,0,85%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,554,2,400,,,400,652,0,85%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,124,7,85,,,85,0,138,6,90%,;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,124,7,85,,,85,138,6,90%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3325,2,2400,,,2.400,3912,0,85%,null;;;;;;;;;;5;Folinato,Fluorouracilo,OXALIplatino,OXALIplatino,Fluorouracilo;Revisar manualmente;FOLFOX,VIDE,AJUSTE,AJUST;Tumor maligno del estomago, parte no especificada;7
3/10/2024;64;1,58;66;1,74;F;Sin Cr;;Sin Cr;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,66,0,1,,,1,0,66,0,100%,null,,1,Frec Check;Ipilimumab 50mg/10mL(5mg/mL) Sol Iny,,198,3,,,3,198,0,100%,null;;;;;;;;;;;;;2;NIVOLUmab,IPILImumab;Revisar manualmente;INF,IPILI,NIVO;Melanoma maligno de la oreja y del conducto auditivo externo;1
3/10/2024;67;1,45;63;1,65;F;Sin Cr;;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,1.050,0,600,,,600,0,990,0,106%,,,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,105,60,,,60,99,0,106%,,;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;;;;;;;;;;;;3;CICLOfosfamida,DOXOrubicina,PEMBROlizumab;Revisar manualmente; AC ,CARBO,CICLOF,DOXO,DOXO,INF,PACLI,PEMBRO,PLATINO,VIDE,90%;Tumor maligno de la mama, parte no especificada;4
3/10/2024;83;1,45;53,6;1,51;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,400,0,400,,,400,0,400,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno del ri√±on, excepto de la pelvis renal;1
3/10/2024;61;1,55;65;1,71;F;Sin Cr;0,64;94,7;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,550,0,550,,,5,0,598,6,92%,null,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,299,25,175,,,175,299,3,100%,null;;;;;;;;;;;;;2;CARBOplatino,PACLItaxel;Revisar manualmente;CARBO,INF,PACLI,PLATINO;Tumor maligno del endometrio;3
3/10/2024;72;1,61;76;1,89;F;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,70,0,70,,,35,0,66,2,106%,null,,1,8,15,22,29,36,Inconsistente, seg˙n proto: 1,8,15,22,29;;;;;;;;;;;;;;1;CISplatino;Revisar manualmente;CisplA,INF,PLATINO,semanal;Tumor maligno de exocervix;1
3/10/2024;51;1,56;60;1,64;F;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,295,2,180,,,180,0,295,2,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3936,2400,,,2.400,3936,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,656,400,,,400,0,656,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,656,400,,,400,656,0,100%,null;;;;;;;;;;;4;Irinotecan,Fluorouracilo,Fluorouracilo,Folinato;Revisar manualmente;CAPEOX,FOLFIRI,INF;Tumor maligno del recto;1
3/10/2024;72;1,65;69;1,8;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,400,0,400,,,400,0,400,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno del ri√±on, excepto de la pelvis renal;1
3/10/2024;51;1,61;72,7;1,84;F;Sin Cr;0,57;134;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,625,0,625,,,5,0,652,7,96%,auc 5,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,320,25,175,,,175,322,0,99%,null;;;;;;;;;;;;;2;CARBOplatino,PACLItaxel;Revisar manualmente;#N/D;Tumor maligno del ovario;6
3/10/2024;56;1,5;57;1,58;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,855,0,15,,,15,0,855,0,100%,,,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;Bevacizumab;Revisar manualmente;Beva,CARBO,DOXO,DOXO,PACLI,PLATINO,TAXOL,CREA,CREAT;Tumor maligno del ovario;1
3/10/2024;76;1,59;69;1,78;F;54,3;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,430,0,430,,,5,0,396,5,108%,calculado 5 AUC con TFG por ckdepi,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,TRUE,80,80,,,80,142,4,56%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,PEMBROlizumab;Revisar manualmente;CARBO,INF,PACLI,PEMBRO,40%,AUC;Tumor maligno de la mama, parte no especificada;1
3/10/2024;75;1,54;48,3;1,45;F;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,435,0,400,,,400,0,580,0,75%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,435,400,,,400,580,0,75%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,92,44,85,,,85,0,123,3,75%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,580,400,,,400,580,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;Revisar manualmente;FOLFOX,AJUSTE,AJUST,5%,25%;Tumor maligno del estomago, parte no especificada;5
3/10/2024;72;1,56;49,5;1,48;F;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,148,5,3,,,3,0,148,5,100%,null,,1,Frec Check;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,148,5,3,,,3,148,5,100%,null;Ipilimumab 50mg/10mL(5mg/mL) Sol Iny,,49,5,1,,,1,0,49,5,100%,null;;;;;;;;;;;;3;NIVOLUmab,NIVOLUmab,IPILImumab;Revisar manualmente;#N/D;Tumor maligno del ri√±on, excepto de la pelvis renal;1
3/10/2024;68;1,68;50,4;1,53;F;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,208,1,170,,,180,0,275,4,76%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3672,2400,,,2.400,3672,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,612,400,,,400,0,612,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,612,400,,,400,612,0,100%,null;;;;;;;;;;;4;Irinotecan,Fluorouracilo,Fluorouracilo,Folinato;Revisar manualmente;#N/D;Tumor maligno del colon, parte no especificada;1
3/10/2024;71;1,67;70,3;1,83;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.392,0,2.400,,,2.400,0,4392,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,732,400,,,400,732,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,732,400,,,400,0,732,0,100%,null;Panitumumab 100mg/5mL (20mg/mL) Sol Iny,,316,35,6,,,6,421,8,75%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,Folinato,PANItumumab;Revisar manualmente;FLUORO,MAYO ,PANItU,PLATINO,AJUST,50%,Suspend;Tumor maligno del recto;11
3/10/2024;63;1,57;83;1,97;F;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,480,0,480,TRUE,Dosis fija,3,0,480,0,100%,null,,1,29,Inconsistente, seg˙n proto: 1,15;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,480,480,,,3,249,0,193%,null;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;NIVO,AJUST,CREA,CREAT;Tumor maligno del ri√±on, excepto de la pelvis renal;1
3/10/2024;61;1,55;58,8;1,62;F;Sin Cr;;Sin Cr;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,125,0,125,,,80,0,129,6,96%,PACLITAXEL (80 MG/M2). DOSIS CALCULADA 125 MG IV. ADMINISTRAR D√çA 1, 8 Y 15,,1,8,15,Frec Check;Trastuzumab 440mg Polv Iny,,348,348,,,6,352,8,99%,TRASTUZUMAB (6 MG/KG). DOSIS CALCULADA 348 MG IV. ADMINISTRAR D√çA 1.;;;;;;;;;;;;;2;PACLItaxel,TRAStuzumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;3
3/10/2024;60;1,52;39;1,29;F;63,5;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,376,2,5,,,5,0,442,5,85%,null,,1,Frec Check;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,191,89,175,,,175,225,8,85%,null;;;;;;;;;;;;;2;CARBOplatino,PACLItaxel;Revisar manualmente;CARBO,INF,TAXOL,AJUST;Tumor maligno del ovario;5
3/10/2024;60;1,57;66;1,73;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,650,0,10,,,10,0,660,0,98%,null,,1,21,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;Bevacizumab;Revisar manualmente;#N/D;Tumor maligno del ovario;11
3/10/2024;54;1,49;64;1,68;F;Sin Cr;0,85;76,4;Bevacizumab 100mg polv iny,,640,0,10,,,10,0,640,0,100%,null,,1,Frec Check;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,495,495,,,5,507,2,98%,null;Bevacizumab 100mg polv iny,,640,10,,,10,0,640,0,100%,null;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,495,495,,,5,507,2,98%,null;Doxorrubicina liposomal 20mg/10mL (2mg/mL) Susp Iny,,50,4,30,,,30,50,4,100%,null;;;;;;;;;;5;Bevacizumab,CARBOplatino,Bevacizumab,CARBOplatino,DOXOrubicina_LIPOSOMAL;Revisar manualmente;#N/D;Tumor maligno del ovario;1
3/10/2024;54;1,57;68;1,76;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,Se formula 8-9 (terminamos con esto) Pembrolizumab 200 mg iv d√≠a 1- 22 UN LABORATORIO SIRVE PARA LOS DOS CICLOS,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente; GC ,INF,PEMBRO,TC ,100%,Suspend;Tumor maligno de la mama, parte no especificada;9
3/10/2024;54;1,56;79;1,91;F;114,6;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,76,4,40,TRUE,,35,0,76,4,100%,null,,1,8,15,22,29,36,Inconsistente, seg˙n proto: 1,8,15,22,29;;;;;;;;;;;;;;1;CISplatino;Revisar manualmente;CisplA,DOCE,INF,PLATINO,semanal;Tumor maligno de exocervix;1
3/10/2024;52;1,49;58;1,59;F;Sin Cr;;Sin Cr;Mitomicina 20mg polv iny,,16,0,0,FALSE,10,0,7,0,15,9,101%,null,,null,Revise recomd, seg˙n proto: 1;;;;;;;;;;;;;;1;MITOmicina C;Revisar manualmente;Capec,MITOm,NIGRO;Tumor maligno del recto;2
3/10/2024;47;1,48;48;1,43;F;65,9;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,FALSE,,420,0,420,0,100%,null,,1,Frec Check;Trastuzumab 440mg Polv Iny,,288,6,FALSE,,6,288,0,100%,null;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,468,1,5,,,5,0,454,4,103%,null;Docetaxel 20mg/mL Sol Iny,,109,5,75,,,75,107,3,102%,null;Trastuzumab 440mg Polv Iny,,288,6,,,6,288,0,100%,null;Trastuzumab 440mg Polv Iny,,288,6,,,6,288,0,100%,null;Trastuzumab 440mg Polv Iny,,288,6,,,6,288,0,100%,null;Trastuzumab 440mg Polv Iny,,288,6,,,6,288,0,100%;Trastuzumab 440mg Polv Iny,,288,6,,,6,288,0,100%,null;;;;;;9;PERTUzumab,TRAStuzumab,CARBOplatino,DOCEtaxel,TRAStuzumab,TRAStuzumab,TRAStuzumab,TRAStuzumab,TRAStuzumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;2
3/10/2024;52;1,6;54;1,56;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,270,0,5,,,5,0,270,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3744,2400,,,2.400,3744,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,624,400,,,400,0,624,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,132,6,85,,,85,132,6,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,132,6,85,,,85,132,6,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,624,400,,,400,624,0,100%,null;;;;;;;;;6;Bevacizumab,Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;Revisar manualmente;Beva,FOLFOX,INF,AJUSTE,AJUST;Tumor maligno del colon, parte no especificada;6
3/10/2024;39;1,57;73;1,83;F;Sin Cr;0,59;147,5;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,TRUE,570,0,570,,,5,0,694,3,82%,Carboplatino (AUC 5). Dosis calculada 570 mg IV. Administrar d√≠a 1.,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,100,100,,,80,146,4,68%,Paclitaxel (80 mg/m2). Dosis calculada 100 mg IV. Administrar d√≠a 1, 8 y 15.;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,40,40,,,80,0,146,4,27%,Paclitaxel (80 mg/m2). Dosis calculada 40 mg IV. Administrar d√≠a 1, 8 y 15.;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,200,0,100%,Pembrolizumab 200 mg IV. Administrar d√≠a 1.;;;;;;;;;;;4;CARBOplatino,PACLItaxel,PACLItaxel,PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;3
3/10/2024;39;1,56;65;1,72;F;Sin Cr;0,64;121,1;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,TRUE,600,0,600,,5,0,6,0,683,3,88%,Dosis calculada 600 mg/IV. Administrar d√≠a 1.,,1,Frec Check;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,140,140,,,80,137,6,102%,Dosis calculada 140 mg/IV. Administrar d√≠as 1, 8.;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,420,0,420,0,100%,Pertuzumab 420 mg. Administrar d√≠a 1.;Trastuzumab 440mg Polv Iny,,400,400,,,6,390,0,103%,Dosis calculada 400 mg/IV, Administrar d√≠a 1.;;;;;;;;;;;4;CARBOplatino,PACLItaxel,PERTUzumab,TRAStuzumab;Revisar manualmente;CARBO,PACLI,PERTU,PLATINO, SC,TRAIN-2,TrastU,AJUST,AUC,CREA,CREAT;Tumor maligno de la mama, parte no especificada;7
3/10/2024;51;1,55;53,3;1,54;M;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,40,7,33,FALSE,,80,0,123,2,33%,null,,1,2,3,Inconsistente, seg˙n proto: 2;Etoposido 100mg/5mL (20mg/mL) Sol Iny,,123,2,100,,,100,154,0,80%,null;;;;;;;;;;;;;2;CISplatino,Etoposido;Revisar manualmente;CisplA,Etopo,INF,Irino,MAYO ,PLATINO,Temoz,AJUSTE,AJUST,20%;Tumor maligno del nervio olfatorio;3
3/10/2024;66;1,7;60;1,69;M;73,4;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,492,1,5,,,5,0,492,1,100%,REC15022021-2,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,135,2,80,,,80,135,2,100%,null;;;;;;;;;;;;;2;CARBOplatino,PACLItaxel;Revisar manualmente;CARBO,PACLI;Tumor maligno del ano, parte no especificada;3
3/10/2024;53;1,74;72;1,88;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.512,0,2.400,,,2.400,0,4512,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,752,400,,,400,752,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,159,8,85,,,85,0,159,8,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,159,8,85,,,85,159,8,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,752,400,,,400,752,0,100%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,400,400,TRUE,,200,400,0,100%,cada 6 semanas;;;;;;;;;6;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato,PEMBROlizumab;Revisar manualmente;FOLFOX,INF,PEMBRO,5%,15%;Tumor maligno del estomago, parte no especificada;5
3/10/2024;63;1,8;87;2,1;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,5.040,0,2.400,,,2.400,0,5040,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,840,400,,,400,840,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,840,400,,,400,0,840,0,100%,null;Bevacizumab 100mg polv iny,,435,5,,,5,435,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,Folinato,Bevacizumab;Revisar manualmente;Beva,FOLFOX,Oxali,PLATINO,VIDE,AJUSTE,AJUST,5%,15%,CREA,CREAT;Tumor maligno del colon, parte no especificada;6
3/10/2024;57;1,75;57;1,65;M;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,171,0,3,,,3,0,171,0,100%,1 ciclo,,1,15,Frec Check;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,171,3,,,3,171,0,100%,1 ciclo: dia 1- dia 15;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;#N/D;Melanoma maligno del miembro inferior, incluida la cadera;1
4/10/2024;37;1,65;62;1,7;F;Sin Cr;;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,85,0,50,TRUE,,60,0,85,0,100%,,,,1,Frec Check;Trabectedina 1mg Polv iny,,2,2,,,1,1,9,107%,2 mg DOSIS FIJA;;;;;;;;;;;;;2;DOXOrubicina,Trabectedina;Revisar manualmente;#N/D;Tumor maligno del endometrio;4
4/10/2024;36;1,66;118;2,42;M;Sin Cr;;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,48,8,20,,,20,0,48,4,101%,null,,1,2,3,Frec Check;Ifosfamida 1gr (1000mg) Polv Iny,,6100,2500,TRUE,,1.500,6050,0,101%,null;Mesna 400mg/4mL (100mg/mL) Sol Iny,,4800,4800,FALSE,2000,300,0,4840,0,99%,1600 mg hora 0, 4 y 8, dias 1 a 3;;;;;;;;;;;;3;DOXOrubicina,IFOSfamida,Mesna;Revisar manualmente;INF,MAI, RT ,5%,15%,100%;Tumor maligno del tejido conjuntivo y tejido blando del miembro inferior, incluida la cadera;1
4/10/2024;63;1,65;49;1,49;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,2.860,8,2.400,,,2.400,0,3576,0,80%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,596,400,,,400,596,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,101,32,85,,,85,0,126,7,80%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,101,32,85,,,85,126,7,80%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,596,400,,,400,596,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;Revisar manualmente;FOLFOX,INF,VIDE;Tumor maligno del esofago, parte no especificada;1
4/10/2024;75;2;52;1,51;M;Sin Cr;;Sin Cr;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,52,0,1,,,1,0,52,0,100%,null,,1,Frec Check;Ipilimumab 50mg/10mL(5mg/mL) Sol Iny,,156,3,,,3,156,0,100%,null;;;;;;;;;;;;;2;NIVOLUmab,IPILImumab;Revisar manualmente;VIDE;Tumor maligno de la conjuntiva;2
4/10/2024;68;1,68;75;1,9;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,740,0,740,,,400,0,760,0,97%,5 - FU (400 MG/M2). DOSIS CALCULADA 740 MG IV. ADMINISTRAR  EN BOLO LOS D√çAS 1 Y 15.,,1,15,Frec Check;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,745,745,,,400,760,0,98%,√ÅCIDO FOL√çNICO (400MG/M2). DOSIS CALCULADA 745 MG IV. ADMINISTRAR D√çA 1 Y 15 EN INFUSI√ìN DE 120 MINS.;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4470,4470,,,2.400,0,4560,0,98%,DESPU√âS (2400 MG/M2). DOSIS CALCULADA 4470 MG IV. ADMINISTRAR EN INFUSI√ìN CONTINUA DE 48 HORAS.;Bevacizumab 100mg polv iny,,375,375,,,5,375,0,100%,BEVACIZUMAB (5 MG/KG). DOSIS CALCULADA 375 MG IV. ADMINISTRAR D√çA 1 Y 15.;;;;;;;;;;;4;Fluorouracilo,Folinato,Fluorouracilo,Bevacizumab;Revisar manualmente;Beva,INF, SC,AJUSTE,BOLO ,AJUST,CREA,CREAT;Tumor maligno del colon, parte no especificada;11
4/10/2024;57;1,51;42;1,34;F;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,536,0,400,,,400,0,536,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3216,2400,,,2.400,3216,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,113,9,85,,,85,0,113,9,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,113,9,85,,,85,113,9,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,536,400,,,400,536,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;Revisar manualmente;#N/D;Tumor maligno del colon, parte no especificada;2
4/10/2024;65;1,6;55;1,58;F;Sin Cr;;Sin Cr;Nab-Paclitaxel 100mg Polv Iny,,197,5,125,,,125,0,197,5,100%,REC15022021-C,,1,8,15,Frec Check;Gemcitabina 1000mg/100mL (10mg/mL) Sol Iny,,1580,1000,,,1.000,1580,0,100%,null;;;;;;;;;;;;;2;Paclitaxel LIGADO a ALBUMINA,GEMcitabina;Revisar manualmente;GEMci,INF,PACLI,CREA,CREAT;Tumor maligno del pancreas, parte no especificada;1
4/10/2024;66;1,56;71;1,8;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;INF,PEMBRO,VIDE,CREA;Tumor maligno del endometrio;2
4/10/2024;52;1,55;71;1,8;F;Sin Cr;0,54;136,6;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,700,0,700,,,5,0,655,8,107%,null,,1,Frec Check;Docetaxel 20mg/mL Sol Iny,,135,75,,,75,135,0,100%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,840,0,840,0,50%,null;Trastuzumab 440mg Polv Iny,,426,6,,,8,568,0,75%,null;;;;;;;;;;;4;CARBOplatino,DOCEtaxel,PERTUzumab,TRAStuzumab;Revisar manualmente;CARBO,DOCE,PERTU,PLATINO, SC,TrastU,60%,AUC;Tumor maligno de la mama, parte no especificada;2
4/10/2024;78;1,55;47;1,43;F;Sin Cr;;Sin Cr;Durvalumab 50mg/mL (500mg/10mL) Solucion Inyectable,,1.500,0,0,FALSE,dosis fija,1.500,0,1500,0,100%,Ciclos cada 21 d√≠as,,null,Revise recomd, seg˙n proto: 1;;;;;;;;;;;;;;1;Durvalumab;Revisar manualmente;Durva;Tumor maligno de los bronquios o del pulmon, parte no especificada;null
4/10/2024;70;1,45;38;1,25;F;Sin Cr;0,83;37,8;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,314,0,314,,,5,0,314,2,100%,-Carboplatino (AUC 4-5)   314 mg IV  d√≠a 1,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,100,80,,,80,100,0,100%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,TRUE,,840,0,420,0,100%,null;Trastuzumab 440mg Polv Iny,,228,6,TRUE,,8,228,0,100%,null;;;;;;;;;;;4;CARBOplatino,PACLItaxel,PERTUzumab,TRAStuzumab;Revisar manualmente;CARBO,DOCE, GC ,INF,PACLI,PERTU,PLATINO, SC,semanal,TrastU,30%,60%,AUC,CREA,CREAT;Tumor maligno de la mama, parte no especificada;5
4/10/2024;69;1,62;54;1,57;F;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3.014,4,2.400,,,2.400,0,3768,0,80%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,502,4,400,,,400,628,0,80%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,502,4,400,,,400,0,628,0,80%,null;Bevacizumab 100mg polv iny,,270,5,,,5,270,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,Folinato,Bevacizumab;Revisar manualmente;Beva,FOLFIRI,FOLFOX,VIDE,AJUST,20%,100%;Tumor maligno del colon, parte no especificada;1
4/10/2024;65;1,52;51;1,49;F;Sin Cr;0,71;63,6;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,Frec Check;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,119,2,80,TRUE,,60,119,2,100%,null;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,160,160,,1,5,2,0,171,7,93%,CARBOPLATINO (AUC 1.5) DOSIS TOTAL 160 MG IV EN INFUSI√ìN DE 1 HORAS D√çA 1,8,15;;;;;;;;;;;;3;PEMBROlizumab,PACLItaxel,CARBOplatino;Revisar manualmente;CARBO,INF,PACLI,PEMBRO,PLATINO,100%,AUC,CREA,CREAT;Tumor maligno de la mama, parte no especificada;1
4/10/2024;48;1,53;83;1,95;F;Sin Cr;;Sin Cr;Mitomicina 20mg polv iny,,19,0,0,,10,00,7,0,19,5,97%,MITOMICINA (10 MG/M2) DOSIS TOTAL 19 MG  IV EN BOLO D√çAS 1 Y 29,,null,Revise recomd, seg˙n proto: 1;;;;;;;;;;;;;;1;MITOmicina C;Revisar manualmente;Capec,CONCURRENTE,INF,MITOm,NIGRO, SC,BOLO ,100%;Tumor maligno del recto;1
4/10/2024;65;1,6;78;1,91;F;Sin Cr;;Sin Cr;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,TRUE,6.240,0,80,FALSE,,3,0,234,0,2667%,null,,1,Frec Check;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,400,400,,,3,234,0,171%,null;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,400,400,,,3,0,234,0,171%,null;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,400,400,,,3,234,0,171%,null;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,400,400,,,3,234,0,171%,null;;;;;;;;;;5;NIVOLUmab,NIVOLUmab,NIVOLUmab,NIVOLUmab,NIVOLUmab;Revisar manualmente;NIVO;Melanoma maligno del miembro superior, incluido el hombro;11
4/10/2024;60;1,6;42;1,36;F;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3.264,0,2.400,,,2.400,0,3264,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,544,400,,,400,544,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,115,6,85,,,85,0,115,6,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,115,6,85,,,85,115,6,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,544,400,,,400,544,0,100%,null;Trastuzumab 440mg Polv Iny,,168,4,TRUE,,6,168,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,544,400,,,400,544,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,544,400,,,400,544,0,100%;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,544,400,,,400,544,0,100%,null;;;;;;9;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato,TRAStuzumab,Fluorouracilo,Fluorouracilo,Fluorouracilo;Revisar manualmente;FOLFOX,INF,RITU,TrastU;Tumor maligno del estomago, parte no especificada;1
4/10/2024;51;1,5;52;1,5;F;107,1;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,660,7,5,,,5,0,660,6,100%,REC15022021-2,,1,Frec Check;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,262,5,175,,,175,262,5,100%,null;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,262,5,175,,,175,0,262,5,100%,null;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,PACLItaxel;Revisar manualmente;CARBO,PACLI,PLATINO;Tumor maligno del ovario;3
4/10/2024;50;1,55;69,5;1,78;F;Sin Cr;;Sin Cr;Pemetrexed 100mg Polv Iny,,880,0,500,,,500,0,890,0,99%,null,,1,Frec Check;;;;;;;;;;;;;;1;Pemetrexed;Revisar manualmente;Beva,GEMci,monoagente,PACLI,Peme,PLATINO,VIDE,AJUSTE,AJUST,Suspend;Tumor maligno del ovario;6
4/10/2024;42;1,55;58,8;1,62;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;CARBO,INF,MAYO ,monoagente,PEMBRO,TAXOL,30%;Tumor maligno de la mama, parte no especificada;3
4/10/2024;70;1,7;50;1,53;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3.672,0,2.400,,,2.400,0,3672,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,612,400,,,400,612,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,612,400,,,400,0,612,0,100%,null;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,240,240,,Dosis fija,240,240,0,100%,null;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,240,240,,,240,12000,0,2%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,Folinato,NIVOLUmab,NIVOLUmab;Revisar manualmente;FOLFOX,INF;Tumor maligno del estomago, parte no especificada;5
4/10/2024;38;1,74;73;1,89;M;Sin Cr;;Sin Cr;Mesna 400mg/4mL (100mg/mL) Sol Iny,,1.630,0,1.630,FALSE,1080,0,5.000,0,2041,2,80%,POR FAVOR DIVIDIR DOSIS PARA ADMON A LAS 0-4-8 HORAS  DE IFOSFAMIDA,,1,2,3,Frec Check;Ifosfamida 1gr (1000mg) Polv Iny,,2721,6,1800,TRUE,,2.600,3402,0,80%,null;;;;;;;;;;;;;2;Mesna,IFOSfamida;Revisar manualmente;CisplA,DOXO,DOXO,IFOSF,monoagente,PLATINO,VIDE,AJUSTE,AJUST,5%,25%,CREA,CREAT;Tumor maligno del tejido conjuntivo y tejido blando, de sitio no especificado;8
5/10/2024;65;1,61;75;1,87;M;Sin Cr;;Sin Cr;Calcio folinato 50mg Polv Iny,,748,0,400,,,400,0,748,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,748,400,,,400,748,0,100%,null;;;;;;;;;;;;;2;Folinato,Fluorouracilo;Revisar manualmente;5FU,Capec,FLUORO,PLATINO,RICE, RT ,AJUSTE,AJUST,Suspend;Tumor maligno del colon, parte no especificada;2
5/10/2024;74;1,62;61;1,68;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,672,0,400,,,400,0,672,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4032,2400,,,2.400,4032,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,109,2,65,,,85,0,142,8,76%,ajustado;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,672,400,,,400,672,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;Revisar manualmente;FOLFOX,PLATINO,AJUST;Tumor maligno del colon, parte no especificada;1
5/10/2024;61;1,62;48;1,47;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,240,0,5,,,5,0,240,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,588,400,,,400,588,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3528,2400,,,2.400,0,3528,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,588,400,,,400,588,0,100%,null;;;;;;;;;;;4;Bevacizumab,Fluorouracilo,Fluorouracilo,Folinato;Revisar manualmente;Beva,FOLFOX,PLATINO, RT ;Tumor maligno del colon, parte no especificada;8
5/10/2024;80;1,53;53;1,53;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,400,0,400,,,400,0,400,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;CARBO,MAYO ,PEMBRO,Peme,PLATINO,AJUST,20%,40%,80%;Tumor maligno de los bronquios o del pulmon, parte no especificada;1
5/10/2024;59;1,61;67;1,76;M;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,88,0,50,,,50,0,88,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4576,2600,,,2.600,4576,0,100%,null;Calcio folinato 50mg Polv Iny,,352,200,,,200,0,352,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,149,6,85,,,85,149,6,100%,null;;;;;;;;;;;4;DOCEtaxel,Fluorouracilo,Folinato,OXALIplatino;Revisar manualmente;FLOT,INF;Tumor maligno del estomago, parte no especificada;1
6/10/2024;24;1,7;63;1,73;M;Sin Cr;;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,64,9,38,,37,5,75,0,64,9,100%,null,,1,2,Inconsistente, seg˙n proto: 1;Vincristina 1mg/mL Sol Iny,,2,2,,dosis fija,2,2,0,100%,null;Ciclofosfamida 500mg  Polv Iny,,2076,1200,,,1.200,0,2076,0,100%,null;Mesna 400mg/4mL (100mg/mL) Sol Iny,,692,400,TRUE,,1.200,692,0,100%,null;;;;;;;;;;;4;DOXOrubicina,VinCRISTina,CICLOfosfamida,Mesna;Revisar manualmente;#N/D;Tumor maligno del tejido conjuntivo y tejido blando, de sitio no especificado;9
6/10/2024;36;1,72;81;1,99;M;Sin Cr;;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,49,8,25,TRUE,,20,0,49,8,100%,null,,1,2,3,Frec Check;Ifosfamida 1gr (1000mg) Polv Iny,,4975,2500,TRUE,,1.500,4975,0,100%,null;Mesna 400mg/4mL (100mg/mL) Sol Iny,,3000,3000,,,300,0,597,0,503%,1000 MG IV HORA 0, 4 Y 8 LOS DIAS DE IFOSFAMIDA;;;;;;;;;;;;3;DOXOrubicina,IFOSfamida,Mesna;Revisar manualmente;INF,MAI, SC;Tumor maligno del tejido conjuntivo y tejido blando, de sitio no especificado;3
6/10/2024;27;1,67;51;1,53;M;Sin Cr;;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,612,0,400,,,400,0,612,0,100%,,,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,612,400,,,400,612,0,100%,.;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,130,05,85,,,85,0,130,1,100%,,;Panitumumab 100mg/5mL (20mg/mL) Sol Iny,,300,300,,,6,306,0,98%,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3672,2400,,,2.400,3672,0,100%,null;;;;;;;;;;5;Folinato,Fluorouracilo,OXALIplatino,PANItumumab,Fluorouracilo;Revisar manualmente;FOLFOX,INF,PANItU, RT ,TC ;Tumor maligno del recto;4
6/10/2024;65;1,65;52;1,54;M;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,154,0,125,,,125,0,192,5,80%,null,,1,8,Frec Check;;;;;;;;;;;;;;1;Irinotecan;Revisar manualmente;CARBO,FOLFOX,INF,Irino,MAYO ,TAXANO,TAXOL,VIDE,AJUSTE,AJUST,20%,CREA,Suspend;Tumor maligno del estomago, parte no especificada;4
6/10/2024;81;1,72;66,7;1,79;M;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,196,9,110,TRUE,,80,0,196,9,100%,null,,1,15,Inconsistente, seg˙n proto: 1,8,15;Ramucirumab  100mg/10mL (10mg/mL) Sol Iny,,533,6,8,,,8,533,6,100%,null;;;;;;;;;;;;;2;PACLItaxel,Ramucirumab;Revisar manualmente;FOLFOX,INF,PACLI,RAMUC, SC,VIDE,AJUST;Tumor maligno del estomago, parte no especificada;2
6/10/2024;71;1,66;51;1,53;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,612,0,400,,,400,0,612,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3672,2400,,,2.400,3672,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,130,05,85,,,85,0,130,1,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,612,400,,,400,612,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;Revisar manualmente;FOLFOX;Tumor maligno del estomago, parte no especificada;2
6/10/2024;44;1,56;50;1,49;F;Sin Cr;0,96;59;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,420,0,420,,,5,0,420,1,100%,null,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,120,80,,,80,119,2,101%,null;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,120,80,,,80,0,119,2,101%,null;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,PACLItaxel;Revisar manualmente;CARBO,NIGRO,PACLI,PLATINO,VIDE;Tumor maligno del recto;4
6/10/2024;45;1,54;48,8;1,46;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,584,0,400,,,400,0,584,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3504,2400,,,2.400,3504,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,86,87,85,,,85,0,124,1,70%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,584,400,,,400,584,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;Revisar manualmente;FOLFOX,INF, RT ,CREA,CREAT;Tumor maligno del recto;5
7/10/2024;24;1,7;54;1,59;M;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,31,8,25,,,25,0,39,8,80%,null,,2,3,4,5,Frec Check;Ifosfamida 1gr (1000mg) Polv Iny,,1908,1500,,,1.500,0,2385,0,80%,null;Mesna 400mg/4mL (100mg/mL) Sol Iny,,1908,1500,TRUE,,300,0,2385,0,80%,divididos a las 0, 4 y 8 horas;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,318,250,,,250,0,397,5,80%,null;;;;;;;;;;;4;CISplatino,IFOSfamida,Mesna,PACLItaxel;Revisar manualmente;#N/D;Tumor maligno del testiculo, no especificado;2
7/10/2024;35;1,62;77;1,9;F;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,142,5,75,,,75,0,142,5,100%,null,,1,Frec Check;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,TRUE,,840,0,420,0,100%,null;Trastuzumab 440mg Polv Iny,,462,6,,,8,0,616,0,75%,null;;;;;;;;;;;;3;DOCEtaxel,PERTUzumab,TRAStuzumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;3
7/10/2024;77;1,6;60;1,66;M;Sin Cr;;Sin Cr;Calcio folinato 50mg Polv Iny,,664,0,400,,,400,0,664,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,664,400,,,400,0,664,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3984,2400,,,2.400,0,3984,0,100%,null;;;;;;;;;;;;3;Folinato,Fluorouracilo,Fluorouracilo;Revisar manualmente;INF,monoagente;Tumor maligno del estomago, parte no especificada;2
7/10/2024;35;1,6;72;1,83;F;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,73,2,40,TRUE,,35,0,73,2,100%,null,,1,Inconsistente, seg˙n proto: 1,8,15,22,29;;;;;;;;;;;;;;1;CISplatino;Revisar manualmente;#N/D;Tumor maligno del cuello del utero, sin otra especificacion;2
7/10/2024;29;1,62;55;1,58;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,Frec Check;Pemetrexed 100mg Polv Iny,,775,500,,,500,0,790,0,98%,null;;;;;;;;;;;;;2;PEMBROlizumab,Pemetrexed;Revisar manualmente;#N/D;Tumor maligno de los bronquios o del pulmon, parte no especificada;17
7/10/2024;80;1,65;80;1,96;M;Sin Cr;;Sin Cr;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,360,0,360,TRUE,Dosis fija,3,0,360,0,100%,null,,1,Frec Check;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,360,360,,,3,0,240,0,150%,null;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;#N/D;Tumor maligno del estomago, parte no especificada;17
7/10/2024;77;1,57;49;1,47;M;Sin Cr;;Sin Cr;Ipilimumab 50mg/10mL(5mg/mL) Sol Iny,,141,0,3,,,3,0,147,0,96%,null,,1,Frec Check;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,49,1,,,1,0,49,0,100%,null;;;;;;;;;;;;;2;IPILImumab,NIVOLUmab;Revisar manualmente;INF,IPILI,NIVO,AJUSTE,AJUST;Melanoma maligno de las otras partes y las no especificadas de la cara;2
7/10/2024;75;1,7;53;1,57;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3.014,4,2.400,,,2.400,0,3768,0,80%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,502,4,400,,,400,0,628,0,80%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,502,4,400,,,400,0,628,0,80%,null;Bevacizumab 100mg polv iny,,265,5,,,5,0,265,0,100%,null;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,226,08,180,,,180,0,282,6,80%,null;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,226,08,180,,,180,0,282,6,80%,null;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,226,08,180,,,180,0,282,6,80%,null;;;;;;;;7;Fluorouracilo,Fluorouracilo,Folinato,Bevacizumab,Irinotecan,Irinotecan,Irinotecan;Revisar manualmente;5FU,Beva,Capec,CAPEOX,FOLFIRI,INF,PANItU,INFUSOR,CREA,CREAT,Suspend;Tumor maligno del colon, parte no especificada;6
7/10/2024;74;1,66;57;1,63;M;37,6;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,300,0,300,,,5,0,312,9,96%,null,,1,Frec Check;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,1630,1000,TRUE,,800,0,1630,0,100%,null;;;;;;;;;;;;3;CARBOplatino,PEMBROlizumab,Fluorouracilo;Revisar manualmente;CisplA,INF,monoagente,PLATINO,VIDE,AJUSTE,AJUST;Lesion de sitios contiguos del labio, de la cavidad bucal y de la faringe;4
7/10/2024;73;1,62;70;1,81;M;Sin Cr;;Sin Cr;Cabazitaxel 60mg/1.5mL (4%) Sol Iny,,29,0,20,,,20,0,36,2,80%,null,,1,Frec Check;;;;;;;;;;;;;;1;CABAzitaxel;Revisar manualmente;CABAzI,DOCE, RT ,AUC;Tumor maligno de la prostata;17
7/10/2024;73;1,74;68;1,82;M;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,340,0,5,,,5,0,340,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4368,2400,,,2.400,0,4368,0,100%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,728,400,,,400,0,728,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,123,76,85,,,85,0,154,7,80%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,123,76,85,,,85,0,154,7,80%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,728,400,,,400,0,728,0,100%,null;;;;;;;;;6;Bevacizumab,Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;Revisar manualmente;FOLFOX,INF,PLATINO,80%;Tumor maligno del colon, parte no especificada;4
7/10/2024;67;1,64;65;1,74;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.176,0,2.400,,,2.400,0,4176,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,696,400,,,400,0,696,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,147,9,85,,,85,0,147,9,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,696,400,,,400,0,696,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;Revisar manualmente;FOLFOX,INF,MAYO ;Tumor maligno del colon, parte no especificada;4
7/10/2024;76;1,46;87;1,97;F;72,2;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,495,9,6,,,6,0,583,4,85%,null,,1,Frec Check;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,495,87,6,,,6,0,583,4,85%,null;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,133,96,80,,,80,0,157,6,85%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,420,0,420,0,100%,null;Trastuzumab 440mg Polv Iny,,528,6,,,6,0,522,0,101%,null;;;;;;;;;;5;CARBOplatino,CARBOplatino,PACLItaxel,PERTUzumab,TRAStuzumab;Revisar manualmente;CARBO,PACLI,PERTU,PLATINO,TRAIN-2,TrastU,5%,15%;Tumor maligno de la mama, parte no especificada;4
7/10/2024;64;1,59;82;1,96;F;Sin Cr;;Sin Cr;Durvalumab 50mg/mL (500mg/10mL) Solucion Inyectable,,1.500,0,0,,dosis fija,1.500,0,1500,0,100%,null,,null,Revise recomd, seg˙n proto: 1;;;;;;;;;;;;;;1;Durvalumab;Revisar manualmente;CARBO,Durva,PACLI,PLATINO;Tumor maligno de los bronquios o del pulmon, parte no especificada;3
7/10/2024;72;1,75;96;2,2;M;Sin Cr;;Sin Cr;Avelumab 200mg/10mL (20mg/mL) Solucion Inyectable,,800,0,0,,,10,0,960,0,83%,D1 Y D15,,null,Revise recomd, seg˙n proto: 1,15;;;;;;;;;;;;;;1;Avelumab;Revisar manualmente;#N/D;Tumor maligno de la vejiga urinaria, parte no especificada;14
7/10/2024;55;1,52;67;1,73;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,DOS CICLOS,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;3
7/10/2024;71;1,55;46;1,42;F;Sin Cr;;Sin Cr;Doxorrubicina liposomal 20mg/10mL (2mg/mL) Susp Iny,,56,8,40,,,40,0,56,8,100%,cada 28 dia s,,1,Frec Check;;;;;;;;;;;;;;1;DOXOrubicina_LIPOSOMAL;Revisar manualmente;Beva,CARBO,DOXO,DOXO,Doxo Lipo,PACLI,PLATINO, SC;Tumor maligno del ovario;5
7/10/2024;79;1,52;70,8;1,79;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;8
7/10/2024;40;1,65;61;1,69;F;118,1;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,625,0,625,,,5,0,685,8,91%,.,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,137,6,80,,,80,0,135,2,102%,,;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,,;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,PEMBROlizumab;Revisar manualmente;CARBO,INF,PACLI,PEMBRO,PLATINO, SC,TC ;Tumor maligno de la mama, parte no especificada;3
7/10/2024;67;1,43;53,7;1,51;F;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3.624,0,2.400,,,2.400,0,3624,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,604,400,,,400,0,604,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,128,35,85,,,85,0,128,4,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,128,35,85,,,85,0,128,4,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,604,400,,,400,0,604,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;Revisar manualmente;FOLFOX,INF;Tumor maligno del colon, parte no especificada;2
7/10/2024;62;1,49;58;1,59;F;Sin Cr;;Sin Cr;Doxorrubicina liposomal 20mg/10mL (2mg/mL) Susp Iny,,71,6,50,,,50,0,79,5,90%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOXOrubicina_LIPOSOMAL;Revisar manualmente;#N/D;Tumor maligno del tejido conjuntivo y tejido blando, de sitio no especificado;4
7/10/2024;59;1,61;67;1,76;F;Sin Cr;0,89;72;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,308,0,175,,,175,0,308,0,100%,null,,1,Frec Check;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,500,500,,,5,0,484,9,103%,null;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,500,500,,,5,0,484,9,103%,null;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,308,175,,,175,0,308,0,100%,null;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,308,175,,,175,0,308,0,100%,null;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,500,500,,,5,0,484,9,103%,null;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,308,175,,,175,0,308,0,100%,null;;;;;;;;7;PACLItaxel,CARBOplatino,CARBOplatino,PACLItaxel,PACLItaxel,CARBOplatino,PACLItaxel;Revisar manualmente;#N/D;Tumor maligno del endometrio;1
7/10/2024;52;1,45;51;1,47;F;Sin Cr;;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,882,0,600,,,600,0,882,0,100%,null,,8,Inconsistente, seg˙n proto: 1;Dactinomicina 0.5 mg Sol Iny,,1,0,,,0,5,0,7,136%,APLICAR IV DIAS 1 Y 2;Etoposido 100mg/5mL (20mg/mL) Sol Iny,,147,100,,,100,0,147,0,100%,null;Metotrexato 500mg/20mL (25mg/mL) Sol Iny,,147,100,TRUE,,300,0,147,0,100%,null;Metotrexato 500mg/20mL (25mg/mL) Sol Iny,,294,200,TRUE,,300,0,294,0,100%,null;Vincristina 1mg/mL Sol Iny,,2,2,,,0,8,1,2,170%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,FALSE,50,0,,,200,0,294,0,17%,null;;;;;;;;7;CICLOfosfamida,DACTINomicina,Etoposido,Metotrexato,Metotrexato,VinCRISTina,Folinato;Revisar manualmente;EMA-CO,MAYO , SC;Tumor maligno de la placenta;6
7/10/2024;52;1,56;74;1,84;F;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,736,0,400,,,400,0,736,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4416,2400,,,2.400,0,4416,0,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,736,400,,,400,0,736,0,100%,null;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,TRUE,180,180,FALSE,,180,0,331,2,54%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,Folinato,Irinotecan;Revisar manualmente;FOLFIRI,Irino,Oxali,PLATINO,XELOX;Tumor maligno del estomago, parte no especificada;1
7/10/2024;45;1,55;55;1,56;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,Frec Check;Bevacizumab 100mg polv iny,,825,15,,,15,0,825,0,100%,null;;;;;;;;;;;;;2;PEMBROlizumab,Bevacizumab;Revisar manualmente;Beva,CisplA,PACLI,PEMBRO,PLATINO;Tumor maligno del cuello del utero, sin otra especificacion;1
7/10/2024;53;1,67;75;1,89;F;104,1;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,625,0,625,,,5,0,645,5,97%,auc de 5 ajustar a funcion renal - TFG maxima 125 ml/min,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,322,175,,,175,0,330,8,97%,null;;;;;;;;;;;;;2;CARBOplatino,PACLItaxel;Revisar manualmente;CARBO,INF,MAYO ,TAXOL;Tumor maligno del ovario;5
7/10/2024;55;1,54;79;1,9;F;97,9;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,555,0,555,,,5,0,534,8,104%,CALCULADO CON CKDEPI 2021, PARA AUC DE 5,,1,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,332,5,175,,,175,0,332,5,100%,null;;;;;;;;;;;;;2;CARBOplatino,PACLItaxel;Revisar manualmente;CARBO,INF,MAYO , RT ,TAXOL;Tumor maligno de la vulva, parte no especificada;2
7/10/2024;83;1,7;61;1,7;M;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;INF,PEMBRO, RT ;Tumor maligno de la piel del cuero cabelludo y del cuello;2
7/10/2024;60;1,64;64;1,73;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,975,0,15,,,15,0,960,0,102%,null,,1,22,Inconsistente, seg˙n proto: 1;;;;;;;;;;;;;;1;Bevacizumab;Revisar manualmente;#N/D;Tumor maligno del ovario;30
7/10/2024;57;1,58;64,5;1,72;F;64,5;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,435,0,435,,,5,0,447,5,97%,CALCULADA CON CKDEPI 2021 PARA AUC 5,,1,Frec Check;Docetaxel 20mg/mL Sol Iny,,129,75,,,75,0,129,0,100%,null;Trastuzumab 440mg Polv Iny,,387,6,TRUE,,8,0,387,0,100%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,TRUE,,840,0,420,0,100%,null;;;;;;;;;;;4;CARBOplatino,DOCEtaxel,TRAStuzumab,PERTUzumab;Revisar manualmente;CARBO,DOCE,PERTU,PLATINO,TrastU;Tumor maligno de la mama, parte no especificada;3
7/10/2024;44;1,7;53;1,57;M;Sin Cr;;Sin Cr;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,360,0,360,,,3,0,159,0,226%,null,,1,Frec Check;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,TRUE,130,130,,,100,0,157,0,83%,null;;;;;;;;;;;;;2;NIVOLUmab,OXALIplatino;Revisar manualmente;CAPEOX,FLOT,INF,NIVO,Oxali,PLATINO,AJUST,5%,25%,Suspend;Tumor maligno del estomago, parte no especificada;1
7/10/2024;58;1,7;67;1,79;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,716,0,400,,,400,0,716,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4296,2400,,,2.400,0,4296,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,116,35,65,TRUE,,85,0,116,4,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,716,400,,,400,0,716,0,100%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,400,400,,,200,0,200,0,200%,*** aplicacion cada 6 semanas ***;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato,PEMBROlizumab;Revisar manualmente;FOLFOX,PEMBRO,PLATINO,AJUST;Tumor maligno del estomago, parte no especificada;3
7/10/2024;56;1,7;73;1,88;M;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,335,0,5,,,5,0,365,0,92%,null,,1,15,Frec Check;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,716,400,,,400,0,752,0,95%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,716,400,,,400,0,752,0,95%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,152,15,85,,,85,0,159,8,95%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4512,2400,,,2.400,0,4512,0,100%,null;;;;;;;;;;5;Bevacizumab,Folinato,Fluorouracilo,OXALIplatino,Fluorouracilo;Revisar manualmente;Beva,FOLFOX,INF;Tumor maligno del colon, parte no especificada;5
7/10/2024;56;1,72;60;1,69;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.056,0,2.400,,,2.400,0,4056,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,676,400,,,400,0,676,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,143,65,85,,,85,0,143,7,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,676,400,,,400,0,676,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;Revisar manualmente;FOLFOX;Tumor maligno del estomago, parte no especificada;6
8/10/2024;29;1,61;73;1,85;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,148,0,80,,,80,0,148,0,100%,,,,1,8,15,Frec Check,1,8,15,PACLItaxel,2385,,;Ramucirumab  500mg/50mL (10mg/mL) Sol Iny,,584,0,,,8,0,584,0,100%,dias 1 y 15 de qt,,null,Revise recomd, seg˙n proto: 1,15,1,15,Ramucirumab,213617,,;;;;;;;;;;;;;2;PACLItaxel,Ramucirumab;Revisar manualmente;FOLFOX,INF,PACLI,RAMUC,TrastU;Tumor maligno del estomago, parte no especificada;6
8/10/2024;37;1,54;53;1,53;F;109,2;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,397,3,3,FALSE,,3,0,402,7,99%,null,,1,8,Frec Check,1,8,CARBOplatino,1168,,;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,123,2,80,,,80,0,122,4,101%,null,,1,8,Frec Check,1,8,PACLItaxel,2385,,;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,123,2,80,,,80,0,122,4,101%,null,,1,8,Frec Check,1,8,PACLItaxel,1456,,;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,TRUE,,420,0,420,0,100%,null,,1,Frec Check,1,PERTUzumab,ONCM11,,;Trastuzumab 440mg Polv Iny,,323,4,6,TRUE,,6,0,318,0,102%,DOSIS DE CARGA,,1,Frec Check,1,TRAStuzumab,2854,,;;;;;;;;;;5;CARBOplatino,PACLItaxel,PACLItaxel,PERTUzumab,TRAStuzumab;Revisar manualmente;INF,TCHP ,TRAIN ,90%;Tumor maligno de la mama, parte no especificada;3
8/10/2024;71;1,74;64;1,76;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.248,0,2.400,,,2.400,0,4224,0,101%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,708,400,,,400,0,704,0,101%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,708,400,,,400,0,704,0,101%,null,,1,15,Frec Check,1,15,Folinato,118,,;Bevacizumab 100mg polv iny,,325,5,,,5,0,320,0,102%,null,,1,15,Frec Check,1,15,Bevacizumab,3352,,;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,Folinato,Bevacizumab;Revisar manualmente;FOLFOX,INF;Tumor maligno del recto;2
8/10/2024;86;1,71;81,5;2;M;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,400,0,400,TRUE,,200,0,400,0,100%,null,,1,Frec Check,1,PEMBROlizumab,ONCM74,,;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;CARBO,INF,PEMBRO,Peme,PLATINO;Tumor maligno de la prostata;1
8/10/2024;76;1,65;78,2;1,93;M;Sin Cr;;Sin Cr;Avelumab 200mg/10mL (20mg/mL) Solucion Inyectable,,800,0,0,,,10,0,782,0,102%,administracion  800  mg   Cada 15 d√≠as. 12 y 26 de agosto. 9 y 23 de septiembre,,null,Revise recomd, seg˙n proto: 1,15,1,15,Avelumab,21422,,;;;;;;;;;;;;;;1;Avelumab;Revisar manualmente;#N/D;Tumor maligno de la vejiga urinaria, parte no especificada;1
8/10/2024;68;1,65;61,3;1,69;M;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,135,2,80,,,80,0,135,2,100%,null,,1,8,15,22,Frec Check,1,8,15,22,PACLItaxel,2385,,;;;;;;;;;;;;;;1;PACLItaxel;Revisar manualmente;#N/D;Tumor maligno del ri√±on, excepto de la pelvis renal;1
8/10/2024;82;1,4;44;1,34;F;Sin Cr;0,74;40,7;Pemetrexed 500mg Polv Iny,,536,0,500,,,500,0,670,0,80%,null,,1,Frec Check,1,Pemetrexed,3217,,;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,370,370,,,5,0,502,8,74%,null,,1,Frec Check,1,CARBOplatino,1168,,;;;;;;;;;;;;;2;Pemetrexed,CARBOplatino;Revisar manualmente;CARBO,INF,Peme,PLATINO,TC ,AJUST,20%,100%,AUC;Mesotelioma de la pleura;2
8/10/2024;65;1,47;49;1,44;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,735,0,15,,,10,0,490,0,150%,null,,1,Frec Check,1,Bevacizumab,3352,,;Docetaxel 20mg/mL Sol Iny,,91,8,75,,,75,0,108,0,85%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;2;Bevacizumab,DOCEtaxel;Revisar manualmente;Beva,DOCE;Tumor maligno de los bronquios o del pulmon, parte no especificada;1
8/10/2024;44;1,73;86;2,06;F;Sin Cr;;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,1.236,0,600,,,600,0,1236,0,100%,null,,1,15,Frec Check,1,15,Ciclofosfamida,1171,,;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,126,60,,,60,0,123,6,102%,null,,1,15,Frec Check,1,15,DOXOrubicina,4838,,;;;;;;;;;;;;;2;Ciclofosfamida,DOXOrubicina;Revisar manualmente; AC ,INF, SC,40%;Tumor maligno de la mama, parte no especificada;2
8/10/2024;64;1,49;69;1,75;F;Sin Cr;;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,,,420,0,420,0,100%,null,,1,21,Inconsistente, seg˙n proto: 1,1,PERTUzumab,ONCM11,,;Trastuzumab 440mg Polv Iny,,414,6,,,6,0,414,0,100%,null,,1,21,Inconsistente, seg˙n proto: 1,1,TRAStuzumab,2854,,;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;Revisar manualmente;cleopatra,Cleopatra,PACLI,PERTU,semanal,TrastU,10%,90%,Suspend;Tumor maligno de la mama, parte no especificada;1
8/10/2024;61;1,68;61;1,7;F;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,306,0,180,,,180,0,306,0,100%,null,,1,15,Frec Check,1,15,Irinotecan,2437,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4080,2400,,,2.400,0,4080,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,680,400,,,400,0,680,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,680,400,,,400,0,680,0,100%,null,,1,15,Frec Check,1,15,Folinato,118,,;;;;;;;;;;;4;Irinotecan,Fluorouracilo,Fluorouracilo,Folinato;Revisar manualmente;FLOT,FOLFIRI,Irino,PLATINO,Suspend;Tumor maligno del estomago, parte no especificada;1
8/10/2024;47;1,64;71;1,83;F;Sin Cr;;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,1.086,0,600,,,600,0,1098,0,99%,null,,1,Frec Check,1,Ciclofosfamida,1171,,;Docetaxel 20mg/mL Sol Iny,,135,75,75,,,75,0,137,3,99%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;2;Ciclofosfamida,DOCEtaxel;Revisar manualmente;#N/D;Tumor maligno de la mama, parte no especificada;3
8/10/2024;67;1,45;41;1,3;F;65,4;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,452,2,5,,,5,0,452,2,100%,null,,1,Frec Check,1,CARBOplatino,1168,,;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,227,5,175,,,175,0,227,5,100%,null,,1,Frec Check,1,PACLItaxel,2385,,;;;;;;;;;;;;;2;CARBOplatino,PACLItaxel;Revisar manualmente;CARBO,MAYO ,PACLI,PLATINO,CREA,CREAT;Tumor maligno del cuello del utero, sin otra especificacion;3
8/10/2024;63;1,53;57;1,59;F;Sin Cr;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,79,5,50,,,50,0,79,5,100%,null,,1,15,Frec Check,1,15,DOCEtaxel,776,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4134,2600,,,2.600,0,4134,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,135,15,85,,,85,0,135,2,100%,null,,1,15,Frec Check,1,15,OXALIplatino,4172,,;Calcio folinato 50mg Polv Iny,,318,200,,,200,0,318,0,100%,null,,1,15,Frec Check,1,15,Folinato,118,,;;;;;;;;;;;4;DOCEtaxel,Fluorouracilo,OXALIplatino,Folinato;Revisar manualmente;FLOT;Tumor maligno del estomago, parte no especificada;5
8/10/2024;64;1,49;56;1,56;F;Sin Cr;0,61;82,4;Bevacizumab 100mg polv iny,FALSE,397,5,8,,,7,5,420,0,95%,null,TRUE,1,Inconsistente, seg˙n proto: 1,15,1,15,Bevacizumab,3352,,;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,TRUE,380,380,,4,5,0,479,0,79%,TFG por CDK epi 2021 = 70 ml min Carboplatino (AUC 4) dosis total 380 mg  d√≠a 1,,1,Frec Check,1,CARBOplatino,1168,,;Gemcitabina 1000mg/100mL (10mg/mL) Sol Iny,,1510,1000,,,1.000,0,1560,0,97%,null,,1,8,Frec Check,1,8,GEMcitabina,1378,,;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,420,0,420,0,100%,null,,1,Frec Check,1,PERTUzumab,ONCM11,,;Trastuzumab 440mg Polv Iny,,324,6,,,6,0,336,0,96%,null,,1,Frec Check,1,TRAStuzumab,2854,,;;;;;;;;;;5;Bevacizumab,CARBOplatino,GEMcitabina,PERTUzumab,TRAStuzumab;Revisar manualmente;Beva,CARBO,GEMci,PERTU,PLATINO,TrastU,100%,AUC;Tumor maligno de la mama, parte no especificada;5
8/10/2024;48;1,65;76;1,9;M;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,400,0,400,,,400,0,400,0,100%,null,,1,Frec Check,1,PEMBROlizumab,ONCM74,,;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno del ri√±on, excepto de la pelvis renal;1
8/10/2024;59;1,52;54;1,54;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,840,0,15,,,15,0,810,0,104%,null,,1,22,Inconsistente, seg˙n proto: 1,1,Bevacizumab,3352,,;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1,1,PEMBROlizumab,ONCM74,,;;;;;;;;;;;;;2;Bevacizumab,PEMBROlizumab;Revisar manualmente;CARBO,INF,PEMBRO,PLATINO,TAXANO,5%,60%,80%,95%,100%;Tumor maligno de exocervix;12
8/10/2024;56;1,62;54;1,57;F;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,628,0,400,,,400,0,628,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3768,2400,,,2.400,0,3768,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,628,400,,,400,0,628,0,100%,null,,1,15,Frec Check,1,15,Folinato,118,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,133,45,85,,,85,0,133,5,100%,null,,1,15,Frec Check,1,15,OXALIplatino,4172,,;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,282,6,180,,,180,0,282,6,100%,null,,1,15,Frec Check,1,15,Irinotecan,2437,,;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,Folinato,OXALIplatino,Irinotecan;Revisar manualmente;FOLFIRI,FOLFIRINOX,INF,Irino,CREA,CREAT;Tumor maligno de la cabeza del pancreas;1
8/10/2024;49;1,53;74;1,83;F;101,9;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,634,6,5,,,5,0,634,6,100%,REC15022021-8,,1,Frec Check,1,CARBOplatino,1168,,;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,320,25,175,,,175,0,320,3,100%,null,,1,Frec Check,1,PACLItaxel,2385,,;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null,,1,Frec Check,1,PEMBROlizumab,ONCM74,,;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,PEMBROlizumab;Revisar manualmente;CARBO,PACLI,PEMBRO,PLATINO,CREA,CREAT;Tumor maligno de exocervix;5
8/10/2024;63;1,53;58;1,6;F;Sin Cr;;Sin Cr;Vinorelbine 50mg/5mL (10mg/mL) Sol Iny,,40,0,0,,25,00,35,0,40,0,100%,APLICAR DIA 1 Y 8,,null,Revise recomd, seg˙n proto: 1,8,1,8,VinORELBina,246A,,;;;;;;;;;;;;;;1;VinORELBina;Revisar manualmente;Beva,GEMci,TAXANO,VinOR,Vinorelbine;Tumor maligno de los bronquios o del pulmon, parte no especificada;null
8/10/2024;59;1,56;65;1,72;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,400,0,400,,,400,0,400,0,100%,null,,1,Frec Check,1,PEMBROlizumab,ONCM74,,;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;PEMBRO;Tumor maligno del ri√±on, excepto de la pelvis renal;1
8/10/2024;80;1,55;47;1,43;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1,1,PEMBROlizumab,ONCM74,,;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;#N/D;Tumor maligno del estomago, parte no especificada;9
8/10/2024;67;1,58;55;1,57;F;Sin Cr;0,73;64,9;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,TRUE,350,0,350,,,5,0,449,7,78%,null,,1,Frec Check,1,CARBOplatino,1168,,;Pemetrexed 500mg Polv Iny,,667,25,500,,,500,0,785,0,85%,null,,1,Frec Check,1,Pemetrexed,3217,,;Pemetrexed 100mg Polv Iny,,667,25,500,,,500,0,785,0,85%,null,,1,Frec Check,1,Pemetrexed,76,,;;;;;;;;;;;;3;CARBOplatino,Pemetrexed,Pemetrexed;Revisar manualmente;#N/D;Tumor maligno de los bronquios o del pulmon, parte no especificada;2
8/10/2024;60;1,49;60;1,62;F;Sin Cr;;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,97,2,60,,,60,0,97,2,100%,null,,1,15,Frec Check,1,15,DOXOrubicina,4838,,;Ciclofosfamida 1gr (1000mg) Polv Iny,,972,600,,,600,0,972,0,100%,null,,1,15,Frec Check,1,15,Ciclofosfamida,1171,,;;;;;;;;;;;;;2;DOXOrubicina,Ciclofosfamida;Revisar manualmente;PLATINO,TAXANO,90%;Tumor maligno de la mama, parte no especificada;1
8/10/2024;83;1,71;70;1,84;M;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,525,0,8,,,7,5,525,0,100%,null,,1,Frec Check,1,Bevacizumab,3352,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,191,36,130,,,130,0,239,2,80%,null,,1,Frec Check,1,OXALIplatino,4172,,;;;;;;;;;;;;;2;Bevacizumab,OXALIplatino;Revisar manualmente;Beva,Capec,INF,Oxali,PLATINO,Suspend;Tumor maligno de la prostata;1
8/10/2024;40;1,6;67;1,76;F;Sin Cr;;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,105,6,60,,,60,0,105,6,100%,null,,1,15,Frec Check,1,15,DOXOrubicina,4838,,;Ciclofosfamida 1gr (1000mg) Polv Iny,,1056,600,,,600,0,1056,0,100%,null,,1,15,Frec Check,1,15,Ciclofosfamida,1171,,;Ciclofosfamida 500mg  Polv Iny,,1056,600,,,600,0,1056,0,100%,null,,1,15,Frec Check,1,15,CICLOfosfamida,852,,;;;;;;;;;;;;3;DOXOrubicina,Ciclofosfamida,CICLOfosfamida;Revisar manualmente;INF,TAXANO,40%,90%;Tumor maligno de la mama, parte no especificada;3
8/10/2024;34;1,65;62,5;1,71;F;Sin Cr;1;78,2;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,480,0,480,,,5,0,493,8,97%,null,,1,Frec Check,1,CARBOplatino,1168,,;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,299,25,175,,,190,0,324,9,92%,null,,1,Frec Check,1,PACLItaxel,2385,,;Bevacizumab 100mg polv iny,,937,5,15,,,15,0,937,5,100%,null,,1,Frec Check,1,Bevacizumab,3352,,;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,Bevacizumab;Revisar manualmente;CisplA,GOG ,INF,PLATINO;Tumor maligno de exocervix;1
8/10/2024;60;1,56;75;1,86;F;Sin Cr;0,46;154;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,678,0,678,,,5,0,646,6,105%,null,,1,Frec Check,1,CARBOplatino,1168,,;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,325,5,175,,,175,0,325,5,100%,null,,1,Frec Check,1,PACLItaxel,2385,,;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null,,1,Frec Check,1,PEMBROlizumab,ONCM74,,;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,PEMBROlizumab;Revisar manualmente;CARBO,INF,PACLI,PEMBRO,PLATINO,AUC,CREA,CREAT;Tumor maligno del endometrio;3
8/10/2024;61;1,42;52,6;1,49;F;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,268,2,180,,,180,0,268,2,100%,null,,1,15,Frec Check,1,15,Irinotecan,2437,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3576,2400,,,2.400,0,3576,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,596,400,,,400,0,596,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,596,400,,,400,0,596,0,100%,null,,1,15,Frec Check,1,15,Folinato,118,,;Bevacizumab 100mg polv iny,,263,5,,,5,0,263,0,100%,null,,1,15,Frec Check,1,15,Bevacizumab,3352,,;;;;;;;;;;5;Irinotecan,Fluorouracilo,Fluorouracilo,Folinato,Bevacizumab;Revisar manualmente;Beva,Capec,FOLFIRI,Oxali,PLATINO,Suspend;Tumor maligno del colon, parte no especificada;1
8/10/2024;59;1,5;63;1,67;F;71,7;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,292,3,175,,,175,0,292,3,100%,null,,1,Frec Check,1,PACLItaxel,2385,,;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,483,6,5,,,5,0,483,6,100%,null,,1,Frec Check,1,CARBOplatino,1168,,;;;;;;;;;;;;;2;PACLItaxel,CARBOplatino;Revisar manualmente;CARBO,INF,PACLI,PLATINO,CREA,CREAT;Tumor maligno del endometrio;1
8/10/2024;57;1,7;59;1,67;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1,1,PEMBROlizumab,ONCM74,,;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente; GC ,keynote,PEMBRO,60%;Tumor maligno de la mama, parte no especificada;7
8/10/2024;49;1,58;57;1,6;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,855,0,15,TRUE,,10,0,855,0,100%,null,,1,22,43,Inconsistente, seg˙n proto: 1,1,Bevacizumab,3352,,;;;;;;;;;;;;;;1;Bevacizumab;Revisar manualmente;Beva,CARBO,DOXO,DOXO,Doxo Lipo,PLATINO;Tumor maligno del ovario;1
8/10/2024;48;1,69;59;1,67;F;Sin Cr;;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,41,3,25,TRUE,,20,0,41,8,99%,null,,1,2,3,Frec Check,1,2,3,DOXOrubicina,4838,,;Ifosfamida 1gr (1000mg) Polv Iny,,3300,2000,TRUE,,1.500,0,3340,0,99%,null,,1,2,3,Inconsistente, seg˙n proto: 1,2,3,4,5,1,2,3,4,5,IFOSfamida,845,,;Ifosfamida 2gr (2000mg) Polv Iny,,3300,2000,TRUE,,1.500,0,3340,0,99%,null,,1,2,3,Inconsistente, seg˙n proto: 1,2,3,4,5,1,2,3,4,5,IFOSfamida,2398,,;Mesna 400mg/4mL (100mg/mL) Sol Iny,,2000,2000,,1200,300,0,2004,0,100%,DIVIDIR EN 3 Y ADMON A LAS 0 HORAS- 4 HORAS Y  8 HOARAS DE IFOSFAMIDA,,1,2,3,Inconsistente, seg˙n proto: 1,2,3,4,5,1,2,3,4,5,Mesna,1541,,;;;;;;;;;;;4;DOXOrubicina,IFOSfamida,IFOSfamida,Mesna;Revisar manualmente;MAI,100%;Tumor maligno del tejido conjuntivo y tejido blando, de sitio no especificado;3
8/10/2024;55;1,67;56;1,61;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,128,8,80,,,80,0,128,8,100%,null,,1,8,15,Inconsistente, seg˙n proto: 1,8,1,8,PACLItaxel,2385,,;Trastuzumab 440mg Polv Iny,,448,8,FALSE,,8,0,448,0,100%,440 mg IV, d√≠a 1.,,1,Frec Check,1,TRAStuzumab,2854,,;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,840,840,,,840,0,840,0,100%,null,,1,Frec Check,1,PERTUzumab,ONCM11,,;;;;;;;;;;;;3;PACLItaxel,TRAStuzumab,PERTUzumab;Revisar manualmente;INF,PACLI,PERTU,semanal,TAXANO,TrastU,70%;Tumor maligno de la mama, parte no especificada;1
8/10/2024;43;1,5;65;1,7;F;126,2;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,625,0,625,,,5,0,678,5,92%,null,,1,Frec Check,1,CARBOplatino,1168,,;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,136,80,,,80,0,136,0,100%,null,,1,8,15,Frec Check,1,8,15,PACLItaxel,2385,,;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null,,1,Frec Check,1,PEMBROlizumab,ONCM74,,;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,136,80,,,80,0,136,0,100%,null,,1,8,15,Frec Check,1,8,15,PACLItaxel,2385,,;;;;;;;;;;;4;CARBOplatino,PACLItaxel,PEMBROlizumab,PACLItaxel;Revisar manualmente;CARBO,INF,PACLI,PEMBRO,PLATINO,AUC;Tumor maligno de la mama, parte no especificada;1
8/10/2024;43;1,61;74;1,86;F;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,74,4,40,,,40,0,74,4,100%,null,,3,17,Inconsistente, seg˙n proto: 1,15,1,15,CISplatino,1173,,;Docetaxel 20mg/mL Sol Iny,,74,4,40,FALSE,,40,0,74,4,100%,null,,1,15,Frec Check,1,15,DOCEtaxel,776,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3720,2000,,,2.000,0,3720,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;;;;;;;;;;;;3;CISplatino,DOCEtaxel,Fluorouracilo;Revisar manualmente;#N/D;Tumor maligno del estomago, parte no especificada;7
8/10/2024;63;1,8;55;1,64;M;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,131,2,80,,,80,0,131,2,100%,null,,1,8,15,Frec Check,1,8,15,PACLItaxel,2385,,;Ramucirumab  500mg/50mL (10mg/mL) Sol Iny,,440,0,,,8,0,440,0,100%,dia  1  y 15,,null,Revise recomd, seg˙n proto: 1,15,1,15,Ramucirumab,213617,,;;;;;;;;;;;;;2;PACLItaxel,Ramucirumab;Revisar manualmente;FOLFOX,INF,NIVO,PACLI,RAMUC,20%;Tumor maligno del estomago, parte no especificada;1
8/10/2024;57;1,7;60;1,69;M;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,400,0,400,FALSE,,3,0,180,0,222%,null,,1,Inconsistente, seg˙n proto: 1,15,1,15,NIVOLUmab,ONCM7,,;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,80,80,,,3,0,180,0,44%,null,,1,Inconsistente, seg˙n proto: 1,15,1,15,NIVOLUmab,ONCM69,,;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;5FU,CETU,CisplA,INF,NIVO,PEMBRO,PLATINO,5%,15%;Tumor maligno de la cabeza, cara y cuello;2
9/10/2024;37;1,68;61;1,7;M;Sin Cr;;Sin Cr;Bleomicina sulfato 15 UI (10mg) Polv Iny,,30,0,30,,,30,0,30,0,100%,null,,1,8,15,Frec Check,1,8,15,Bleomicina sulfato,1166,,;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,34,20,,,20,0,34,0,100%,null,,1,2,3,4,5,Frec Check,1,2,3,4,5,CISplatino,1173,,;Etoposido 100mg/5mL (20mg/mL) Sol Iny,,170,100,,,100,0,170,0,100%,null,,1,2,3,4,5,Frec Check,1,2,3,4,5,Etoposido,1179,,;;;;;;;;;;;;3;Bleomicina sulfato,CISplatino,Etoposido;Revisar manualmente; BEP ;Tumor maligno del testiculo descendido;2
9/10/2024;76;1,51;51;1,49;F;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,268,2,180,,,180,0,268,2,100%,null,,1,15,Frec Check,1,15,Irinotecan,2437,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3576,2400,,,2.400,0,3576,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,596,400,,,400,0,596,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,596,400,,,400,0,596,0,100%,null,,1,15,Frec Check,1,15,Folinato,118,,;Bevacizumab 100mg polv iny,,255,5,,,5,0,255,0,100%,null,,1,15,Frec Check,1,15,Bevacizumab,3352,,;;;;;;;;;;5;Irinotecan,Fluorouracilo,Fluorouracilo,Folinato,Bevacizumab;Revisar manualmente;Beva,FOLFIRI,FOLFOX,INF,AJUSTE,AJUST,Suspend;Tumor maligno del colon, parte no especificada;5
9/10/2024;36;1,6;59;1,64;F;Sin Cr;;Sin Cr;Bevacizumab 100mg polv iny,,600,0,600,,,10,0,590,0,102%,null,,1,15,30,45,Inconsistente, seg˙n proto: 1,15,1,15,Bevacizumab,3352,,;;;;;;;;;;;;;;1;Bevacizumab;Revisar manualmente;Beva;Lesion de sitios contiguos del encefalo y otras partes del sistema nervioso central;4
9/10/2024;72;1,68;76;1,91;M;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,95,5,50,FALSE,,50,0,95,5,100%,null,TRUE,1,8,29,33,Inconsistente, seg˙n proto: 1,8,29,36,1,8,29,36,CISplatino,1173,,;Etoposido 100mg/5mL (20mg/mL) Sol Iny,,95,5,50,,,50,0,95,5,100%,null,FALSE,1,2,3,4,5,29,30,31,32,33,Frec Check,1,2,3,4,5,29,30,31,32,33,Etoposido,1179,,;;;;;;;;;;;;;2;CISplatino,Etoposido;Revisar manualmente;#N/D;Tumor maligno de los bronquios o del pulmon, parte no especificada;1
9/10/2024;70;1,63;59;1,65;M;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3.960,0,2.400,,,2.400,0,3960,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,660,400,,,400,0,660,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,660,400,,,400,0,660,0,100%,null,,1,15,Frec Check,1,15,Folinato,118,,;;;;;;;;;;;;3;Fluorouracilo,Fluorouracilo,Folinato;Revisar manualmente;EMA CO,FOLFOX,INF;Tumor maligno del recto;1
9/10/2024;68;1,62;48;1,47;M;Sin Cr;;Sin Cr;Nivolumab 100mg/10mL (10mg/mL) Sol Iny,,200,0,200,,,3,0,144,0,139%,240 mg IV dias 1 y 15,,1,15,Frec Check,1,15,NIVOLUmab,ONCM7,,;Nivolumab 40mg/4mL (10mg/mL) Sol Iny,,40,40,,,3,0,144,0,28%,240 mg IV dias 1 y 15,,1,15,Frec Check,1,15,NIVOLUmab,ONCM69,,;;;;;;;;;;;;;2;NIVOLUmab,NIVOLUmab;Revisar manualmente;INF,IPILI,MAYO ,NIVO, RT ;Melanoma maligno de piel, sitio no especificado;6
9/10/2024;72;1,7;53;1,57;F;33,2;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,294,4,5,,,5,0,291,2,101%,,,,,1,Frec Check,1,CARBOplatino,1168,,;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,267,75,175,,,175,0,274,8,97%,null,,1,Frec Check,1,PACLItaxel,2385,,;;;;;;;;;;;;;2;CARBOplatino,PACLItaxel;Revisar manualmente;CARBO,PACLI,TAXOL;Tumor maligno del ovario;4
9/10/2024;57;1,55;61;1,66;F;Sin Cr;;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,119,5,80,,,80,0,132,8,90%,null,,1,8,15,22,Frec Check,1,8,15,22,PACLItaxel,2385,,;;;;;;;;;;;;;;1;PACLItaxel;Revisar manualmente;INF,PACLI,semanal,TAXANO,AJUST,10%,20%,80%;Tumor maligno de la mama, parte no especificada;3
9/10/2024;41;1,42;44;1,35;F;87,2;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,515,0,515,,5,00,6,0,560,8,92%,,,1,Frec Check,1,CARBOplatino,1168,,;Docetaxel 20mg/mL Sol Iny,,86,06,75,,,75,0,101,3,85%,null,,1,Frec Check,1,DOCEtaxel,776,,;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,420,0,420,0,100%,null,,1,Frec Check,1,PERTUzumab,ONCM11,,;Trastuzumab 440mg Polv Iny,,264,6,,,6,0,264,0,100%,null,,1,Frec Check,1,TRAStuzumab,2854,,;;;;;;;;;;;4;CARBOplatino,DOCEtaxel,PERTUzumab,TRAStuzumab;Revisar manualmente;INF, SC,TCHP ,AJUSTE,AJUST,90%,100%;Tumor maligno de la mama, parte no especificada;6
9/10/2024;53;1,53;46;1,41;F;63,8;;Sin Cr;Docetaxel 20mg/mL Sol Iny,,105,8,75,,,75,0,105,8,100%,null,,1,Frec Check,1,DOCEtaxel,776,,;Trastuzumab 440mg Polv Iny,,276,6,,,6,0,276,0,100%,null,,1,Frec Check,1,TRAStuzumab,2854,,;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,420,0,420,0,100%,null,,1,Frec Check,1,PERTUzumab,ONCM11,,;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,444,25,5,TRUE,,6,0,444,2,100%,null,,1,Frec Check,1,CARBOplatino,1168,,;;;;;;;;;;;4;DOCEtaxel,TRAStuzumab,PERTUzumab,CARBOplatino;Revisar manualmente;CARBO,DOCE,INF,PERTU,PLATINO,TrastU,40%,80%,100%;Tumor maligno de la mama, parte no especificada;1
9/10/2024;53;1,57;50;1,49;F;Sin Cr;;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3.576,0,2.400,,,2.400,0,3576,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,596,400,,,400,0,596,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Calcio folinato 50mg Polv Iny,,596,400,,,400,0,596,0,100%,null,,1,15,Frec Check,1,15,Folinato,118,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,126,65,85,,,85,0,126,7,100%,null,,1,15,Frec Check,1,15,OXALIplatino,4172,,;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,223,5,150,TRUE,,180,0,223,5,100%,null,,1,15,Frec Check,1,15,Irinotecan,2437,,;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,Folinato,OXALIplatino,Irinotecan;Revisar manualmente;FOLFIRI,FOLFIRINOX,Irino,CREA,CREAT;Tumor maligno del pancreas, parte no especificada;2
9/10/2024;78;1,55;74;1,84;F;78,5;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,310,5,5,,,5,0,517,5,60%,REC15022021-1,,1,Frec Check,1,CARBOplatino,1168,,;Doxorrubicina liposomal 20mg/10mL (2mg/mL) Susp Iny,,44,16,40,TRUE,,30,0,73,6,60%,null,,1,Frec Check,1,DOXOrubicina_LIPOSOMAL,2423,,;;;;;;;;;;;;;2;CARBOplatino,DOXOrubicina_LIPOSOMAL;Revisar manualmente;CARBO,PLATINO,TAXOL;Tumor maligno del ovario;2
9/10/2024;67;1,57;55;1,57;F;Sin Cr;;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,TRUE,548,0,400,FALSE,,400,0,628,0,87%,null,,1,15,Frec Check,1,15,Folinato,118,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,TRUE,548,400,,,400,0,628,0,87%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,282,6,180,,,180,0,282,6,100%,null,,1,15,Frec Check,1,15,Irinotecan,2437,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3768,2400,,,2.400,0,3768,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;;;;;;;;;;;4;Folinato,Fluorouracilo,Irinotecan,Fluorouracilo;Revisar manualmente;FOLFIRI,FOLFOX,INF,Irino,MAYO ;Tumor maligno del colon, parte no especificada;2
9/10/2024;63;1,57;60,8;1,66;F;Sin Cr;;Sin Cr;Gemcitabina 1000mg/100mL (10mg/mL) Sol Iny,,1.245,0,1.000,,,1.000,0,1660,0,75%,null,,1,8,15,Frec Check,1,8,15,GEMcitabina,1378,,;Nab-Paclitaxel 100mg Polv Iny,,155,62,125,,,125,0,207,5,75%,null,,1,8,15,Frec Check,1,8,15,Paclitaxel LIGADO a ALBUMINA,13738735,,;;;;;;;;;;;;;2;GEMcitabina,Paclitaxel LIGADO a ALBUMINA;Revisar manualmente;#N/D;Tumor maligno del pancreas, parte no especificada;4
9/10/2024;64;1,66;52;1,55;F;47,6;;Sin Cr;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,330,8,5,,,5,0,363,0,91%,REC15022021-3,,1,Frec Check,1,CARBOplatino,1168,,;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null,,1,Frec Check,1,PEMBROlizumab,ONCM74,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,1550,1000,TRUE,,5,0,1550,0,100%,null,,1,2,3,4,Frec Check,1,2,3,4,Fluorouracilo,1181,,;;;;;;;;;;;;3;CARBOplatino,PEMBROlizumab,Fluorouracilo;Revisar manualmente; RT ,5%,15%;Tumor maligno de la amigdala, parte no especificada;4
9/10/2024;57;1,54;78,7;1,9;F;Sin Cr;0,67;115,1;Carboplatino 450mg/45mL (10mg/mL) Sol Iny,,165,0,165,,1,50,2,0,183,5,90%,null,,1,8,15,Frec Check,1,8,15,CARBOplatino,1168,,;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,152,80,TRUE,,60,0,152,0,100%,null,,1,8,15,Frec Check,1,8,15,PACLItaxel,2385,,;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null,,1,Frec Check,1,PEMBROlizumab,ONCM74,,;;;;;;;;;;;;3;CARBOplatino,PACLItaxel,PEMBROlizumab;Revisar manualmente;CARBO,CICLOF,DOXO,DOXO,INF,keynote,PACLI,PEMBRO,PLATINO, SC,AJUST,5%,95%,AUC;Tumor maligno de la mama, parte no especificada;3
9/10/2024;48;1,55;66;1,73;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,22,Inconsistente, seg˙n proto: 1,1,PEMBROlizumab,ONCM74,,;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;Suspend;Tumor maligno de la mama, parte no especificada;8
9/10/2024;41;1,7;70;1,83;F;Sin Cr;;Sin Cr;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,0,200,,,200,0,200,0,100%,null,,1,Frec Check,1,PEMBROlizumab,ONCM74,,;;;;;;;;;;;;;;1;PEMBROlizumab;Revisar manualmente;INF,PEMBRO;Tumor maligno del endometrio;12
9/10/2024;73;1,64;65;1,74;M;Sin Cr;;Sin Cr;Trastuzumab 440mg Polv Iny,,260,0,4,,,4,0,260,0,100%,null,,1,15,Frec Check,1,15,TRAStuzumab,2854,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4176,2400,,,2.400,0,4176,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,696,400,,,400,0,696,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,696,400,,,400,0,696,0,100%,null,,1,15,Frec Check,1,15,Folinato,118,,;;;;;;;;;;;4;TRAStuzumab,Fluorouracilo,Fluorouracilo,Folinato;Revisar manualmente;FOLFOX,TrastU;Tumor maligno del estomago, parte no especificada;5
9/10/2024;59;1,6;64;1,72;M;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,309,6,180,,,180,0,309,6,100%,null,,1,15,Frec Check,1,15,Irinotecan,2437,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4128,2400,,,2.400,0,4128,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,688,400,,,400,0,688,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,688,400,,,400,0,688,0,100%,null,,1,15,Frec Check,1,15,Folinato,118,,;Bevacizumab 100mg polv iny,,320,5,,,5,0,320,0,100%,null,,1,15,Frec Check,1,15,Bevacizumab,3352,,;;;;;;;;;;5;Irinotecan,Fluorouracilo,Fluorouracilo,Folinato,Bevacizumab;Revisar manualmente;FOLFIRI,FOLFOX,GRAMONT,PANItU;Tumor maligno del colon, parte no especificada;4
9/10/2024;51;1,67;80;1,96;M;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,159,2,80,TRUE,,70,0,156,8,102%,null,,1,Frec Check,1,CISplatino,1173,,;Gemcitabina 1000mg/100mL (10mg/mL) Sol Iny,,1990,1000,,,1.000,0,1960,0,102%,null,,1,8,Inconsistente, seg˙n proto: 1,8,15,1,8,15,GEMcitabina,1378,,;;;;;;;;;;;;;2;CISplatino,GEMcitabina;Revisar manualmente;CisplA,GEMci,PLATINO;Tumor maligno de la nasofaringe, parte no especificada;2
9/10/2024;45;1,75;82;2,02;M;Sin Cr;;Sin Cr;Irinotecan 100mg/5mL (20mg/mL) Sol Iny,,363,6,180,,,180,0,363,6,100%,null,,1,15,Frec Check,1,15,Irinotecan,2437,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4848,2400,,,2.400,0,4848,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,808,400,,,400,0,808,0,100%,null,,1,15,Frec Check,1,15,Fluorouracilo,1181,,;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,808,400,,,400,0,808,0,100%,null,,1,15,Frec Check,1,15,Folinato,118,,;Cetuximab 100mg/20mL (5mg/mL) Sol Iny,,1010,500,TRUE,,400,0,1010,0,100%,null,,1,15,Inconsistente, seg˙n proto: 1,1,CETUximab,3865,,;;;;;;;;;;5;Irinotecan,Fluorouracilo,Fluorouracilo,Folinato,CETUximab;Revisar manualmente;FOLFIRI,INF;Tumor maligno del recto;2
9/10/2024;39;1,7;67;1,79;M;Sin Cr;;Sin Cr;Cisplatino 50mg/50mL (1mg/mL) Sol Iny,,134,3,75,,,75,0,134,3,100%,75 mg ISC los d√≠as 1,,1,Frec Check,1,CISplatino,1173,,;Docetaxel 20mg/mL Sol Iny,,134,25,75,,,75,0,134,3,100%,75 mg ISC,,1,Frec Check,1,DOCEtaxel,776,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,1342,5,750,TRUE,,75,0,1342,5,100%,null,,1,Inconsistente, seg˙n proto: 1,2,3,4,5,1,2,3,4,5,Fluorouracilo,1181,,;;;;;;;;;;;;3;CISplatino,DOCEtaxel,Fluorouracilo;Revisar manualmente;INF,30%,70%;Tumor maligno de la cabeza, cara y cuello;3
